767751445	O
ELMVH	O

45154940	O

6035801	O

12/6/2005	O
12:00:00	O
AM	O

COPD	B-disease
exacerbation	I-disease
with	O
NSTEMI	B-disease

DIS	O

Admission	O
Date	O
:	O

12/06/2005	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

12/10/2005	O

******	O
FINAL	O
DISCHARGE	O
ORDERS	O
******	O

SCHOELLSULLKOTEFONG	O
,	O
MAUSTINIE	O

161-66-98-5	O
W53	O

Room	O
:	O

66R-249	O

Service	O
:	O

MED	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

12/09/05	O
AT	O
08:00	O
PM	O

CONTINGENT	O
UPON	O

Attending	O
evaluation	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

FREIERMFUSC	O
,	O
SHAIGAYDONA	O
,	O
M.D.	O
,	O
M.DIV.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Home	O
w/	O
services	O

DISCHARGE	O
MEDICATIONS	O
:	O

VITAMIN	O
C	O
(	O
ASCORBIC	O
ACID	O
)	O
1,000	O
MG	O
PO	O
QD	O
ECASA	O
(	O
ASPIRIN	O
ENTERIC	O
COATED	O
)	O
81	O
MG	O
PO	O
QD	O
CALCIUM	O
CARBONATE	O
(	O
500	O
MG	O
ELEMENTAL	O
CA++	O
)	O
500	O
MG	O
PO	O
BID	O
PREDNISONE	O
20	O
MG	O
PO	O
QAM	O
Starting	O
Today	O
(	O
12/09	O
)	O

Instructions	O
:	O

taper	O
over	O
2	O
weeks	O
MULTIVITAMIN	O
THERAPEUTIC	O
(	O
THERAPEUTIC	O
MULTIVI	O
...	O
)	O
5	O
MILLILITERS	O
PO	O
QD	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
12/07/05	O
by	O
BELB	O
,	O
BRITHERL	O
,	O
M.D.	O
on	O
order	O
for	O
ATORVASTATIN	O
PO	O
(	O
ref	O
#	O
33823759	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

NIACIN	O
,	O
VIT	O
.	O

B-3	O
and	O
ATORVASTATIN	O
CALCIUM	O

Reason	O
for	O
override	O
:	O

md	O
aware	O

Previous	O
override	O
information	O
:	O

Override	O
added	O
on	O
12/06/05	O
by	O
BELB	O
,	O
BRITHERL	O
,	O
M.D.	O
on	O
order	O
for	O
ZOCOR	O
PO	O
(	O
ref	O
#	O
33033281	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

NIACIN	O
,	O
VIT	O
.	O

B-3	O
and	O
SIMVASTATIN	O

Reason	O
for	O
override	O
:	O

md	O
aware	O

FLOVENT	O
(	O
FLUTICASONE	O
PROPIONATE	O
)	O
44	O
MCG	O
INH	O
BID	O
Starting	O
Today	O
(	O
12/09	O
)	O
LEVAQUIN	O
(	O
LEVOFLOXACIN	O
)	O
500	O
MG	O
PO	O
QD	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Administer	O
iron	O
products	O
a	O
minimum	O
of	O
2	O
hours	O
before	O
or	O
after	O
a	O
levofloxacin	O
or	O
ciprofloxacin	O
dose	O
dose	O

If	O
on	O
tube	O
feeds	O
,	O
please	O
cycle	O
(	O
hold	O
1	O
hr	O
before	O
to	O
2	O
hr	O
after	O
)	O

Take	O
2	O
hours	O
before	O
or	O
2	O
hours	O
after	O
dairy	O
products	O
.	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
12/06/05	O
by	O
BELB	O
,	O
BRITHERL	O
,	O
M.D.	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SALMETEROL	O
XINAFOATE	O
and	O
LEVOFLOXACIN	O

Reason	O
for	O
override	O
:	O

md	O
aware	O

SEREVENT	O
DISKUS	O
(	O
SALMETEROL	O
DISKUS	O
)	O
1	O
PUFF	O
INH	O
BID	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
12/06/05	O
by	O
BELB	O
,	O
BRITHERL	O
,	O
M.D.	O
on	O
order	O
for	O
LEVAQUIN	O
PO	O
(	O
ref	O
#	O
57095042	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SALMETEROL	O
XINAFOATE	O
and	O
LEVOFLOXACIN	O

Reason	O
for	O
override	O
:	O

md	O
aware	O

LISINOPRIL	O
5	O
MG	O
PO	O
QD	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
12/08/05	O
by	O
:	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

POTASSIUM	O
CHLORIDE	O
and	O
LISINOPRIL	O

Reason	O
for	O
override	O
:	O

md	O
aware	O

TOPROL	O
XL	O
(	O
METOPROLOL	O
SUCCINATE	O
EXTENDED	O
RELEASE	O
)	O
25	O
MG	O
PO	O
QD	O
Starting	O
Today	O
(	O
12/09	O
)	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
consistently	O
with	O
meals	O
or	O
on	O
empty	O
stomach	O
.	O

ALENDRONATE	O
70	O
MG	O
PO	O
QWEEK	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Give	O
on	O
an	O
empty	O
stomach	O
(	O
give	O
1hr	O
before	O
or	O
2hr	O
after	O
food	O
)	O

Take	O
with	O
8	O
oz	O
of	O
plain	O
water	O
ALBUTEROL	O
INHALER	O
2	O
PUFF	O
INH	O
QID	O
Starting	O
Today	O
(	O
12/09	O
)	O
ATROVENT	O
INHALER	O
(	O
IPRATROPIUM	O
INHALER	O
)	O
2	O
PUFF	O
INH	O
QID	O
Starting	O
Today	O
(	O
12/09	O
)	O

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Gento	O
Yaneslaunt	O
03/17/06	O
scheduled	O
,	O

Arois	O
Maillliepslighsint	O
02/18/06	O
scheduled	O
,	O

ALLERGY	O
:	O

NKA	B-disease
ADMIT	O
DIAGNOSIS	O
:	O

COPD	B-disease
exacerbation	I-disease

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
COPD	B-disease
exacerbation	I-disease
with	O
NSTEMI	B-disease

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

severe	B-disease
COPD	I-disease
Pneumonia	B-disease
recovering	O
alcoholic	O
recovering	O
barbituate	O
abuse	O
unexplained	B-disease
hct	I-disease
drop	I-disease
poor	B-disease
appetite	I-disease
x	O
1	O
week	O

STEROID	B-disease
PSYCHOSIS	I-disease
NO	O
BENZOS	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

none	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

Heparin	O
while	O
having	O
a	B-disease
demand	I-disease
ischemic	I-disease
episode	I-disease

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

*	O
CC	O
:	O

82F	O
with	O
COPD	B-disease
exacerpation	I-disease

*	O
DDx	O
:	O

COPD	B-disease
exacerpation	I-disease
with	O
troponin	B-disease
leak	I-disease
likely	O
NSTEMI	B-disease
secondary	O
to	O
demand	B-disease
ischemia	I-disease
.	O

*	O
HPI	O
:	O

4	O
days	O
of	O
worsening	B-disease
SOB	I-disease
with	O
sore	B-disease
throat	I-disease
and	O
cough	B-disease
productive	I-disease
of	I-disease
yellow	I-disease
/	I-disease
green	I-disease
sputum	I-disease
.	O

Fatigue	B-disease
secondary	O
to	O
worsening	B-disease
dyspnea	I-disease
.	O

took	O
Prednisone	O
40	O
at	O
home	O
and	O
presented	O
to	O
ED	O
where	O
found	O
to	O
have	O
1mm	B-disease
lateral	I-disease
ST	I-disease
depressions	I-disease
and	O
slight	B-disease
troponin	I-disease
and	I-disease
MB	I-disease
leak	I-disease
.	O

no	O
N	B-disease
/	O
V/HA	B-disease
/	O
D	B-disease
no	O
sweats	B-disease
,	O
no	O
chills	B-disease
,	O
of	O
abdominal	B-disease
pain	I-disease
,	O
no	O
chest	B-disease
pain	I-disease
,	O
no	O
pleuricy	B-disease
,	O
no	O
LEE	B-disease
,	O
no	O
paresthesias	B-disease
,	O
no	O
numbness	B-disease
,	O
no	O
shoulder	B-disease
pain	I-disease
,	O
no	O
jaw	B-disease
pain	I-disease
.	O

*	O
PMH	O
:	O

COPD	B-disease
(	O
s	O
/	O
p	O
lung	O
resection	O
FEV1	O
25%	O
)	O
,	O
chronic	B-disease
pericardial	I-disease
effusion	I-disease
,	O
PVD	B-disease
,	O
R	B-disease
renal	I-disease
artery	I-disease
stenosis	I-disease
,	O
osteoporosis	B-disease
,	O
presbylaryngis	B-disease

**************	O
PATIENT	O
STATUS	O
********************	O

98.4	O
,	O
94	O
,	O
22	O
,	O
120/96	O
,	O
98%	O
on	O
2L.	O
NAD	B-disease
,	O
using	O
scalenes	O
,	O
AT	O
/	O
NC	O
,	O
no	O
oral	B-disease
lesions	I-disease
,	O
Bibasilar	B-disease
rales	I-disease
otherwise	O
clear	O
,	O
good	O
air	O
movement	O
,	O
RRR	O
,	O
no	O
MRG	O
,	O
NTND	O
+BS	O
,	O
no	O
CCE	O
,	O
2+	O
DPs	O
.	O

Guiac	O
negative	O

***************	O
STUDIES	O
***********************	O

LABS	O
:	O

WBC	O
12.91	O

CXR	O
:	O

small	B-disease
pleural	I-disease
effusion	I-disease
,	O
flat	O
diaphrams	O
no	O
acute	B-disease
changes	I-disease

Echo	O
-	O

***********	O
HOSPITAL	O
COURSE	O
****************	O

1.	O
CV	O
:	O

likely	O
having	O
a	B-disease
NSTEMI	I-disease
secondary	O
to	O
demand	B-disease
.	O

Cardiac	O
enzymes	O
trending	O
down	O
on	O
12.7.05	O
,	O
anticoagulated	O
while	O
having	O
leak	O
.	O

I	O
-	O
heparin	O
for	O
PTT	B-disease
50-70	O
durin	O
enzyme	B-disease
leak	I-disease
.	O
metoprolol	O
12	O
QID	O
.	O

Cardiac	O
enzymes	O
BID	O
while	O
actively	O
having	O
leak	B-disease
,	O
ASA	O

R	O
-	O
monitor	O
on	O
telemetry	O

P	O
-	O
no	O
evidence	B-disease
of	I-disease
failure	I-disease

-	O
Echo	O
:	O

2.	O
COPD	O
:	O

likely	O
exacerbation	B-disease
possibly	O
from	O
URI	B-disease
/	O
pneumonia	B-disease
.	O

Aputum	O
cultures	O
pending	O
.	O

Treated	O
with	O
:	O

atrovent	O
NEB	O
QID	O
,	O
albuterol	O
Neb	O
QID	O
,	O
ipratropium	O
NEB	O
BID	O
,	O
flovent	O
INH	O
BID	O
,	O
Serevent	O
INH	O
BID	O
,	O
and	O
prednisone	O
30	O
QD	O
taper	O
.	O

Levaquin	O
500	O
QD	O
empirically	O

3.	O
GI	O
:	O

PPI	O
prophylaxis	O

4.	O
FEN	O
:	O

MVI	B-disease
,	O
Cardiac	O
diet	O

ADDITIONAL	O
COMMENTS	O
:	O

Please	O
make	O
an	O
appointment	O
to	O
see	O
dr.	O
Arois	O
Maillliepslighsint	O
within2-3	O
weeks	O
after	O
you	O
leave	O
the	O
hospital	O

Please	O
taper	O
off	O
your	O
prednisone	O
within	O
2	O
weeks	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

PT	O
:	O

please	O
evaluate	O
ambutlation	O
ability	O
and	O
O2	O
requirement	O

Please	O
evaluate	O
resolution	O
of	O
cardiac	B-disease
troponin	I-disease
leak	I-disease
and	O
stable	O
EKG	O
.	O

Please	O
evaluate	O
resolution	O
of	O
COPD	B-disease
exacerbation	I-disease
and	O
need	O
for	O
any	O
further	O
antibiocis	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

BELB	O
,	O
BRITHERL	O
,	O
M.D.	O
(	O
IL35	O
)	O
12/10/05	O
02:50	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2009-03-27	O

Discharge	O
Date	O
:	O

2009-04-03	O

Date	O
of	O
Birth	O
:	O

1960-03-06	O

Sex	O
:	O

F	O

Service	O
:	O

GYNECOLOGY	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
49-year-old	O
gravida	O
III	O
,	O
para	O
II	O
,	O
who	O
was	O
sent	O
from	O
her	O
primary	O
care	O
physician	O
's	O
office	O
secondary	O
to	O
lower	B-disease
abdominal	I-disease
pain	I-disease
.	O

The	O
patient	O
is	O
status	O
post	O
uterine	O
artery	O
embolization	O
on	O
2009-01-07	O
secondary	O
to	O
fibroids	B-disease
.	O

She	O
has	O
had	O
continuing	B-disease
vaginal	I-disease
discharge	I-disease
,	O
and	O
was	O
diagnosed	O
with	O
bacterial	B-disease
vaginosis	I-disease
one	O
day	O
prior	O
to	O
admission	O
,	O
and	O
was	O
given	O
a	O
prescription	O
for	O
Flagyl	O
.	O

She	O
noted	O
increasing	B-disease
abdominal	I-disease
pain	I-disease
two	O
days	O
prior	O
to	O
admission	O
,	O
which	O
became	O
more	O
severe	O
on	O
the	O
day	O
prior	O
to	O
admission	O
.	O

She	O
went	O
to	O
her	O
primary	O
care	O
physician	O
's	O
office	O
on	O
the	O
day	O
of	O
admission	O
complaining	O
of	O
abdominal	B-disease
pain	I-disease
,	O
which	O
she	O
stated	O
was	O
constant	O
but	O
intermittently	O
sharper	O
at	O
times	O
.	O

The	O
location	O
was	O
variable	O
.	O

She	O
also	O
complained	O
of	O
some	B-disease
loose	I-disease
stools	I-disease
on	O
the	O
day	O
of	O
admission	O
,	O
no	O
nausea	B-disease
or	O
vomiting	B-disease
.	O

Her	O
temperature	O
was	O
100.4	O
in	O
the	O
office	O
,	O
and	O
she	O
had	O
no	O
chills	B-disease
.	O

She	O
was	O
sent	O
for	O
a	O
CT	O
scan	O
of	O
her	O
abdomen	O
,	O
which	O
revealed	O
fluid	B-disease
and	O
question	O
of	O
gas	B-disease
in	I-disease
the	I-disease
endometrial	I-disease
cavity	I-disease
,	O
and	O
she	O
was	O
sent	O
to	O
Pinewood	O
,	O
Norfolk	O
for	O
treatment	O
and	O
admission	O
.	O

PAST	O
OBSTETRICAL	O
HISTORY	O
:	O

Cesarean	O
section	O
x	O
2	O
,	O
spontaneous	B-disease
abortion	I-disease
x	O
1	O
.	O

PAST	O
GYNECOLOGIC	O
HISTORY	O
:	O

Last	O
menstrual	O
period	O
2009-02-21	O
.	O

Some	B-disease
spotting	I-disease
on	O
the	O
day	O
prior	O
to	O
admission	O
,	O
but	O
not	O
a	O
normal	O
period	O
.	O

Periods	O
regular	O
.	O

Lupron	O
x	O
three	O
months	O
prior	O
to	O
embolization	O
.	O

Fibroid	B-disease
uterus	I-disease
status	O
post	O
embolization	O
on	O
2009-01-07	O
.	O

Dilatation	O
and	O
curettage	O
x	O
1	O
for	O
SAB	B-disease
.	O

History	O
of	O
herpes	B-disease
simplex	I-disease
virus	I-disease
,	O
last	O
outbreak	O
in	O
2000	O
.	O

No	O
history	O
of	O
abnormal	B-disease
Pap	I-disease
smears	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

None	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Cesarean	O
section	O
x	O
2	O
,	O
dilatation	O
and	O
curettage	O
x	O
1	O
,	O
neck	O
fusion	O
after	O
motor	O
vehicle	O
accident	O
,	O
shoulder	O
surgery	O
after	O
motor	O
vehicle	O
accident	O
.	O

MEDICATIONS	O
:	O

Flagyl	O
.	O

ALLERGIES	O
:	O

None	O
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
smoking	O
,	O
alcohol	O
or	O
drugs	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Temperature	O
100.4	O
,	O
pulse	O
108	O
,	O
respirations	O
20	O
,	O
blood	O
pressure	O
110/70	O
,	O
oxygen	O
saturation	O
100%	O
on	O
room	O
air	O
.	O

In	O
general	O
,	O
she	O
was	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

Her	O
abdomen	O
was	O
notable	O
for	O
voluntary	B-disease
guarding	I-disease
but	O
no	O
involuntary	B-disease
guarding	I-disease
or	O
rebound	B-disease
,	O
mild	B-disease
right	I-disease
lower	I-disease
quadrant	I-disease
tenderness	I-disease
greater	O
than	O
left	O
lower	O
quadrant	O
,	O
nondistended	B-disease
.	O

Her	O
pelvic	O
examination	O
was	O
notable	O
for	O
some	B-disease
brownish	I-disease
discharge	I-disease
.	O

Her	O
uterus	O
and	O
adnexa	O
were	O
difficult	O
to	O
assess	O
secondary	O
to	O
voluntary	B-disease
tensing	I-disease
of	I-disease
her	I-disease
abdomen	I-disease
.	O

ASSESSMENT	O
:	O

This	O
is	O
a	O
49-year-old	O
gravida	O
III	O
,	O
para	O
II	O
,	O
status	O
post	O
uterine	O
artery	O
embolization	O
on	O
2009-01-07	O
due	O
to	O
uterine	B-disease
fibroids	I-disease
,	O
with	O
continued	B-disease
abdominal	I-disease
pain	I-disease
and	O
CT	O
scan	O
revealing	O
fluid	B-disease
and	I-disease
gas	I-disease
in	I-disease
the	I-disease
endometrial	I-disease
cavity	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
and	O
was	O
initially	O
started	O
on	O
intravenous	O
ampicillin	O
,	O
gentamicin	O
and	O
clindamycin	O
.	O

Her	O
initial	O
white	O
blood	O
cell	O
count	O
was	O
11.3	O
,	O
with	O
a	O
normal	O
differential	O
.	O

Her	O
sedimentation	O
rate	O
was	O
elevated	B-disease
at	O
110	O
.	O

Her	O
electrolytes	O
were	O
within	O
normal	O
limits	O
.	O

She	O
was	O
maintained	O
on	O
intravenous	O
antibiotics	O
.	O

On	O
hospital	O
day	O
number	O
three	O
,	O
her	O
blood	O
cultures	O
came	O
back	O
positive	B-disease
in	O
the	O
anaerobic	O
culture	O
for	O
gram-positive	B-disease
cocci	I-disease
in	I-disease
pairs	I-disease
and	I-disease
clusters	I-disease
.	O

Further	O
identification	O
revealed	O
staphylococcus	B-disease
coag-negative	I-disease
,	O
which	O
was	O
sensitive	O
to	O
gentamicin	O
and	O
clindamycin	O
.	O

She	O
was	O
continued	O
on	O
her	O
antibiotics	O
,	O
and	O
was	O
afebrile	B-disease
until	O
hospital	O
day	O
number	O
five	O
,	O
when	O
she	O
had	O
a	B-disease
temperature	I-disease
spike	I-disease
to	O
102.3	O
.	O

Repeat	O
blood	O
cultures	O
were	O
sent	O
.	O

Her	O
white	O
blood	O
cell	O
count	O
was	O
12.8	O
,	O
with	O
a	O
normal	O
differential	O
.	O

At	O
this	O
time	O
,	O
an	O
Infectious	O
Disease	O
consult	O
was	O
obtained	O
,	O
and	O
the	O
recommendation	O
was	O
to	O
discontinue	O
the	O
ampicillin	O
,	O
gentamicin	O
and	O
clindamycin	O
,	O
and	O
start	O
her	O
on	O
intravenous	O
Unasyn	O
.	O

She	O
underwent	O
a	O
pelvic	O
ultrasound	O
and	O
an	O
abdomen	O
and	O
pelvis	O
CT	O
,	O
which	O
revealed	O
continued	B-disease
air	I-disease
in	I-disease
the	I-disease
endometrial	I-disease
cavity	I-disease
vs.	O
in	O
the	B-disease
fundal	I-disease
fibroid	I-disease
.	O

Discussion	O
was	O
had	O
at	O
this	O
time	O
with	O
the	O
patient	O
regarding	O
whether	O
or	O
not	O
this	O
represented	O
an	B-disease
infected	I-disease
abscess	I-disease
vs.	O
post-surgical	B-disease
change	I-disease
.	O

Extensive	O
discussion	O
was	O
held	O
,	O
and	O
second	O
opinion	O
was	O
obtained	O
regarding	O
the	O
need	O
for	O

possible	O
drainage	O
of	O
the	B-disease
abscess	I-disease
vs.	O
hysterectomy	O
.	O

The	O
patient	O
requested	O
an	O
outside	O
second	O
opinion	O
,	O
as	O
she	O
was	O
reluctant	O
to	O
undergo	O
hysterectomy	O
at	O
this	O
time	O
.	O

She	O
was	O
discharged	O
to	O
home	O
on	O
hospital	O
day	O
number	O
eight	O
,	O
on	O
oral	O
antibiotics	O
.	O

The	O
patient	O
was	O
to	O
have	O
a	O
repeat	O
CT	O
scan	O
in	O
one	O
week	O
.	O

She	O
was	O
also	O
to	O
obtain	O
a	O
second	O
opinion	O
regarding	O
the	O
question	O
of	O
possible	O
surgical	O
management	O
.	O

Claude	O
U	O
Bolanos	O
,	O
M.D.	O

95-182	O

Dictated	O
By	O
:	O
William	O
MP	O
Lajoie	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2009-04-02	O
22:09	O

T	O
:	O
2009-04-03	O
01:26	O

JOB	O
#:	O

61261	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Suzanne	O
Simpson	O
on	O
:	O
FRI	O
2009-04-24	O
12:48	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2010-05-17	O

Discharge	O
Date	O
:	O

2010-05-29	O

Date	O
of	O
Birth	O
:	O

1923-11-09	O

Sex	O
:	O

F	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
an	O
86-year-old	O
female	O
with	O
a	O
past	O
medical	O
history	O
of	O
diabetes	B-disease
and	O
hypertension	B-disease
who	O
presented	O
to	O
the	O
Emergency	O
Department	O
with	O
a	O
two	O
day	O
history	O
of	O
shortness	B-disease
of	I-disease
breath	I-disease
and	O
easy	B-disease
fatigability	I-disease
.	O

She	O
also	O
noted	O
increased	B-disease
dyspnea	I-disease
on	O
exertion	O
.	O

Prior	O
to	O
this	O
patient	O
could	O
walk	O
upstairs	O
but	O
now	O
cannot	O
.	O

She	O
denies	O
chest	B-disease
pain	I-disease
,	O
orthopnea	B-disease
,	O
paroxysmal	B-disease
nocturnal	I-disease
dyspnea	I-disease
.	O

However	O
,	O
the	O
patient	O
has	O
noted	O
some	B-disease
abdominal	I-disease
pain	I-disease
,	O
intermittent	O
times	O
a	O
couple	O
of	O
days	O
,	O
none	O
on	O
the	O
day	O
of	O
admission	O
.	O

Denied	O
nausea	B-disease
,	O
vomiting	B-disease
,	O
diaphoresis	B-disease
,	O
bowel	B-disease
movement	I-disease
changes	I-disease
.	O

She	O
has	O
noted	O
increased	B-disease
urinary	I-disease
frequency	I-disease
.	O

Denies	O
fever	B-disease
or	O
chills	B-disease
.	O

Of	O
note	O
,	O
she	O
has	O
had	O
recent	O
medication	O
changes	O
which	O
included	O
discontinuing	O
Diovan	O
and	O
starting	O
terazosin	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Diabetes	B-disease
mellitus	I-disease
.	O

2.	O
Hypertension	B-disease
.	O

3.	O
Osteoarthritis	B-disease
.	O

4.	O
_______________	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

HOME	O
MEDICATIONS	O
:	O

1.	O
Aspirin	O
325	O
mg	O
p.o.	O
q.	O
day	O
.	O

2.	O
Norvasc	O
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

3.	O
Isosorbide	O
mononitrate	O
30	O
q.	O
day	O
.	O

4.	O
Terazosin	O
1	O
mg	O
p.o.	O
q.	O
day	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
alone	O
.	O

Has	O
a	O
remote	O
tobacco	O
history	O
.	O

No	O
ethanol	O
.	O

FAMILY	O
HISTORY	O
:	O

Positive	O
for	O
diabetes	B-disease
.	O

No	O
coronary	B-disease
artery	I-disease
disease	I-disease
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
blood	O
pressure	O
151/61	O
,	O
heart	O
rate	O
75	O
,	O
SaO2	O
93%	O
on	O
room	O
air	O
.	O

In	O
general	O
,	O
patient	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

Speaks	O
in	O
full	O
sentences	O
.	O

Neck	O
:	O

Jugular	O
venous	O
pressure	O
notable	O
at	O
the	O
mid	O
neck	O
upright	O
about	O
80	O
degree	O
angles	O
.	O

Cardiovascular	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	B-disease
1-2/6	I-disease
holosystolic	I-disease
murmur	I-disease
.	O

Pulmonary	O
:	O

Crackles	B-disease
bilaterally	I-disease
one-third	O
to	O
one-half	O
the	O
way	O
up	O
.	O

Abdomen	O
:	O

Bowel	O
sounds	O
positive	O
,	O
soft	O
,	O
non-tender	B-disease
,	O
non-distended	B-disease
.	O

Extremities	O
:	O

1+	B-disease
lower	I-disease
extremity	I-disease
edema	I-disease
.	O

LABORATORIES	O
ON	O
ADMISSION	O
:	O

Included	O
normal	O
CBC	O
,	O
BUN	O
47	O
,	O
creatinine	O
2.4	O
up	O
from	O
baseline	O
of	O
about	O
1.5	O
.	O

Troponin	O
4.7	O
,	O
CK	O
101	O
,	O
MB	O
3	O
.	O

RADIOLOGY	O
:	O

Chest	O
x-ray	O
showed	O
patient	O
was	O
in	O
congestive	B-disease
heart	I-disease
failure	I-disease
.	O

ELECTROCARDIOGRAM	O
:	O

Showed	O
normal	O
sinus	O
rhythm	O
at	O
107	O
beats	O
per	O
minute	O
with	O
left	B-disease
axis	I-disease
deviation	I-disease
and	O
poor	B-disease
R-wave	I-disease
progression	I-disease
.	O

However	O
,	O
no	O
acute	B-disease
changes	I-disease
were	O
apparent	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Cardiac	O
Medicine	O
Service	O
and	O
treated	O
for	O
presumed	O
diastolic	B-disease
and	I-disease
systolic	I-disease
dysfunction	I-disease
.	O

Echocardiogram	O
was	O
obtained	O
which	O
showed	O
moderately	B-disease
depressed	I-disease
left	I-disease
ventricular	I-disease
systolic	I-disease
function	I-disease
as	O
well	O
as	O
hypokinesis	B-disease
of	I-disease
the	I-disease
lower	I-disease
half	I-disease
of	I-disease
septum	I-disease
and	I-disease
apex	I-disease
.	O

Also	O
of	O
note	O
was	O
the	B-disease
distal	I-disease
lateral	I-disease
wall	I-disease
hypokinesis	I-disease
.	O

The	B-disease
wall	I-disease
motion	I-disease
abnormalities	I-disease
were	O
noted	O
to	O
be	O
new	O
.	O

It	O
was	O
believed	O
that	O
a	O
troponin	O
on	O
admission	O
in	O
addition	O
to	O
the	B-disease
wall	I-disease
motion	I-disease
abnormalities	I-disease
she	O
underwent	O
a	B-disease
non-Q	I-disease
wave	I-disease
myocardial	I-disease
infarction	I-disease
prior	O
to	O
resulted	O
in	O
her	B-disease
current	I-disease
cardiac	I-disease
failure	I-disease
.	O

Throughout	O
hospital	O
course	O
patient	O
's	O
troponin	O
trended	O
down	O
to	O
less	O
than	O
0.3	O
.	O

Heart	O
Failure	O
Service	O
was	O
involved	O
.	O

She	O
was	O
continued	O
with	O
aggressive	O
diuresis	O
.	O

She	O
was	O
started	O
on	O
_________	O
with	O
excellent	O
diuresis	O
,	O
however	O
,	O
her	B-disease
renal	I-disease
functioning	I-disease
worsening	I-disease
.	O

A	O
cardiac	O
catheterization	O
was	O
deferred	O
until	O
the	B-disease
renal	I-disease
issue	I-disease
could	O
be	O
resolved	O
.	O

However	O
,	O
her	O
creatinine	O
continued	O
to	O
increase	O
.	O

Diuresis	O
was	O
halted	O
and	O
without	O
improvement	O
in	O
creatinine	O
.	O

Renal	O
was	O
consulted	O
.	O

A	O
renal	O
ultrasound	O
was	O
obtained	O
.	O

It	O
showed	O
a	O
right	O
kidney	O
size	O
of	O
6.3	O
cm	O
and	O
a	O
left	O
kidney	O
size	O
of	O
8.4	O
cm	O
.	O

Given	O
her	B-disease
hypertension	I-disease
which	O
was	O
very	O
difficult	O
to	O
control	O
,	O
it	O
was	O
felt	O
that	O
she	O
had	O
renal	B-disease
artery	I-disease
stenosis	I-disease
and	O
thus	O
she	O
underwent	O
MRA	O
of	O
the	O
kidney	O
which	O
showed	O
severe	B-disease
right	I-disease
renal	I-disease
artery	I-disease
stenosis	I-disease
at	I-disease
its	I-disease
origin	I-disease
.	O

There	O
was	O
also	O
moderate	B-disease
to	I-disease
severe	I-disease
focal	I-disease
stenosis	I-disease
of	I-disease
the	I-disease
left	I-disease
renal	I-disease
artery	I-disease
approximately	O
1.3	O
cm	O
from	O
its	O
origin	O
.	O

Dr.	O
______________	O
consulted	O
on	O
the	O
case	O
.	O

She	O
was	O
transferred	O
to	O
the	O
unit	O
overnight	O
to	O
assess	O
volume	O
which	O
was	O
noted	O
to	O
be	O
optimal	O
.	O

On	O
05-25	O
she	O
underwent	O
catheterization	O
and	O
subsequent	O
stenting	O
of	O
the	O
left	O
renal	O
artery	O
.	O

Due	O
to	O
dye	O
load	O
required	O
to	O
assess	O
the	B-disease
coronary	I-disease
disease	I-disease
were	O
not	O
visualized	O
.	O

After	O
the	O
procedure	O
the	O
patient	O
did	O
well	O
.	O

However	O
,	O
her	O
creatinine	O
has	O
worsened	B-disease
up	O
to	O
4.2	O
.	O

However	O
,	O
her	O
urine	O
output	O
has	O
improved	O
.	O

She	O
has	O
not	O
required	O
hemodialysis	O
at	O
this	O
time	O
.	O

She	O
will	O
need	O
close	O
follow	O
up	O
of	O
her	O
renal	O
functioning	O
.	O

The	O
patient	O
is	O
discharged	O
to	O
an	O
extended	O
discharge	O
facility	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Non-Q	B-disease
wave	I-disease
myocardial	I-disease
infarction	I-disease
.	O

2.	O
Systolic	B-disease
and	I-disease
diastolic	I-disease
congestive	I-disease
heart	I-disease
failure	I-disease
.	O

3.	O
Bilateral	B-disease
renal	I-disease
artery	I-disease
stenosis	I-disease
status	O
post	O
stent	O
left	O
renal	O
artery	O
.	O

4.	O
Acute	B-disease
renal	I-disease
failure	I-disease
.	O

5.	O
Hypertension	B-disease
.	O

FOLLOW	O
UP	O
:	O

She	O
is	O
to	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
in	O
one	O
week	O
.	O

She	O
is	O
to	O
follow	O
up	O
Heart	O
Failure	O
and	O
Cardiology	O
in	O
one	O
week	O
as	O
well	O
.	O

In	O
addition	O
,	O
patient	O
is	O
to	O
have	O
her	O
own	O
appointment	O
with	O
Podiatry	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Aspirin	O
325	O
mg	O
p.o.	O
q.	O
day	O
.	O

2.	O
Norvasc	O
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

3.	O
Atorvastatin	O
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

4.	O
Protonix	O
20	O
mg	O
p.o.	O
q.	O
day	O
.	O

5.	O
Multivitamin	O
one	O
p.o.	O
q.	O
day	O
.	O

6.	O
Carvedilol	O
3.125	O
p.o.	O
b.i.d.	O

7.	O
___________	O
dinitrate	O
20	O
mg	O
p.o.	O
t.i.d.	O

8.	O
Erythropoietin	O
10,000	O
units	O
two	O
times	O
a	O
week	O
Tuesday	O
and	O
Saturday	O
.	O

9.	O
Calcium	O
acetate	O
Tums	O
one	O
p.o.	O
t.i.d.	O
with	O
meals	O
.	O

10.	O
Tylenol	O
325	O
mg	O
p.o.	O
q.	O
4-6	O
h.	O
p.r.n.	O

11.	O
Iron	O
sulfate	O
325	O
mg	O
p.o.	O
q.	O
day	O
.	O

12.	O
Colace	O
100	O
mg	O
p.o.	O
b.i.d.	O

13.	O
Hydralazine	O
10	O
mg	O
p.o.	O
q.	O
6h.	O

14.	O
Plavix	O
75	O
mg	O
p.o.	O
q.	O
day	O
times	O
30	O
days	O
.	O

Kathy	O
Tillis	O
,	O
M.D.	O

85-987	O

Dictated	O
By	O
:	O
John	O
V.E.	O
Jameson	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2010-05-27	O
14:29	O

T	O
:	O
2010-05-27	O
14:10	O

JOB	O
#:	O

80987	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kathy	O
Tillis	O
on	O
:	O
MON	O
2010-06-07	O
4:00	O
PM	O

(	O
End	O
of	O
Report	O
)	O

455343475	O
PUMC	O

4322324	O

195078	O

781135	O

6/15/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

KOTE	O
,	O
YGA	O

MRN	O
:	O

4322324	O

Age	O
:	O

43y	O

REGISTRATION	O
DATE	O
:	O

06/15/2000	O
01:09	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
KOTE	O
,	O
YGA	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ponta,itri-	O
University	O
Medical	O
Center	O
on	O
06/15/2000	O
01:09	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
R	B-disease
THUMB	I-disease
INJURY	I-disease
.	O

Following	O
triage	O
,	O
the	O
patient	O
LEFT	O
WITHOUT	O
TREATMENT	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
937-599-6520	O
.	O

Admission	O
Date	O
:	O

2014-04-23	O

Discharge	O
Date	O
:	O

2014-04-28	O

Date	O
of	O
Birth	O
:	O

1980-02-05	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Penicillins	O
/	O
Sulfonamides	O

Attending	O
:	O
Louie	O
A.	O
Keith	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Benzo	B-disease
overdose	I-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Intubation	O
for	O
airway	O
protection	O

History	O
of	O
Present	O
Illness	O
:	O

HPI	O
:	O

Ms.	O
Franklin	O
is	O
a	O
34	O
-	O
year-old	O
woman	O
with	O
Bipolar	B-disease
disorder	I-disease
and	O
group	O
home	O
resident	O
who	O
by	O
way	O
of	O
EMS	O
for	O
apparent	B-disease
alprazolam	I-disease
overdose	I-disease
.	O

In	O
the	O
St.	O
Margaret	O
's	O
Center	O
for	O
Women	O
&	O
Infants	O
,	O
the	O
patient	O
was	O
lethargic	B-disease
and	O
unable	O
to	O
give	O
a	O
history	O
.	O

She	O
was	O
promptly	O
intubated	O
for	O
airway	O
protection	O
and	O
in	O
order	O
to	O
administer	O
charcoal	O
.	O

Patient	O
was	O
found	O
at	O
group	O
home	O
in	O
am	O
laying	O
on	O
floor	O
by	O
bed	O
unresponsive	B-disease
,	O
last	O
seen	O
awake	O
8	O
hours	O
prior	O
at	O
dinner	O
.	O

Group	O
home	O
states	O
that	O
patient	O
"	O
may	O
have	O
taken	O
too	O
many	O
Xanax	O
.	O

Patient	O
has	O
a	O
history	O
of	O
suicidal	B-disease
ideations	I-disease
and	O
self	B-disease
mutilation	I-disease
.	O

Later	O
patient	O
told	O
CMED	O
CCU	O
that	O
she	O
was	O
feeling	O
down	O
and	O
impulsively	O
ingested	O
5	O
days	O
worth	O
of	O
medications	O
,	O
she	O
states	O
that	O
her	O
intent	O
at	O
that	O
time	O
was	O
to	O
end	O
her	O
life	O
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Bipolar	B-disease
disorder	I-disease
.	O

2.	O
Asthma	B-disease
.	O

3.	O
Posttraumatic	B-disease
stress	I-disease
disorder	I-disease
.	O

4.	O
GERD	B-disease

5.	O
Chronic	B-disease
constipation	I-disease
from	O
laxative	B-disease
abuse	I-disease
.	O

Social	O
History	O
:	O

Denies	O
any	O
recent	O
use	O
of	O
EtOH	O
or	O
illicit	O
drugs	O
.	O

Per	O
OMR	O
,	O
h/o	O
sporadic	O
marijuana	O
use	O
.	O

Now	O
living	O
at	O
the	O
DBT	O
House	O
on	O
Treva	O
Williamson	O
in	O
Westborough	O
.	O

In	O
currently	O
in	O
a	O
relationship	O
with	O
a	O
man	O
whom	O
she	O
met	O
during	O
a	O
previous	O
inpt	O
admission	O
.	O

Per	O
OMR	O
,	O
the	O
patient	O
is	O
currently	O
not	O
in	O
contact	O
with	O
her	O
family	O
.	O

She	O
was	O
raised	O
in	O
multiple	O
foster	O
care	O
homes	O
because	O
her	O
mother	O
could	O
not	O
care	O
for	O
her	O
.	O

She	O
was	O
physically	O
abused	O
and	O
severely	O
neglected	O
as	O
a	O
child	O
and	O
been	O
sexually	O
assaulted	O
.	O

She	O
has	O
no	O
current	O
romantic	O
relationship	O
.	O

She	O
has	O
never	O
been	O
married	O
.	O

She	O
has	O
completed	O
up	O
to	O
the	O
tenth	O
grade	O
of	O
high	O
school	O
.	O

She	O
has	O
no	O
current	O
legal	O
issues	O
.	O

Family	O
History	O
:	O

Substance	O
abuse	O
in	O
mother	O
and	O
brother	O
.	O

Two	O
sisters	O
with	O
h/o	O
depression	B-disease
and	O
suicidality	B-disease
.	O

Physical	O
Exam	O
:	O

VS	O
95.4	O
HR	O
62	O
BP	O
99/70	O
RR	O
20	O
O2Sat	O
100%	O

Gen	O
:	O

Intubated	O
and	O
sedated	O

HEENT	O
:	O

ATNC	B-disease
,	O
Pupils	O
dialted	O
at	O
5	O
mm	O
but	O
minimally	B-disease
reactive	I-disease
,	O
anicteric	B-disease

Chest	O
:	O

CTA	O
ant/lat	O

Cor	O
:	O

RR	O
nl	O
S1	O
S2	O
no	O
m	B-disease

Abd	O
:	O

Soft	O
,	O
nd	B-disease
,	O
hypoactive	B-disease
bowel	I-disease
sounds	I-disease

Ext	O
:	O

WWP	B-disease
,	O
multiple	B-disease
linear	I-disease
scars	I-disease
and	O
burns	B-disease
on	I-disease
hands	I-disease
and	I-disease
arms	I-disease

Neuro	O
:	O

Sedated	O
,	O
DTRs	O
:	O

Skin	O
:	O

No	O
rashes	B-disease
or	O
petechiae	B-disease
,	O
linear	B-disease
and	I-disease
burn	I-disease
scars	I-disease
as	O
above	O

Pertinent	O
Results	O
:	O

2014-04-23	O
07:56	O
AM	O

WBC	O
-	O
9.4	O
#	O
RBC	O
-	O
4.75	O
HGB	O
-	O
14.7	O
HCT	O
-	O
42.2	O
MCV	O
-	O
89	O
MCH	O
-	O
30.9	O
MCHC	O
-	O
34.8	O
RDW	O
-	O
13.6	O

2014-04-23	O
07:56	O
AM	O

PLT	O
COUNT	O
-	O
330	O

2014-04-23	O
07:56	O
AM	O

NEUTS	O
-	O
73.0	O
*	O
LYMPHS	O
-	O
21.8	O
MONOS	O
-	O
3.8	O
EOS	O
-	O
1.1	O
BASOS	O
-	O
0.3	O

2014-04-23	O
07:56	O
AM	O

ASA	O
-	O
NEG	O
ETHANOL	O
-	O
NEG	O
ACETMNPHN	O
-	O
NEG	O
bnzodzpn	O
-	O
NEG	O
barbitrt	O
-	O
NEG	O
tricyclic	O
-	O
POS	O

2014-04-23	O
07:56	O
AM	O

LITHIUM	O
-	O
LESS	O
THAN	O

2014-04-23	O
07:56	O
AM	O

DIGOXIN	O
-<	O
0.2	O
*	O

2014-04-23	O
07:56	O
AM	O

GLUCOSE	O
-	O
116	O
*	O
UREA	O
N	O
-	O
14	O
CREAT	O
-	O
1.0	O
SODIUM	O
-	O
137	O
POTASSIUM	O
-	O
4.5	O
CHLORIDE	O
-	O
105	O
TOTAL	O
CO2	O
-	O
20	O
*	O
ANION	O
GAP	O
-	O
17	O

2014-04-23	O
07:56	O
AM	O

CALCIUM	O
-	O
9.7	O
PHOSPHATE	O
-	O
3.7	O
MAGNESIUM	O
-	O
2.1	O

2014-04-23	O
07:56	O
AM	O

ALT	O
(	O
SGPT	O
)-	O
21	O
AST	O
(	O
SGOT	O
)-	O
40	O
ALK	O
PHOS	O
-	O
70	O
AMYLASE	O
-	O
59	O
TOT	O
BILI	O
-	O
0.4	O

2014-04-23	O
07:56	O
AM	O

LIPASE	O
-	O
66	O
*	O

2014-04-23	O
08:00	O
AM	O
URINE	O

BLOOD	O
-	O
NEG	O
NITRITE	O
-	O
NEG	O
PROTEIN	O
-	O
NEG	O
GLUCOSE	O
-	O
NEG	O
KETONE	O
-	O
TR	O
BILIRUBIN	O
-	O
NEG	O
UROBILNGN	O
-	O
NEG	O
PH	O
-	O
6.5	O
LEUK	O
-	O
NEG	O

2014-04-23	O
08:13	O
AM	O
URINE	O
bnzodzpn	O
-	O
POS	O
barbitrt	O
-	O
NEG	O
opiates	O
-	O
NEG	O
cocaine	O
-	O
NEG	O
amphetmn	O
-	O
NEG	O
mthdone	O
-	O
NEG	O

2014-04-23	O
01:38	O
PM	O

CK	O
(	O
CPK	O
)-	O
4713	O
*	O

2014-04-23	O
03:45	O
PM	O
URINE	O

UCG	O
-	O
NEGATIVE	O

2014-04-23	O
03:56	O
PM	O

D-DIMER	O
-	O
7998	O
*	O

CXR	O
:	O

Probable	O
ateletasis	B-disease
of	I-disease
lingula	I-disease
,	O
consistent	O
with	O
pneumonitis	B-disease

EKG	O
:	O

NSR	O
R	O
60	O
Normal	O
axis	O
,	O
intervals	O
,	O
incomplete	B-disease
RBBB	I-disease
,	O
flat	B-disease
T	I-disease
aVL	I-disease
,	O
V2	O
,	O
TWI	B-disease
V1	I-disease

CT	O
Chest	O
-	O
shows	O
bilateral	B-disease
segmental	I-disease
,	I-disease
subsegmental	I-disease
PEs	I-disease

B/L	O
LE	O
LENIs	O
-	O
negative	O

Brief	O
Hospital	O
Course	O
:	O

CMED	O
CSRU	O
Course	O
:	O

Patient	O
was	O
intubated	O
in	O
John	O
for	O
airway	O
protection	O
and	O
administation	O
of	O
charcoal	O
.	O

Toxicology	O
consulted	O
and	O
felt	O
that	O
patient	O
most	O
likely	O
had	O
benzo	B-disease
overdose	I-disease
.	O

ABG	O
revealed	O
widened	B-disease
A-a	I-disease
gradient	I-disease
so	O
a	O
d-dimer	O
was	O
sent	O
which	O
was	O
elevated	B-disease
.	O

Patient	O
had	O
CTA	O
which	O
showed	O
bilateral	B-disease
pulmonary	I-disease
embolisms	I-disease
.	O

Patient	O
was	O
started	O
on	O
heparin	O
drip	O
and	O
bilateral	O
lower	O
extremeties	O
were	O
done	O
which	O
were	O
negative	O
for	O
DVT	B-disease
.	O

Patient	O
was	O
exubated	O
after	O
1	O
day	O
in	O
ICU	O
after	O
waking	O
up	O
.	O

Overnight	O
in	O
the	O
ICU	O
patient	O
was	O
noticed	O
to	O
have	O
painful	B-disease
bullae	I-disease
on	I-disease
hands	I-disease
and	I-disease
arm	I-disease
along	O
with	O
swelling	B-disease
.	O

Dermatology	O
and	O
plastic	O
surgery	O
were	O
consulted	O
who	O
felt	O
that	O
symptoms	B-disease
were	O
due	O
to	O
trauma	B-disease
;	O
it	O
was	O
not	O
felt	O
that	O
patient	O
had	O
compartment	B-disease
syndrome	I-disease
.	O

Patient	O
was	O
splinted	O
and	O
UE	O
were	O
kept	O
elevated	O
.	O

Patient	O
was	O
gradually	O
put	O
back	O
on	O
her	O
outpatient	O
xanax	O
dose	O
of	O
1	O
mg	O
qid	O
and	O
clozaril	O
was	O
restarted	O
.	O

Patient	O
was	O
transferred	O
to	O
floor	O
after	O
spending	O
1	O
day	O
in	O
the	O
ICU	O
.	O

Once	O
on	O
the	O
floor	O
patient	O
stable	O
.	O

Plastic	O
did	O
not	O
feel	O
that	O
patient	O
had	O
any	B-disease
compartment	I-disease
syndrome	I-disease
and	O
recommended	O
aggresive	O
upper	O
extremity	O
elevation	O
for	O
swelling	O
reduction	O
.	O

While	O
on	O
the	O
floor	O
patient	O
's	O
hands	O
improved	O
with	O
good	O
range	O
of	O
motion	O
of	O
left	O
hand	O
,	O
however	O
Jones	O
some	B-disease
poor	I-disease
range	I-disease
of	I-disease
motion	I-disease
of	O
right	O
.	O

X-ray	O
of	O
the	O
hands	O
and	O
wrist	O
were	O
obtained	O
which	O
were	O
negative	O
.	O

Patient	O
seen	O
by	O
PT	O
and	O
OT	O
who	O
recommended	O
hand	O
exercises	O
and	O
splints	O
for	O
patient	O
.	O

Patient	O
was	O
put	O
on	O
coumadin	O
that	O
was	O
bridged	O
with	O
lovenox	O
unti	O
lINR	O
theraputic	O
01-23	O
.	O

Patient	O
conitnued	O
to	O
have	O
SI	B-disease
while	O
on	O
floor	O
and	O
was	O
transferred	O
to	O
psychiatry	O
.	O

While	O
on	O
the	O
floor	O
patient	O
's	O
urinalysis	O
suggestive	O
of	O
UTI	B-disease
and	O
was	O
put	O
on	O
6	O
day	O
course	O
of	O
levofloxacin	O
.	O

Medications	O
on	O
Admission	O
:	O

Propanolol	O
XL	O
80	O
mg	O
qd	O

Modifinal	O
100	O
mg	O
po	O
qd	O

Lamictal	O
100	O
mg	O
po	O
bid	O

Alprazolam	O
1	O
mg	O
po	O
qid	O

Senna	O

Trazadone	O
200	O
mg	O
po	O
qhs	O

Clomipramine	O
100	O
mg	O
po	O
qhs	O

Pantopraozle	O
40	O
mg	O
po	O
qd	O

Clozapine	O
300	O
mg	O
po	O
qhs	O

Folate	O
1	O
mg	O
po	O
qd	O

Multivitamin	O

Discharge	O
Medications	O
:	O

1.	O
Acetaminophen	O
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

2.	O
Lamotrigine	O
100	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

3.	O
Pantoprazole	O
Sodium	O
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
.	O

4.	O
Folic	O
Acid	O
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

5.	O
Multivitamin	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

6.	O
Senna	O
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

7.	O
Clozapine	O
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
.	O

8.	O
Warfarin	O
Sodium	O
3	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
at	O
bedtime	O
.	O

9.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

10.	O
Trazodone	O
HCl	O
100	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
as	O
needed	O
.	O

11.	O
Alprazolam	O
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
.	O

12.	O
Levofloxacin	O
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
for	O
3	O
days	O
.	O

13.	O
Bisacodyl	O
5	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
as	O
needed	O
.	O

14.	O
Nicotine	O
14	O
mg	O
/	O
24	O
hr	O
Patch	O
24	O
HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Patch	O
24	O
HR	O
Transdermal	O
DAILY	O
(	O
Daily	O
)	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

Benzodiazapine	B-disease
Overdose	I-disease

Traumatic	B-disease
/	I-disease
pressure	I-disease
bullae	I-disease

Bipolar	B-disease
Disorder	I-disease

Discharge	O
Condition	O
:	O

Stable	O
-	O
Swelling	B-disease
in	I-disease
hands	I-disease
reduced	O
and	O
range	O
of	O
motion	O
continue	O
to	O
improve	O
.	O

Discharge	O
Instructions	O
:	O

Please	O
continue	O
to	O
take	O
coumadin	O
as	O
directed	O
by	O
your	O
doctors	O
until	O
told	O
to	O
stop	O
for	O
clots	B-disease
found	O
in	O
your	O
lungs	O
.	O

Please	O
continue	O
to	O
take	O
antibiotics	O
as	O
directed	O
for	O
urinary	B-disease
tract	I-disease
infection	I-disease
for	O
3	O
more	O
days	O
.	O

Please	O
conitnue	O
to	O
keep	O
hands	O
elevated	O
in	O
bed	O
until	O
follow	O
up	O
appointment	O
with	O
plastic	O
surgery	O
.	O

Followup	O
Instructions	O
:	O

Patient	O
will	O
be	O
admitted	O
to	O
psychiatry	O
service	O

Patient	O
should	O
follow	O
up	O
with	O
at	O
plastic	O
surgery	O
clinic	O
in	O
2	O
weeks	O
.	O

Appointment	O
setup	O
for	O
Tues.	O
05-13	O
at	O
10	O
am	O
.	O

3rd	O
floor	O
Henderson	O
Building	O
with	O
Dr.	O
Black	O
(	O
650	O
)	O
866-1361	O

Raymond	O
William	O
MD	O
50-154	O

Completed	O
by	O
:	O
Simon	O
Claudine	O
Audrey	O
MD	O
82-812	O
2014-04-28	O
@	O
1227	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Tracey	O
Mccourtney	O
on	O
:	O
MON	O
2014-05-05	O
10:26	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-02-12	O

Discharge	O
Date	O
:	O

2013-02-16	O

Date	O
of	O
Birth	O
:	O

1937-03-25	O

Sex	O
:	O

F	O

Service	O
:	O

CARDIOTHORACIC	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
was	O
referred	O
from	O
an	O
outside	O
hospital	O
with	O
a	O
chief	O
complaint	O
of	O
increasing	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
and	O
tires	B-disease
easily	I-disease
with	O
exertion	O
.	O

Admitted	O
to	O
Bay	O
State	O
Medical	O
Center	O
Hospital	O
in	O
2012-10-22	O
in	O
congestive	B-disease
heart	I-disease
failure	I-disease
at	O
that	O
time	O
.	O

Via	O
echocardiogram	O
,	O
found	O
to	O
have	O
aortic	B-disease
stenosis	I-disease
.	O

Referred	O
to	O
Memorial	O
Hospital	O
(	O
Worcester	O
)	O
for	O
cardiac	O
catheterization	O
to	O
further	O
evaluate	O
her	B-disease
aortic	I-disease
stenosis	I-disease
.	O

Cardiac	O
catheterization	O
done	O
on	O
01-07	O
showed	O
an	O
aortic	O
valve	O
area	O
of	O
.38	O
cm.sq.	O
,	O
with	O
a	O
mean	O
gradient	O
of	O
62	O
,	O
and	O
a	O
peak	O
gradient	O
of	O
85	O
.	O

Moderate	B-disease
pulmonary	I-disease
hypertension	I-disease
,	O
PA	O
pressure	O
48/24	O
,	O
1+	B-disease
mitral	I-disease
regurgitation	I-disease
,	O
severe	B-disease
aortic	I-disease
stenosis	I-disease
with	O
an	O
LVEDP	O
of	O
19	O
and	O
an	O
ejection	O
fraction	O
of	O
43%	O
.	O

She	O
was	O
then	O
referred	O
to	O
Cardiothoracic	O
Surgery	O
for	O
aortic	O
valve	O
replacement	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Aortic	B-disease
stenosis	I-disease

2.	O
Diabetes	B-disease
mellitus	I-disease
Type	I-disease
2	I-disease

3.	O
Right	O
hip	O
replacement	O

4.	O
Noninsulin	B-disease
dependent	I-disease
diabetes	I-disease
mellitus	I-disease

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Include	O
Glucovance	O
5/500	O
one	O
tablet	O
twice	O
a	O
day	O
,	O
Univasc	O
7.5	O
mg	O
once	O
daily	O
,	O
lasix	O
20	O
mg	O
every	O
other	O
day	O
,	O
and	O
aspirin	O
325	O
mg	O
once	O
daily	O
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

FAMILY	O
HISTORY	O
:	O

Significant	O
for	O
her	O
father	O
,	O
who	O
died	O
at	O
50	O
years	O
from	O
myocarditis	B-disease
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
lives	O
alone	O
in	O
Methuen	O
with	O
five	O
stairs	O
.	O

She	O
has	O
a	O
remote	O
tobacco	O
history	O
,	O
quit	O
in	O
October	O
,	O
one	O
pack	O
per	O
day	O
for	O
50	O
years	O
.	O

No	O
alcohol	O
use	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	O
signs	O
:	O

Heart	O
rate	O
108	O
and	O
regular	O
,	O
blood	O
pressure	O
145/76	O
,	O
respiratory	O
rate	O
20	O
,	O
height	O
5'2"	O
,	O
weight	O
141	O
pounds	O
.	O

General	O
:	O

Healthy-appearing	O
woman	O
,	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

Skin	O
:	O

No	O
lesions	B-disease
or	O
rashes	B-disease
.	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
:	O

Pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
,	O
extraocular	O
movements	O
intact	O
,	O
anicteric	B-disease
,	O
not	O
injected	B-disease
.	O

Oropharynx	O
:	O

Mucous	O
membranes	O
moist	O
.	O

Neck	O
:	O

Supple	O
,	O
no	O
lymphadenopathy	B-disease
,	O
no	O
jugular	B-disease
venous	I-disease
distention	I-disease
,	O
no	O
thyromegaly	B-disease
.	O

Chest	O
:	O

Clear	O
to	O
auscultation	O
bilaterally	O
.	O

Heart	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
S1	O
,	O
S2	O
,	O
with	O
III/VI	B-disease
blowing	I-disease
murmur	I-disease
.	O

Abdomen	O
:	O

Soft	O
,	O
nontender	B-disease
,	O
nondistended	B-disease
,	O
normal	O
active	O
bowel	O
sounds	O
,	O
no	O
hepatosplenomegaly	B-disease
.	O

Extremities	O
:	O

Warm	O
and	O
well	O
perfused	O
,	O
with	O
no	O
cyanosis	B-disease
,	O
clubbing	B-disease
or	O
edema	B-disease
,	O
no	O
varicosities	B-disease
.	O

Neurological	O
:	O

Cranial	O
nerves	O
II	O
through	O
XII	O
grossly	O
intact	O
.	O

Moves	O
all	O
extremities	O
.	O

Strength	O
5/5	O
in	O
upper	O
and	O
lower	O
extremities	O
.	O

Sensation	O
intact	O
in	O
all	O
dermatomes	O
.	O

Pulses	O
:	O

Femoral	O
2	O
+	O
bilaterally	O
,	O
dorsalis	O
pedis	O
1	O
+	O
bilaterally	O
,	O
posterior	O
tibial	O
1	O
+	O
bilaterally	O
,	O
and	O
radial	O
2	O
+	O
bilaterally	O
.	O

No	O
carotid	B-disease
bruits	I-disease
were	O
noted	O
.	O

LABORATORY	O
DATA	O
:	O

White	O
count	O
5.3	O
,	O
hematocrit	O
43	O
,	O
platelets	O
200	O
.	O

Sodium	O
138	O
,	O
potassium	O
4.9	O
,	O
chloride	O
102	O
,	O
CO2	O
25	O
,	O
BUN	O
24	O
,	O
creatinine	O
0.9	O
,	O
glucose	O
309	O
.	O

Electrocardiogram	O
:	O

Rate	O
of	O
91	O
,	O
first	B-disease
degree	I-disease
AV	I-disease
block	I-disease
,	O
intervals	O
.22	O
,	O
.92	O
,	O
.36	O
,	O
with	O
left	B-disease
ventricular	I-disease
hypertrophy	I-disease
.	O

Chest	O
x-ray	O
is	O
pending	O
at	O
the	O
time	O
of	O
physical	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
a	O
direct	O
admission	O
to	O
the	O
operating	O
room	O
on	O
02-12	O
,	O
at	O
which	O
time	O
she	O
underwent	O
an	O

aortic	O
valve	O
replacement	O
.	O

Please	O
see	O
the	O
operative	O
report	O
for	O
full	O
details	O
.	O

In	O
summary	O
,	O
she	O
had	O
an	O
aortic	O
valve	O
replacement	O
with	O
a	O
#21	O
mosaic	O
porcine	O
valve	O
.	O

She	O
tolerated	O
the	O
operation	O
well	O
,	O
and	O
was	O
transferred	O
from	O
the	O
operating	O
room	O
to	O
the	O
Cardiothoracic	O
Intensive	O
Care	O
Unit	O
.	O

The	O
patient	O
did	O
well	O
in	O
the	O
immediate	O
postoperative	O
period	O
,	O
however	O
,	O
her	O
blood	O
pressure	O
remained	O
somewhat	B-disease
labile	I-disease
.	O

Therefore	O
,	O
she	O
was	O
continued	O
on	O
a	O
Neo-Synephrine	O
drip	O
to	O
maintain	O
a	O
systolic	O
blood	O
pressure	O
greater	O
than	O
110	O
.	O

In	O
addition	O
,	O
she	O
was	O
slow	O
to	O
awaken	O
after	O
her	O
anesthesia	O
was	O
reversed	O
,	O
and	O
in	O
several	O
attempts	O
to	O
wean	O
from	O
the	O
ventilator	O
,	O
she	O
developed	O
a	B-disease
respiratory	I-disease
acidosis	I-disease
.	O

She	O
therefore	O
remained	O
on	O
the	O
ventilator	O
throughout	O
the	O
day	O
of	O
postoperative	O
day	O
one	O
.	O

On	O
postoperative	O
day	O
two	O
,	O
the	O
patient	O
remained	O
hemodynamically	O
stable	O
.	O

Her	O
Neo-Synephrine	O
drip	O
was	O
weaned	O
to	O
off	O
.	O

She	O
was	O
again	O
weaned	O
from	O
the	O
ventilator	O
,	O
and	O
successfully	O
extubated	O
.	O

Her	O
chest	O
tubes	O
were	O
discontinued	O
and	O
,	O
at	O
the	O
end	O
of	O
the	O
day	O
,	O
she	O
was	O
transferred	O
from	O
the	O
Cardiothoracic	O
Intensive	O
Care	O
Unit	O
to	O
the	O
floor	O
for	O
continuing	O
postoperative	O
care	O
and	O
cardiac	O
rehabilitation	O
.	O

After	O
being	O
transferred	O
to	O
the	O
floor	O
,	O
the	O
patient	O
did	O
well	O
.	O

Over	O
the	O
next	O
several	O
days	O
,	O
her	O
activity	O
level	O
was	O
increased	O
with	O
the	O
assistance	O
of	O
Physical	O
Therapy	O
and	O
the	O
nursing	O
staff	O
.	O

She	O
remained	O
hemodynamically	O
stable	O
.	O

Her	O
respiratory	O
condition	O
remained	O
stable	O
and	O
,	O
on	O
postoperative	O
day	O
four	O
,	O
she	O
was	O
deemed	O
stable	O
and	O
ready	O
to	O
be	O
transferred	O
to	O
rehabilitation	O
for	O
continuing	O
postoperative	O
care	O
and	O
physical	O

therapy	O
.	O

At	O
the	O
time	O
of	O
transfer	O
,	O
the	O
patient	O
's	O
physical	O
examination	O
is	O
as	O
follows	O
:	O

Vital	O
signs	O
:	O

Temperature	O
98.4	O
,	O
heart	O
rate	O
78	O
and	O
sinus	O
rhythm	O
,	O
blood	O
pressure	O
106/50	O
,	O
respiratory	O
rate	O
18	O
,	O
oxygen	O
saturation	O
97%	O
on	O
room	O
air	O
.	O

Weight	O
preoperatively	O
was	O
67	O
kg	O
,	O
at	O
discharge	O
is	O
70.9	O
kg	O
.	O

Laboratory	O
data	O
on	O
02-15	O
:	O

White	O
count	O
4.1	O
,	O
hematocrit	O
23	O
,	O
platelets	O
144	O
.	O

Sodium	O
141	O
,	O
potassium	O
4.3	O
,	O
chloride	O
108	O
,	O
CO2	O
25	O
,	O
BUN	O
24	O
,	O
creatinine	O
0.8	O
,	O
glucose	O
140	O
.	O

Physical	O
examination	O
:	O

Alert	O
and	O
oriented	O
x	O
3	O
,	O
moves	O
all	O
extremities	O
,	O
conversant	O
.	O

Respiratory	O
:	O

Scattered	B-disease
rhonchi	I-disease
with	O
diminished	B-disease
breath	I-disease
sounds	I-disease
in	I-disease
the	I-disease
bases	I-disease
.	O

Cor	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
S1	O
,	O
S2	O
,	O
with	O
soft	B-disease
systolic	I-disease
ejection	I-disease
murmur	I-disease
.	O

Sternum	O
is	O
stable	O
.	O

Incision	B-disease
with	O
staples	O
,	O
open	O
to	O
air	O
,	O
clean	O
and	O
dry	O
.	O

Abdomen	O
:	O

Soft	O
,	O
nontender	B-disease
,	O
nondistended	B-disease
,	O
normal	O
active	O
bowel	O
sounds	O
.	O

Extremities	O
:	O

Warm	O
and	O
well	O
perfused	O
,	O
with	O
no	O
cyanosis	B-disease
,	O
clubbing	B-disease
or	O
edema	B-disease
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Ranitidine	O
150	O
mg	O
twice	O
a	O
day	O
,	O
enteric-coated	O
aspirin	O
325	O
mg	O
once	O
daily	O
,	O
Glucovance	O
5/500	O
one	O
tablet	O
twice	O
a	O
day	O
,	O
metoprolol	O
25	O
mg	O
twice	O
a	O
day	O
,	O
Furosemide	O
20	O
mg	O
once	O
daily	O
for	O
14	O
days	O
,	O
potassium	O
chloride	O
20	O
mEq	O
once	O
daily	O
for	O
14	O
days	O
,	O
Colace	O
100	O
mg	O
twice	O
a	O
day	O
,	O
Niferex	O
150	O
mg	O
once	O
daily	O
,	O
Percocet	O
5/325	O
one	O
to	O
two	O
tablets	O
every	O
four	O
hours	O
as	O
needed	O
,	O
ibuprofen	O
400	O
mg	O
every	O
six	O
hours	O
as	O
needed	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Aortic	B-disease
stenosis	I-disease
status	O
post	O
aortic	O
valve	O
replacement	O
with	O
a	O
#21	O
mosaic	O
porcine	O
valve	O

2.	O
Diabetes	B-disease
mellitus	I-disease
Type	I-disease
2	I-disease

3.	O
Right	O
hip	O
replacement	O

CONDITION	O
ON	O
TRANSFER	O
:	O

Stable	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

She	O
is	O
to	O
have	O
follow	O
up	O
with	O
Dr.	O
Bloomfield	O
in	O
one	O
month	O
,	O
and	O
follow	O
up	O
in	O
the	O
Wound	O
Clinic	O
in	O
two	O

weeks	O
.	O

Alice	O
S.	O
Shadle	O
,	O
M.D.	O

37-538	O

Dictated	O
By	O
:	O
James	O
F.	O
Buchanan	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2013-02-15	O
18:35	O

T	O
:	O
2013-02-16	O
01:03	O

JOB	O
#:	O

59205	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Richard	O
Gray	O
on	O
:	O
Tommy	O
2013-02-17	O
12:05	O
AM	O

(	O
End	O
of	O
Report	O
)	O

598403789	O
DH	O

8993683	O

816711	O

963035	O

02/25/2001	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

GLYN	O
,	O
AEA	O

MRN	O
:	O

8993683	O

Age	O
:	O

67y	O

REGISTRATION	O
DATE	O
:	O

02/25/2001	O
12:20	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
GLYN	O
,	O
AEA	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Daughtersvillshamen&apos;s	O
Hospital	O
on	O
02/25/2001	O
12:20	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
HEMATURIA	B-disease
.	O

Following	O
evaluation	O
and	O
treatment	O
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
DAUGHTERSVILLSHAMEN&apos;S	O
HOSPITAL	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
LINKETHORE	O
,	O
HANSVERLLEN	O
G	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
HEMATURIA	B-disease
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
613-870-0699	O
.	O

PCP	O
Name	O
:	O

SWANKEMANDESSKIAIS	O
,	O
SANTCINET	O
E	O

Provider	O
Number	O
:	O

42283	O

176746010	O
WGH	O

0014633	O

546385	O

8603421	O

12/7/2004	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

GLOTZASRHALT	O
,	O
SHIRLH	O

MRN	O
:	O

0014633	O

Age	O
:	O

25y	O

REGISTRATION	O
DATE	O
:	O

12/07/2004	O
10:08	O
PM	O

Provider	O
:	O

Gram	O
Meedner	O

PRELIMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

12/07/2004	O
22:57	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

FLANK	B-disease
PAIN	I-disease
URI	B-disease
?	O

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
urinary	B-disease
tract	I-disease
infection	I-disease
(	O
Portugese	O
)	O
.	O

Diagnosis	O
:	O

Urinary	B-disease
Tract	I-disease
Infection	I-disease

Treatment	O
Rendered	O
:	O

Exam	O
,	O
urinalysis	O
,	O
medication	O

Discharge	O
Medications	O
:	O

Levofloxacin	O
500	O
mg	O
every	O
day	O
for	O
7	O
days	O

Follow	O
up	O
Service	O
:	O

If	O
you	O
do	O
not	O
have	O
a	O
primary	O
care	O
physician	O
,	O
it	O
is	O
recommended	O
that	O
you	O
select	O
one	O
.	O

If	O
you	O
would	O
like	O
an	O
WGH	O
primary	O
care	O
physician	O
,	O
please	O
call	O
the	O
Eghelas	O
Medical	O
Centers	O
at	O
265-573-2272	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Return	O
to	O
the	O
ER	O
for	O
high	B-disease
fevers	I-disease
,	O
vomiting	B-disease
,	O
uncontrolled	B-disease
pains	I-disease
or	O
other	B-disease
concerns	I-disease
as	O
needed	O
.	O

PCP	O
Name	O
:	O

NONE	O
,	O
PHYSICIAN	O

Provider	O
Number	O
:	O

51669	O

This	O
report	O
was	O
created	O
by	O
Meedner	O
,	O
Shaza	O
12/07/2004	O
10:59	O
PM	O

134300717	O

FIH	O

9099750	O

22777/5p0t	O

355178	O

2/23/1993	O
12:00:00	O
AM	O

DEEP	B-disease
VENOUS	I-disease
THROMBOSIS	I-disease
OF	I-disease
RIGHT	I-disease
LOWER	I-disease
EXTREMITY	I-disease
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

2-23-93	O

DISCHARGE	O
DATE	O
:	O

2-24-93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Deep	B-disease
venous	I-disease
thrombosis	I-disease
of	I-disease
right	I-disease
lower	I-disease
extremity	I-disease
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Metastatic	B-disease
melanoma	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
the	O
second	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
admission	O
for	O
Taroby	O
Patient	O
,	O
a	O
70	O
year	O
old	O
male	O
with	O
a	O
history	O
of	O
metastatic	B-disease
melanoma	I-disease
.	O

His	B-disease
melanoma	I-disease
was	O
originally	O
diagnosed	O
last	O
fall	O
when	O
he	O
presented	O
with	O
lesions	B-disease
in	I-disease
the	I-disease
liver	I-disease
and	I-disease
spleen	I-disease
,	O
and	O
a	O
chest	O
CT	O
showed	O
left	B-disease
upper	I-disease
lobe	I-disease
nodules	I-disease
.	O

A	O
head	O
CT	O
scan	O
was	O
negative	O
,	O
but	O
an	O
MRI	O
scan	O
of	O
the	O
spine	O
showed	O
an	O
L5	B-disease
metastasis	I-disease
with	O
a	B-disease
fracture	I-disease
and	O
had	O
with	O
epidural	B-disease
and	I-disease
paraspinal	I-disease
extension	I-disease
.	O

In	O
addition	O
,	O
there	O
was	O
a	B-disease
T11	I-disease
metastasis	I-disease
with	O
cord	B-disease
compression	I-disease
.	O

Approximately	O
one	O
week	O
ago	O
,	O
he	O
was	O
admitted	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
for	O
chemotherapy	O
with	O
DTIC	O
and	O
Tamoxifen	O
.	O

At	O
that	O
time	O
,	O
he	O
also	O
began	O
radiation	O
therapy	O
to	O
his	O
lumbosacral	O
spine	O
.	O

He	O
is	O
continuing	O
on	O
the	O
radiation	O
therapy	O
to	O
date	O
.	O

On	O
February	O
23	O
,	O
Mr.	O
Patient	O
presented	O
to	O
Dr.	O
Patient	O
&apos;s	O
office	O
with	O
two	B-disease
major	I-disease
symptoms	I-disease
.	O

First	O
,	O
he	O
had	O
right	B-disease
lower	I-disease
extremity	I-disease
swelling	I-disease
and	O
lower	O
extremity	O
noninvasives	O
confirmed	O
the	O
diagnosis	O
of	O
a	B-disease
femoral	I-disease
deep	I-disease
venous	I-disease
thrombosis	I-disease
.	O

Second	O
,	O
he	O
had	O
a	B-disease
witnessed	I-disease
episode	I-disease
in	O
which	O
his	O
eyes	O
rolled	O
to	O
the	O
back	O
of	O
his	O
head	O
and	O
there	O
was	O
a	O
question	O
of	O
some	B-disease
seizure	I-disease
activity	I-disease
.	O

In	O
the	O
past	O
,	O
he	O
has	O
not	O
been	O
known	O
to	O
have	O
a	O
history	O
of	O
CNS	B-disease
metastases	I-disease
.	O

The	O
episode	O
of	O
potential	B-disease
seizure	I-disease
activity	I-disease
occurred	O
in	O
the	O
setting	O
of	O
a	O
bowel	O
movement	O
and	O
may	O
have	O
been	O
associated	O
with	O
vasovagal	B-disease
activity	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
past	O
medical	O
history	O
is	O
as	O
above	O
.	O

FAMILY	O
HISTORY	O
:	O

Noncontributory	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

The	O
review	O
of	O
systems	O
is	O
negative	O
,	O
except	O
as	O
above	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
physical	O
examination	O
reveals	O
a	O
pleasant	O
70	O
year	O
old	O
male	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

The	O
blood	O
pressure	O
was	O
113/70	O
,	O
pulse	O
66	O
,	O
respirations	O
20	O
,	O
and	O
a	O
temperature	O
of	O
96.8	O
.	O

HEENT	O
showed	O
pupils	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
and	O
accommodation	O
,	O
and	O
extra	O
ocular	O
movements	O
intact	O
.	O

The	O
sclerae	O
were	O
anicteric	O
.	O

The	O
neck	O
was	O
supple	O
,	O
without	O
jugular	B-disease
venous	I-disease
distention	I-disease
or	O
increased	B-disease
thyroid	I-disease
.	O

Nodes	O
:	O

There	O
was	O
no	O
appreciable	B-disease
cervical	I-disease
,	I-disease
supraclavicular	I-disease
,	I-disease
axillary	I-disease
,	I-disease
or	I-disease
inguinal	I-disease
adenopathy	I-disease
.	O

The	O
chest	O
was	O
clear	O
to	O
auscultation	O
and	O
percussion	O
.	O

Cardiac	O
:	O

regular	O
rate	O
and	O
rhythm	O
,	O
with	O
a	B-disease
I	I-disease
/	I-disease
VI	I-disease
systolic	I-disease
ejection	I-disease
murmur	I-disease
.	O

The	O
abdomen	O
showed	O
a	O
10	O
cm	O
liver	O
with	O
the	O
edge	O
palpable	O
2	O
fingerbreadths	O
below	O
the	O
right	O
costal	O
margin	O
.	O

The	O
extremity	O
exam	O
was	O
notable	O
for	O
2+	B-disease
pitting	I-disease
edema	I-disease
in	I-disease
the	I-disease
right	I-disease
lower	I-disease
extremity	I-disease
extending	O
to	O
the	O
knee	O
.	O

The	O
neurological	O
examination	O
was	O
nonfocal	O
.	O

HOSPITAL	O
COURSE	O
:	O

Mr.	O
Patient	O
underwent	O
venogram	O
and	O
inferior	O
vena	O
cava	O
filter	O
placement	O
on	O
February	O
23	O
,	O
1993	O
and	O
was	O
then	O
he	O
was	O
admitted	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
for	O
postoperative	O
care	O
.	O

He	O
tolerated	O
the	O
procedure	O
well	O
.	O

In	O
addition	O
,	O
the	O
second	O
major	O
event	O
that	O
had	O
occurred	O
yesterday	O
was	O
a	B-disease
neurologic	I-disease
event	I-disease
of	O
some	O
kind	O
.	O

Over	O
the	O
24	O
hours	O
of	O
in	O
house	O
hospitalization	O
,	O
he	O
did	O
not	O
have	O
any	B-disease
further	I-disease
neurologic	I-disease
activity	I-disease
and	O
was	O
able	O
to	O
ambulate	O
without	O
assistance	O
prior	O
to	O
discharge	O
.	O

He	O
will	O
be	O
scheduled	O
for	O
an	O
MRI	O
scan	O
,	O
Neurology	O
consult	O
,	O
and	O
an	O
EEG	O
next	O
week	O
as	O
an	O
out	O
patient	O
.	O

Mr.	O
Patient	O
was	O
a	O
poor	O
candidate	O
for	O
anticoagulation	O
because	O
of	O
his	O
history	O
of	O
metastatic	B-disease
melanoma	I-disease
and	O
the	O
question	O
of	O
CNS	B-disease
metastases	I-disease
.	O

An	O
IVC	O
filter	O
placement	O
was	O
accomplished	O
without	O
complication	B-disease
.	O

He	O
is	O
stable	O
on	O
February	O
24	O
and	O
ready	O
for	O
discharge	O
to	O
home	O
.	O

PROCEDURES	O
:	O

IVC	O
filter	O
placement	O
.	O

COMPLICATIONS	O
:	O

None	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Decadron	O
4	O
mg	O
PO	O
bid	O
,	O
Dilantin	O
100	O
mg	O
PO	O
tid	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISPOSITION	O
:	O

Mr.	O
Patient	O
will	O
be	O
discharged	O
to	O
home	O
.	O

He	O
will	O
have	O
follow	O
up	O
arranged	O
with	O
Dr.	O
Guabenfranda	O
Patient	O
.	O

ESTIMATED	O
DISABILITY	O
AND	O
PROBABLE	O
DURATION	O
:	O

Permanent	O
.	O

CA	O
SHUFF	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

GUABENFRANDA	O
PATIENT	O
,	O
M.D.	O

TR	O
:	O

it	O
/	O
bmot	O

DD	O
:	O

2-24-93	O

TD	O
:	O

02/26/93	O

CC	O
:	O

Admission	O
Date	O
:	O

2016-04-05	O

Discharge	O
Date	O
:	O

2016-04-11	O

Date	O
of	O
Birth	O
:	O

1948-10-18	O

Sex	O
:	O

M	O

Service	O
:	O

Cardiothoracic	O
Surgery	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
67	O
-	O
year-old	O
male	O
with	O
a	O
history	O
of	O
high	B-disease
cholesterol	I-disease
who	O
was	O
in	O
his	O
usual	O
state	O
of	O
health	O
until	O
2016-04-03	O
.	O

He	O
was	O
raking	O
leaves	O
on	O
04-02	O
and	O
then	O
developed	O
episodes	O
of	O
mid	B-disease
chest	I-disease
pain	I-disease
and	O
burning	B-disease
which	O
radiated	O
to	O
the	O
left	O
arm	O
.	O

That	O
night	O
he	O
reportedly	O
stopped	O
breathing	B-disease
and	O
was	O
unresponsive	B-disease
.	O

His	O
wife	O
gave	O
him	O
mouth-to-mouth	O
resuscitation	O
and	O
he	O
regained	O
consciousness	O
.	O

He	O
presented	O
to	O
an	O
outside	O
hospital	O
with	O
an	B-disease
acute	I-disease
inferior	I-disease
myocardial	I-disease
infarction	I-disease
and	O
was	O
treated	O
with	O
thrombolytic	O
therapy	O
.	O

His	O
troponin	O
was	O
20	O
and	O
he	O
had	O
EKG	B-disease
changes	I-disease
.	O

He	O
underwent	O
catheterization	O
on	O
2016-04-05	O
which	O
revealed	O
a	O
left	O
ventricular	O
ejection	O
fraction	O
of	O
50%	O
,	O
no	O
mitral	B-disease
regurgitation	I-disease
,	O
insufficiency	B-disease
or	O
hypokinesis	B-disease
.	O

Left	O
main	O
coronary	O
artery	O
was	O
narrowed	B-disease
50-60%	O
,	O
left	O
anterior	O
descending	O
coronary	O
artery	O
70%	O
proximally	O
,	O
right	B-disease
coronary	I-disease
artery	I-disease
dominant	I-disease
diseased	I-disease
up	O
to	O
90%	O
proximally	O
in	O
the	O
midportion	O
,	O
70%	O
distally	O
.	O

The	O
left	O
circumflex	O
coronary	O
artery	O
was	O
50%	O
proximally	O
,	O
90%	O
obtuse	O
marginal	O
#3	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
History	O
of	O
high	B-disease
cholesterol	I-disease
.	O

2.	O
Hemorrhoidectomy	O
.	O

3.	O
Carotid	B-disease
disease	I-disease
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

1.	O
Lipitor	O
20	O
mg	O
p.o.	O
q.d.	O

2.	O
Aspirin	O
325	O
mg	O
p.o.	O
q.d.	O

3.	O
Lopressor	O
25	O
mg	O
p.o.	O
b.i.d.	O

4.	O
Plavix	O
75	O
mg	O
p.o.	O
q.d.	O
which	O
has	O
been	O
discontinued	O
prior	O
to	O
surgery	O
.	O

FAMILY	O
HISTORY	O
:	O

Positive	O
for	O
coronary	B-disease
artery	I-disease
disease	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
cigarettes	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

In	O
general	O
the	O
patient	O
was	O
in	O
no	O
acute	B-disease
distress	I-disease
,	O
afebrile	B-disease
,	O
vital	O
signs	O
stable	O
.	O

HEENT	O
:	O
Normocephalic	O
,	O
atraumatic	B-disease
.	O

Pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O

Extraocular	O
movements	O
intact	O
.	O

Nasopharynx	O
benign	O
.	O

Neck	O
:	O
Supple	O
with	O
full	O
range	O
of	O
motion	O
,	O
no	O
lymphadenopathy	B-disease
nor	O
thyromegaly	B-disease
.	O

Carotids	O
were	O
1+	O
bilaterally	O
.	O

Positive	O
right	B-disease
carotid	I-disease
bruits	I-disease
.	O

Lungs	O
:	O
Clear	O
to	O
auscultation	O
bilaterally	O
.	O

Cardiovascular	O
:	O
Regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmurs	B-disease
.	O

Abdomen	O
:	O
Positive	O
bowel	O
sounds	O
,	O
soft	O
,	O
nontender	B-disease
,	O
nondistended	B-disease
,	O
no	O
masses	B-disease
,	O
no	O
hepatosplenomegaly	B-disease
.	O

Extremities	O
:	O
Without	O
cyanosis	B-disease
,	O
clubbing	B-disease
or	O
edema	B-disease
.	O

Pulses	O
were	O
2+	O
bilaterally	O
throughout	O
.	O

Neurologic	O
:	O
Nonfocal	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
and	O
on	O
2016-04-06	O
the	O
patient	O
underwent	O
coronary	O
artery	O
bypass	O
grafting	O
x	O
4	O
with	O
left	O
internal	O
mammary	O
artery	O
to	O
the	O
left	O
anterior	O
descending	O
coronary	O
artery	O
,	O
saphenous	O
vein	O
graft	O
to	O
the	O
diagonal	O
,	O
saphenous	O
vein	O
graft	O
to	O
obtuse	O
marginal	O
,	O
saphenous	O
vein	O
graft	O
to	O
right	O
coronary	O
artery	O
,	O
posterior	O
descending	O
coronary	O
artery	O
.	O

The	O
patient	O
appeared	O
to	O
have	O
tolerated	O
the	O
procedure	O
and	O
was	O
transferred	O
to	O
the	O
cardiac	O
intensive	O
care	O
unit	O
for	O
postoperative	O
management	O
.	O

He	O
was	O
started	O
on	O
beta	O
blockers	O
.	O

The	O
patient	O
had	O
pacing	O
wires	O
and	O
chest	O
tubes	O
in	O
place	O
,	O
both	O
of	O
which	O
over	O
the	O
course	O
of	O
his	O
stay	O
were	O
removed	O
successfully	O
.	O

The	O
patient	O
did	O
well	O
postoperatively	O
and	O
was	O
transported	O
to	O
the	O
regular	O
cardiac	O
surgery	O
floor	O
where	O
he	O
tolerated	O
a	O
regular	O
diet	O
,	O
ambulated	O
well	O
,	O
did	O
well	O
with	O
his	O
activities	O
of	O
daily	O
living	O
.	O

He	O
was	O
seen	O
by	O
physical	O
therapy	O
and	O
cleared	O
.	O

They	O
requested	O
that	O
he	O
follow	O
up	O
in	O
three	O
to	O
five	O
weeks	O
for	O
endurance	O
training	O
,	O
however	O
then	O
physical	O
therapy	O
followed	O
him	O
a	O
number	O
of	O
times	O
afterward	O
and	O
decided	O
that	O
he	O
was	O
in	O
good	O
condition	O
and	O
did	O
not	O
need	O
further	O
physical	O
therapy	O
.	O

On	O
2016-04-11	O
the	O
patient	O
was	O
in	O
good	O
condition	O
and	O
he	O
is	O
being	O
discharged	O
on	O
a	O
regular	O
heart-healthy	O
diet	O
.	O

He	O
may	O
observe	O
regular	O
activity	O
although	O
he	O
should	O
avoid	O
strenuous	O
activity	O
and	O
should	O
not	O
drive	O
while	O
on	O
pain	O
medications	O
.	O

He	O
should	O
follow	O
up	O
with	O
Dr.	O
Dushaj	O
in	O
four	O
weeks	O
.	O

He	O
should	O
follow	O
up	O
with	O
his	O
cardiologist	O
in	O
two	O
to	O
three	O
weeks	O
and	O
he	O
should	O
follow	O
up	O
with	O
his	O
primary	O
care	O
physician	O
in	O
one	O
to	O
two	O
weeks	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Lasix	O
20	O
mg	O
p.o.	O
q.	O
12	O
.	O

2.	O
Potassium	O
20	O
mEq	O
p.o.	O
q.	O
12	O
.	O

3.	O
Colace	O
100	O
mg	O
p.o.	O
b.i.d.	O

4.	O
Aspirin	O
325	O
mg	O
p.o.	O
q.d.	O

5.	O
Percocet	O
1-2	O
tablets	O
p.o.	O
q.	O
4	O
p.r.n.	O
pain	B-disease
.	O

6.	O
Lopressor	O
12.5	O
mg	O
p.o.	O
b.i.d.	O

Alexander	O
S.	O
Young	O
,	O
M.D.	O
29-418	O

Dictated	O
By	O
:	O
Lila	O
I	O
Morgan	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2016-04-11	O
10:48	O

T	O
:	O
2016-04-11	O
10:59	O

JOB	O
#:	O
75073	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jose	O
Kines	O
on	O
:	O
TUE	O
2016-04-12	O
7:03	O
AM	O

(	O
End	O
of	O
Report	O
)	O

405507617	O

FIH	O

2887168	O

132052	O

543394	O

11/12/2002	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

SPALDFREIERMPLCA	O
,	O
IEOLY	O
E	O

UNIT	O
NUMBER	O
:	O

251-62-95	O

ADMISSION	O
DATE	O
:	O

11/12/2002	O

DISCHARGE	O
DATE	O
:	O

11/15/2002	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Alzheimer	B-disease
&apos;s	I-disease
disease	I-disease
secondary	O
to	O
Down	B-disease
&apos;s	I-disease
syndrome	I-disease
.	O

CHIEF	O
COMPLAINT	O
:	O

This	O
is	O
a	O
44	O
year-old	O
right	O
handed	O
woman	O
with	O
Down	B-disease
&apos;s	I-disease
syndrome	I-disease
who	O
presents	O
with	O
falling	B-disease
and	O
a	B-disease
decrease	I-disease
in	I-disease
her	I-disease
activities	I-disease
of	O
daily	O
living	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
44	O
year-old	O
right	O
handed	O
woman	O
with	O
Down	B-disease
&apos;s	I-disease
syndrome	I-disease
who	O
presents	O
with	O
increased	B-disease
falling	I-disease
and	O
gait	B-disease
unsteadiness	I-disease
and	O
an	B-disease
increased	I-disease
inability	I-disease
to	O
perform	O
her	O
activities	O
of	O
daily	O
living	O
over	O
the	O
past	O
three	O
years	O
.	O

The	O
diagnosis	O
of	O
Alzheimer	B-disease
&apos;s	I-disease
was	O
made	O
in	O
1998	O
.	O

The	O
patient	O
had	O
an	O
MRI	O
at	O
an	O
outside	O
hospital	O
which	O
showed	O
enlarged	B-disease
lateral	I-disease
ventricles	I-disease
and	O
the	O
possible	O
diagnosis	O
of	O
normal	B-disease
pressure	I-disease
hydrocephalus	I-disease
was	O
entertained	O
and	O
the	O
patient	O
was	O
admitted	O
for	O
diagnostic	O
lumbar	O
puncture	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Notable	O
for	O
Down	B-disease
&apos;s	I-disease
syndrome	I-disease
,	O
Altzheimer	B-disease
&apos;s	I-disease
disease	I-disease
secondary	O
to	O
Down	B-disease
&apos;s	I-disease
syndrome	I-disease
diagnosed	O
in	O
1998	O
,	O
status	O
post	O
multiple	B-disease
falls	I-disease
,	O
no	O
heart	B-disease
disease	I-disease
,	O
ankle	O
surgery	O
and	O
an	B-disease
abnormal	I-disease
EEG	I-disease
.	O

MEDICATIONS	O
:	O

Include	O
Lamictal	O
50	O
mgs	O
bid	O
,	O
Aricept	O
10	O
mgs	O
qhs	O
,	O
BuSpar	O
15	O
mgs	O
bid	O
,	O
Trazodone	O
100	O
mgs	O
qhs	O
.	O

ALLERGIES	O
:	O

There	O
are	O
no	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
at	O
home	O
with	O
her	O
family	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Notable	O
for	O
decreased	B-disease
ability	I-disease
to	O
do	O
her	O
activities	O
of	O
daily	O
living	O
,	O
a	B-disease
decrease	I-disease
in	I-disease
her	I-disease
language	I-disease
,	O
some	B-disease
urinary	I-disease
accidents	I-disease
,	O
increased	B-disease
falls	I-disease
and	O
a	B-disease
poor	I-disease
gait	I-disease
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Noted	O
for	O
friendly	O
,	O
jovial	O
44	O
year-old	O
woman	O
with	O
Down	B-disease
&apos;s	I-disease
.	O

Vital	O
signs	O
:	O

Blood	O
pressure	O
150/82	O
,	O
heart	O
rate	O
88	O
,	O
respiratory	O
rate	O
18	O
.	O

HEENT	O
examination	O
is	O
notable	O
for	O
bilateral	B-disease
esotropia	I-disease
.	O

Chest	O
was	O
clear	O
to	O
auscultation	O
.	O

Cardiac	O
examination	O
was	O
regular	O
rate	O
and	O
rhythm	O
.	O

Abdominal	O
examination	O
was	O
soft	O
,	O
non-tender	B-disease
,	O
positive	O
bowel	O
sounds	O
.	O

Extremities	O
:	O

Left	O
ankle	O
was	O
notable	O
for	O
swelling	B-disease
secondary	O
to	O
status	O
post	O
left	O
ankle	O
surgery	O
.	O

Skin	O
:	O

The	O
patient	O
had	O
back	B-disease
folliculitis	I-disease
.	O

Neuro	O
examination	O
was	O
notable	O
for	O
a	O
patient	O
who	O
was	O
alert	O
and	O
oriented	O
x	O
1	O
.	O

She	O
could	O
identify	O
her	O
siblings	O
.	O

She	O
can	O
name	O
several	O
words	O
such	O
as	O
thumb	O
,	O
watch	O
and	O
knuckle	O
.	O

She	O
was	O
unable	O
to	O
name	O
glasses	O
.	O

Cranial	O
nerves	O
notable	O
for	O
bilateral	B-disease
esotropia	I-disease
.	O

Her	O
extraocular	O
motions	O
were	O
full	O
.	O

The	O
face	O
was	O
symmetrical	O
.	O

The	O
motor	O
tone	O
was	O
within	O
normal	O
limits	O
in	O
the	O
upper	O
and	O
lower	O
extremities	O
.	O

The	O
strength	O
was	O
5	O
out	O
of	O
5	O
.	O

Reflexes	O
were	O
2+	O
bilaterally	O
with	O
down	O
going	O
toes	O
.	O

Her	O
gait	O
was	O
notable	O
for	O
requiring	O
assist	O
.	O

The	O
patient	O
walked	O
with	O
her	B-disease
feet	I-disease
externally	I-disease
rotated	I-disease
with	O
a	B-disease
wide	I-disease
based	I-disease
gait	I-disease
with	O
shuffling	B-disease
short	I-disease
steps	I-disease
with	O
a	B-disease
tendency	I-disease
to	I-disease
fall	I-disease
back	I-disease
and	O
she	O
was	O
unable	O
to	O
walk	O
without	O
assist	O
.	O

MRI	O
,	O
as	O
discussed	O
,	O
was	O
done	O
at	O
outside	O
hospital	O
and	O
demonstrated	O
large	B-disease
ventricles	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Arkzie-	O
Memorial	O
for	O
lumbar	O
puncture	O
.	O

On	O
the	O
night	O
of	O
admission	O
lumbar	O
puncture	O
was	O
attempted	O
on	O
the	O
floor	O
,	O
but	O
we	O
were	O
unable	O
to	O
get	O
cerebral	O
spinal	O
fluid	O
due	O
to	O
difficulty	O
with	O
compliance	O
with	O
the	O
patient	O
who	O
was	O
severely	B-disease
agitated	I-disease
and	O
would	O
not	O
comply	O
with	O
the	O
examination	O
.	O

On	O
hospital	O
day	O
the	O
patient	O
underwent	O
conscious	O
sedation	O
in	O
the	O
operating	O
room	O
where	O
lumbar	O
puncture	O
was	O
performed	O
.	O

Opening	O
pressure	O
was	O
17	O
and	O
approximately	O
20-25	O
cc	O
of	O
CSF	O
was	O
removed	O
.	O

CSF	O
was	O
notable	O
for	O
sugar	O
level	O
of	O
65	O
and	O
total	O
protein	O
level	O
of	O
56	O
.	O

OTHER	O
LABORATORIES	O
THAT	O
WERE	O
NOTABLE	O
:	O

Vitamin	O
B12	O
of	O
855	O
,	O
folic	O
acid	O
of	O
15.4	O
.	O

Chem-7	O
was	O
within	O
normal	O
limits	O
.	O

Tube	O
and	O
requisition	O
of	O
the	O
CSF	O
labeled	O
tube	O
#	O
1	O
was	O
notable	O
for	O
color	O
pink	O
,	O
turbidity	O
slight	O
,	O
xanthochromia	O
yes	O
,	O
red	O
blood	O
cells	O
3,800	O
,	O
white	O
blood	O
cells	O
3	O
,	O
neutrophils	O
58	O
,	O
bands	O
4	O
,	O
lymphs	O
29	O
,	O
monos	O
6	O
,	O
eos	O
2	O
and	O
basos	O
1	O
.	O

CSF	O
tube	O
labeled	O
#	O
4	O
was	O
notable	O
for	O
CSF	O
color	O
pink	O
,	O
CSF	O
turbidity	O
slight	O
,	O
CSF	O
xanthochromia	O
yes	O
,	O
CSF	O
RBCs	O
3,900	O
,	O
CSF	O
white	O
blood	O
cells	O
3	O
,	O
CSF	O
neutrophils	O
61	O
,	O
CSF	O
bands	O
3	O
,	O
CSF	O
lymphs	O
31	O
,	O
CSF	O
monos	O
1	O
,	O
CSF	O
eos	O
3	O
,	O
CSF	O
basos	O
1	O
.	O

CSF	O
gram	O
stain	O
was	O
notable	O
for	O
no	O
polys	B-disease
and	O
no	O
organisms	B-disease
seen	O
.	O

The	O
fluid	O
culture	O
was	O
no	O
growth	O
to	O
date	O
.	O

One	O
day	O
prior	O
to	O
lumbar	O
puncture	O
,	O
an	O
aerobic	O
culture	O
was	O
similarly	O
pending	O
.	O

Lyme	O
capture	O
was	O
pending	O
and	O
at	O
the	O
time	O
of	O
discharge	O
.	O

Other	O
notable	O
tests	O
:	O

RPR	O
card	O
test	O
was	O
negative	O
.	O

Because	O
of	O
poor	O
compliance	O
with	O
the	O
gait	O
examination	O
it	O
was	O
very	O
difficult	O
to	O
assess	O
changing	B-disease
gait	I-disease
post	O
lumbar	O
puncture	O
.	O

The	O
patient	O
&apos;s	O
gait	O
remained	O
wide	O
based	O
and	O
shuffling	O
and	O
requiring	O
assist	O
.	O

Her	O
mental	O
status	O
remained	O
similarly	O
to	O
her	O
admission	O
examination	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
on	O
11/15/02	O
with	O
instructions	O
to	O
the	O
family	O
to	O
observe	O
her	O
gait	O
in	O
her	O
home	O
environment	O
and	O
to	O
observe	O
her	O
behavior	O
in	O
her	O
home	O
environment	O
over	O
the	O
next	O
day	O
and	O
to	O
report	O
back	O
to	O
the	O
primary	O
neurologist	O
,	O
Dr.	O
Flythegach	O
,	O
as	O
to	O
changes	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Were	O
as	O
they	O
were	O
on	O
admission	O
.	O

The	O
patient	O
&apos;s	O
neuro	O
examination	O
was	O
largely	O
unchanged	O
from	O
the	O
admission	O
neuro	O
examination	O
.	O

LATO	O
TIKFREIERM	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

_____________________________	O
LATO	O
TIKFREIERM	O
,	O
M.D.	O

TR	O
:	O

yh	O

DD	O
:	O

11/14/2002	O

TD	O
:	O

11/19/2002	O
3:35	O
P	O

cc	O
:	O

SIE	O
FLYTHEGACH	O
,	O
M.D.	O
TIFFILL	O
SAPNINS	O
,	O
M.D.	O
STA	O
THERNLIN	O
BALLOON	O
,	O
M.D.	O
LATO	O
TIKFREIERM	O
,	O
M.D.	O
/PCP	O
,	O
Jofredd	O
Mones	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2015-03-26	O

Discharge	O
Date	O
:	O

2015-03-30	O

Date	O
of	O
Birth	O
:	O

1967-03-08	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Morphine	O
/	O
Histamine	O
H2	O
Inhibitors	O
/	O
Heparin	O
Agents	O

Attending	O
:	O
Terry	O
T	O
Trott	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Increasing	B-disease
abdominal	I-disease
girth	I-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

4u	O
FFP	O

Paracentesis	O

History	O
of	O
Present	O
Illness	O
:	O

47	O
female	O
with	O
h/o	O
HCV	B-disease
cirrhosis	I-disease
compocated	O
by	O
encephalopathy	B-disease
,	O
ascites	B-disease
,	O
and	O
h/o	O
portal	B-disease
vein	I-disease
thrombosis	I-disease
(	O
right	O
anterior	O
portal	O
vein	O
)	O
and	O
portalcaval	O
shunt	O
(	O
reversed	O
flow	O
in	O
main	O
portal	O
vein	O
)	O
presents	O
from	O
liver	O
clinic	O
with	O
increasing	B-disease
abdominal	I-disease
girth	I-disease
.	O

She	O
also	O
described	O
sob	B-disease
,	O
nausea	B-disease
,	O
worsening	B-disease
lower	I-disease
ext	I-disease
edema	I-disease
.	O

She	O
denied	O
abd	B-disease
pain	I-disease
,	O
fevers	B-disease
,	O
chills	B-disease
.	O

She	O
was	O
admitted	O
for	O
a	O
large	O
volume	O
paracentesis	O
but	O
her	O
INR	O
on	O
admission	O
was	O
3.8	O
.	O

She	O
received	O
4units	O
of	O
FFP	O
which	O
decreased	O
her	O
INR	O
to	O
2.2	O
and	O
then	O
2	O
more	O
units	O
during	O
the	O
tap	O
.	O

She	O
then	O
had	O
6L	O
of	O
non-bloody	B-disease
ascitic	I-disease
fluid	I-disease
removed	O
without	O
complication	B-disease
.	O

She	O
received	O
36gm	O
of	O
albumin	O
following	O
the	O
tap	O
.	O

Her	O
BP	O
on	O
admission	O
was	O
120/70	O
and	O
remained	O
stable	O
following	O
the	O
tap	O
.	O

Over	O
the	O
next	O
several	O
hours	O
,	O
pt	O
complained	O
of	O
abd	B-disease
pain	I-disease
but	O
this	O
resolved	O
on	O
its	O
own	O
without	O
medication	O
.	O

In	O
the	O
am	O
,	O
she	O
was	O
found	O
to	O
have	O
a	O
hct	O
of	O
24	O
,	O
down	O
from	O
32	O
and	O
plts	O
35	O
,	O
down	O
from	O
72	O
.	O

She	O
received	O
2	O
units	O
of	O
plts	O
and	O
1	O
unit	O
of	O
PRBC	O
s.	O

Her	O
BP	O
was	O
then	O
noted	O
to	O
be	O
decreased	B-disease
at	O
80/40	O
which	O
improved	O
mildly	O
to	O
90/30	O
with	O
1.5L	O
of	O
NS	O
.	O

Temp	O
noted	O
to	O
be	O
low	B-disease
at	O
94	O
and	O
she	O
was	O
placed	O
on	O
bear	O
hugger	O
which	O
improved	O
temp	O
to	O
96.7	O
.	O

Her	O
mental	O
status	O
also	O
had	O
decreased	B-disease
from	O
admission	O
and	O
her	O
urine	O
output	O
was	O
minimal	B-disease
,	O
225cc	O
over	O
the	O
past	O
12	O
hours	O
.	O

Creatinine	O
this	O
am	O
was	O
1.9	O
from	O
0.9	O
yesterday	O
.	O

Previous	O
hospital	O
course	O
(	O
per	O
H&P	O
):	O

She	O
was	O
recently	O
hospitalised	O
from	O
02-23	O
/	O
03-04	O
for	O
abdominal	B-disease
discomfort	I-disease
at	O
which	O
time	O
she	O
underwent	O
paracentesis	O
that	O
ruled	O
out	O
SBP	B-disease
and	O
relieved	O
her	B-disease
abdominal	I-disease
pain	I-disease
.	O

She	O
also	O
underwent	O
US	O
that	O
revealed	O
patent	O
portal	O
and	O
hepatic	O
vessels	O
.	O

While	O
her	O
discharge	O
summary	O
maintains	O
that	O
she	O
was	O
continued	O
on	O
Furosemide	O
/	O
Spirinolactone	O
/	O
Propranolol	O
,	O
the	O
patient	O
did	O
not	O
receive	O
any	O
scripts	O
on	O
discharge	O
and	O
as	O
a	O
result	O
did	O
not	O
take	O
these	O
medications	O
.	O

Also	O
,	O
due	O
to	O
worsening	B-disease
renal	I-disease
function	I-disease
,	O
she	O
was	O
started	O
on	O
octreotide	O
/	O
midodrine	O
/	O
albumin	O
for	O
hepatorenal	O

syndrome	B-disease
(	O
Cr	O
3.3	O
at	O
its	O
worst	O
)	O
which	O
resolved	O
prior	O
to	O
her	O
discharge	O
.	O

The	O
hospitalisation	O
was	O
also	O
significant	O
for	O
mild	B-disease
DIC	I-disease
for	O
which	O
she	O
received	O
cryoglobulins	O
and	O
UTI	B-disease
(+	O
Enterococcus	B-disease
and	O
+	O
Klebsiella	B-disease
).	O

She	O
received	O
a	O
7	O
day	O
course	O
of	O
amoxicillin	O
for	O
which	O
Enterococcus	B-disease
was	O
sensitive	O
but	O
Klebsiella	B-disease
unknown	O
.	O

Past	O
Medical	O
History	O
:	O

HCV	B-disease
cirrhosis	I-disease
c/b	O
esophageal	B-disease
varices	I-disease
,	O
ascites	B-disease
,	O
partial	B-disease
portal	I-disease
vein	I-disease
thrombosis	I-disease

h/o	O
gastritis	B-disease

morbid	B-disease
obesity	I-disease

recent	O
cholecystitis	B-disease
08-10	O

h/o	O
EtOH	O
abuse	O

sickle	B-disease
cell	I-disease
trait	I-disease

Social	O
History	O
:	O

Patient	O
denies	O
etoh	O
and	O
tobacco	O
use	O
.	O

She	O
has	O
a	O
history	O
of	O
heavy	O
alcohol	O
use	O
.	O

Lives	O
alone	O
second	O
floor	O
apartment	O
;	O
son	O
and	O
mother	O
nearby	O

Family	O
History	O
:	O

None	O

Physical	O
Exam	O
:	O

Physical	O
Exam	O
:	O
T	O
95	O
,	O
BP	O
120/70	O
,	O
HR	O
82	O
,	O
RR	O
20	O
,	O
96%	O
RA	O
Wt	O
301.6	O
lb	O

HEENT	O
:	O
+	O
scleral	B-disease
icterus	I-disease
.	O

No	O
thrush	B-disease
.	O

Neck	O
:	O
No	O
Donna	O
,	O
normal	O
thyroid	O
contour	O

Lungs	O
:	O
CTAB	O

Cardiac	O
:	O
RRR	O
,	O
no	O
murmurs	B-disease

Abdomen	O
:	O
obese	B-disease
,	O
soft	O
,	O
mildly	B-disease
distended	I-disease
dull	B-disease
to	O
percussion	O
throughout	O
,	O
no	O
tenderness	B-disease
,	O
liver	B-disease
non-palpable	I-disease
due	O
to	O
large	B-disease
volume	I-disease
of	I-disease
ascited	I-disease

Extremities	O
:	O
05-09	O
+	O
pretibial	B-disease
edema	I-disease
extending	O
above	O
knee	O
R	O
>	O
L	O
,	O
no	O
asterixis	B-disease
.	O

No	O
palmar	B-disease
erythema	I-disease

Pertinent	O
Results	O
:	O

2015-03-26	O
10:10	O
AM	O
BLOOD	O
WBC	O
-	O
8.1	O
RBC	O
-	O
3.69	O
*	O
Hgb	O
-	O
11.0	O
*	O
Hct	O
-	O
32.4	O
*	O
MCV	O
-	O
88	O
MCH	O
-	O
29.8	O
MCHC	O
-	O
33.9	O
RDW	O
-	O
26.0	O
*	O
Plt	O
Ct	O
-	O
72	O
*#	O

2015-03-26	O
10:10	O
AM	O
BLOOD	O
Neuts	O
-	O
68.3	O
Bands	O
-	O
0	O
Lymphs	O
-	O
19.8	O
Monos	O
-	O
10.6	O
Eos	O
-	O
1.1	O
Baso	O
-	O
0.2	O

2015-03-26	O
10:10	O
AM	O
BLOOD	O
Hypochr	O
-	O
1	O
+	O
Anisocy	O
-	O
2	O
+	O
Poiklo	O
-	O
2	O
+	O
Macrocy	O
-	O
2	O
+	O
Microcy	O
-	O
NORMAL	O
Polychr	O
-	O
NORMAL	O
Ovalocy	O
-	O
OCCASIONAL	O
Target	O
-	O
OCCASIONAL	O
Schisto	O
-	O
OCCASIONAL	O
Tear	O
Dr	O
Clark	O

2015-03-26	O
10:10	O
AM	O
BLOOD	O
PT	O
-	O
23.0	O
*	O
PTT	O
-	O
63.2	O
*	O
INR(PT)	O
-	O
3.8	O

2015-03-26	O
10:10	O
AM	O
BLOOD	O
Glucose	O
-	O
76	O
UreaN	O
-	O
17	O
Creat	O
-	O
0.8	O
Na	O
-	O
129	O
*	O
K	O
-	O
3.9	O
Cl	O
-	O
101	O
HCO3	O
-	O
19	O
*	O
AnGap	O
-	O
13	O

2015-03-26	O
10:10	O
AM	O
BLOOD	O
ALT	O
-	O
33	O
AST	O
-	O
65	O
*	O
AlkPhos	O
-	O
70	O
TotBili	O
-	O
30.3	O
*	O
DirBili	O
-	O
20.8	O
*	O
IndBili	O
-	O
9.5	O

2015-03-26	O
10:10	O
AM	O
BLOOD	O
Albumin	O
-	O
3.1	O
*	O

2015-03-26	O
10:10	O
AM	O
BLOOD	O
Ammonia	O
-	O
39	O

RADIOLOGY	O

1.	O
Small	B-disease
cirrhotic	I-disease
liver	I-disease
with	O
what	O
appears	O
to	O
be	O
a	O
portocaval	O
shunt	O
.	O

2.	O
Moderate	B-disease
ascites	I-disease
.	O

3.	O
Cholelithiasis	B-disease
without	O
evidence	O
of	O
acute	B-disease
cholecystitis	I-disease
.	O

4.	O
No	O
hydronephrosis	B-disease
.	O

5.	O
Borderline	B-disease
splenomegaly	I-disease
.	O

Brief	O
Hospital	O
Course	O
:	O

A/P	O
:	O
48	O
yo	O
morbidly	O
obese	O
woman	O
with	O
HCV	B-disease
cirrhosis	I-disease
c/b	O
encephalopathy	B-disease
,	O
esophageal	B-disease
varices	I-disease
and	O
partial	B-disease
vein	I-disease
thrombosis	I-disease
(	O
but	O
no	O
hx	O
of	O
SBP	B-disease
)	O
presents	O
with	O
increasing	B-disease
abdominal	I-disease
girth	I-disease
likely	O
secondary	O
to	O
ascites	B-disease
.	O

Admitted	O
for	O
diagnostic	O
/	O
therapeutic	O
paracentesis	O
and	O
then	O
transferred	O
to	O
the	O
ICU	O
for	O
hypotension	B-disease
,	O
confusion	B-disease
and	O
anemia	B-disease
.	O

#	O
Liver	B-disease
cirrhosis	I-disease
:	O
MELD	O
score	O
of	O
34	O
on	O
admission	O
.	O

Pt	O
became	O
more	B-disease
encephalopathic	I-disease
during	O
her	O
hospital	O
course	O
.	O

She	O
was	O
not	O
a	O
transplant	O
candidate	O
due	O
to	O
her	B-disease
obesity	I-disease
.	O

A	O
family	O
meeting	O
was	O
held	O
on	O
hospital	O
day	O
#4	O
which	O
included	O
the	O
pt	O
's	O
closest	O
family	O
members	O
,	O
her	O
hepatologist	O
,	O
Dr.	O
Steidl	O
,	O
her	O
PCP	O
,	O
Dr.	O
Popoff	O
and	O
the	O
ICU	O
team	O
.	O

After	O
it	O
was	O
explained	O
that	O
the	B-disease
pt	I-disease
's	I-disease
prognosis	I-disease
was	O
very	O
poor	O
given	O
that	O
she	O
was	O
not	O
a	O
transplant	O
candidate	O
,	O
the	O

decision	O
was	O
made	O
by	O
the	O
family	O
and	O
the	O
medical	O
team	O
to	O
withdraw	O
care	O
.	O

The	O
pt	O
was	O
made	O
comfortable	O
and	O
she	O
expired	O
several	O
hours	O
later	O
.	O

#	O
Recurrent	B-disease
ascites	I-disease
:	O
On	O
the	O
medical	O
floor	O
,	O
pt	O
had	O
a	O
large	O
volume	O
paracentesis	O
(	O
6	O
liters	O
)	O
followed	O
by	O
replacement	O
with	O
albumin	O
.	O

She	O
had	O
no	O
evidence	O
of	O
SBP	B-disease
.	O

#	O
Hypotension	B-disease
:	O
Pt	O
became	O
hypotensive	B-disease
following	O
the	O
large	O
volume	O
paracentesis	O
despite	O
replacement	O
with	O
albumin	O
.	O

This	O
was	O
thought	O
to	O
be	O
04-09	O
the	O
large	O
volume	O
tap	O
verses	O
sepsis	B-disease
though	O
she	O
had	O
no	O
other	O
evidence	O
of	O
sepsis	B-disease
.	O

She	O
was	O
placed	O
on	O
pressors	O
to	O
maintain	O
a	O
MAP	O
>	O
55	O
.	O

Once	O
the	O
decision	O
was	O
made	O
to	O
withdraw	O
care	O
,	O
the	O
pressors	O
were	O
discontinued	O
.	O

#	O
Anemia	B-disease
:	O
Hct	B-disease
dropped	I-disease
following	O
the	O
tap	O
and	O
there	O
was	O
concern	O
for	O
bleed	B-disease
into	I-disease
her	I-disease
abdomen	I-disease
.	O

She	O
received	O
one	O
unit	O
of	O
PRBC	O
s.	O

CT	O
of	O
the	O
abdomen	O
and	O
pelvis	O
showed	O
no	O
evidence	O
of	O
bleed	B-disease
.	O

Her	O
hematocrit	O
remained	O
stable	O
at	O
24-26	O
following	O
the	B-disease
acute	I-disease
drop.	I-disease

#	O
ARF	B-disease
:	O
Creatinine	O
has	O
increased	O
from	O
0.9	O
on	O
admission	O
to	O
1.9	O
on	O
admission	O
to	O
ICU	O
.	O

Urine	O
lytes	O
with	O
Na	O
of	O
10	O
indicating	O
either	O
pre-renal	B-disease
or	O
hepatorenal	B-disease
.	O

Fluid	O
challenge	O
with	O
36gm	O
of	O
albumin	O
,	O
one	O
unit	O
of	O
PRBCs	O
and	O
2L	O
of	O
NS	O
.	O

Will	O
check	O
creatinine	O
this	O
afternoon	O
.	O

Pt	O
previously	O
diagnosed	O
with	O
hepatorenal	B-disease
and	O
was	O
started	O
on	O
midodrine	O
,	O
octreotide	O
and	O
albumin	O
;	O
these	O
were	O

continued	O
.	O

Her	O
creatinine	O
continued	O
to	O
increase	O
,	O
likely	O
due	O
to	O
her	B-disease
worsening	I-disease
liver	I-disease
failure	I-disease
.	O

Pt	O
expired	O
during	O
this	O
admission	O
after	O
family	O
discussion	O
to	O
make	O
her	O
comfort	O
care	O
only	O
.	O

Medications	O
on	O
Admission	O
:	O

Rifaximine	O
200	O
mg	O
tid	O

Lactulose	O
30	O
cc	O
qid	O
titrated	O
to	O
3-4	O
BM	O
/	O
day	O

Protonix	O
40	O
mg	O
po	O
qd	O

Discharge	O
Medications	O
:	O

none	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

none	O

Discharge	O
Condition	O
:	O

expired	B-disease

Discharge	O
Instructions	O
:	O

none	O

Followup	O
Instructions	O
:	O

none	O

Tracy	O
Doris	O
MD	O
79-274	O

Completed	O
by	O
:	O
Melvin	O
Thomas	O
MD	O
50-805	O
2015-06-22	O
@	O
1413	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Micheal	O
J.	O
Rozzi	O
on	O
:	O
MON	O
2015-07-20	O
1:53	O
PM	O

(	O
End	O
of	O
Report	O
)	O

723989226	O

OMH	O

6410178	O

996067	O

3/30/1999	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

NETSHUFFSCARVTRACE	O
,	O
RIRA	O

UNIT	O
NUMBER	O
:	O

005-27-20	O

ADMISSION	O
DATE	O
:	O

03/30/1999	O

DISCHARGE	O
DATE	O
:	O

09/16/2006	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Severe	B-disease
chronic	I-disease
obstructive	I-disease
pulmonary	I-disease
disease	I-disease
.	O

Respiratory	B-disease
failure	I-disease
.	O

Congestive	B-disease
heart	I-disease
failure	I-disease
.	O

Right	B-disease
lower	I-disease
lobe	I-disease
pneumonia	I-disease
.	O

Atonic	B-disease
bladder	I-disease
with	O
suprapubic	O
catheter	O
.	O

Anxiety	B-disease
.	O

Coronary	B-disease
artery	I-disease
disease	I-disease
.	O

History	O
of	O
colon	B-disease
cancer	I-disease
status	O
post	O
hemicolectomy	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
76	O
year	O
old	O
white	O
male	O
with	O
severe	B-disease
chronic	I-disease
obstructive	I-disease
pulmonary	I-disease
disease	I-disease
who	O
has	O
had	O
several	O
recent	O
admissions	O
to	O
Oaksgekesser/	O
Memorial	O
Hospital	O
for	O
respiratory	B-disease
insuffiencey	I-disease
most	O
often	O
secondary	O
to	O
pneumonia	B-disease
.	O

He	O
was	O
most	O
recently	O
discharged	O
from	O
Oaksgekesser/	O
Memorial	O
Hospital	O
on	O
03/06/99	O
and	O
was	O
then	O
transferred	O
to	O
Linghs	O
County	O
Medical	O
Center	O
from	O
which	O
he	O
was	O
discharged	O
on	O
03/20/99	O
.	O

The	O
patient	O
was	O
doing	O
relatively	O
at	O
home	O
until	O
one	O
day	O
prior	O
to	O
admission	O
he	O
complained	O
discomfort	B-disease
over	O
a	O
suprapubic	O
catheter	O
area	O
.	O

The	O
patient	O
had	O
missed	O
his	O
usual	O
monthly	O
change	O
of	O
his	O
suprapubic	O
catheter	O
and	O
felt	O
discomfort	B-disease
and	O
noticed	O
some	B-disease
blood	I-disease
at	I-disease
the	I-disease
site	I-disease
of	O
the	O
catheter	O
.	O

The	O
patient	O
was	O
brought	O
to	O
the	O
Emergency	O
Room	O
one	O
day	O
prior	O
to	O
admission	O
where	O
he	O
was	O
evaluated	O
by	O
Urology	O
and	O
had	O
his	O
catheter	O
changed	O
.	O

The	O
patient	O
at	O
that	O
time	O
noted	O
slight	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
but	O
was	O
sent	O
home	O
anyway	O
.	O

On	O
the	O
day	O
of	O
admission	O
the	O
patient	O
noticed	O
increasing	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
.	O

The	O
patient	O
was	O
noted	O
to	O
be	O
confused	B-disease
and	O
to	O
be	O
disoriented	B-disease
toward	O
the	O
end	O
of	O
the	O
day	O
after	O
complaining	O
of	O
shortness	B-disease
of	I-disease
breath	I-disease
for	O
most	O
of	O
the	O
day	O
.	O

The	O
patient	O
denies	O
any	O
recent	B-disease
upper	I-disease
respiratory	I-disease
infections	I-disease
,	O
no	O
fevers	B-disease
,	O
no	O
chills	B-disease
,	O
no	O
change	B-disease
in	I-disease
cough	I-disease
,	O
sputum	B-disease
.	O

He	O
also	O
denies	O
any	O
chest	B-disease
pain	I-disease
.	O

No	O
orthopnea	B-disease
.	O

No	O
paroxysmal	B-disease
nocturnal	I-disease
dyspnea	I-disease
.	O

The	O
patient	O
had	O
been	O
taking	O
his	O
usual	O
medications	O
and	O
using	O
his	O
nasal	O
oxygen	O
at	O
home	O
.	O

By	O
the	O
time	O
the	O
patient	O
arrived	O
at	O
the	O
Oaksgekesser/	O
Memorial	O
Hospital	O
Emergency	O
Room	O
he	O
was	O
in	O
moderate	B-disease
respiratory	I-disease
distress	I-disease
.	O

His	O
initial	O
blood	O
gases	O
on	O
40%	O
02	O
was	O
P02	O
102	O
,	O
PC02	O
115	O
,	O
PH	O
7.11	O
.	O

The	O
patient	O
was	O
given	O
respiratory	O
therapy	O
in	O
the	O
way	O
of	O
nebulizer	O
treatments	O
in	O
the	O
Oaksgekesser/	O
Memorial	O
Hospital	O
Emergency	O
Room	O
because	O
of	O
a	O
longstanding	O
desire	O
by	O
patient	O
and	O
family	O
to	O
refrain	O
from	O
intubation	O
to	O
be	O
considered	O
Do	O
Not	O
Resuscitate	O
.	O

The	O
patient	O
was	O
not	O
intubated	O
.	O

However	O
he	O
was	O
transferred	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
where	O
he	O
received	O
continuous	O
respiratory	O
therapy	O
in	O
theway	O
of	O
Albuterol	O
nebulizers	O
as	O
well	O
as	O
nasal	O
oxygen	O
,	O
intravenous	O
steroids	O
and	O
intravenous	O
antibiotics	O
.	O

A	O
chest	O
x-ray	O
in	O
the	O
Oaksgekesser/	O
Memorial	O
Hospital	O
Emergency	O
Room	O
showed	O
new	B-disease
changes	I-disease
on	O
his	O
chest	O
x-ray	O
on	O
top	O
of	O
his	B-disease
usual	I-disease
severe	I-disease
bilateral	I-disease
emphysema_____	I-disease
with	O
scarring	B-disease
in	I-disease
both	I-disease
lungs	I-disease
.	O

There	O
were	O
new	B-disease
air	I-disease
space	I-disease
opacifications	I-disease
in	I-disease
the	I-disease
left	I-disease
apex	I-disease
and	I-disease
the	I-disease
right	I-disease
lower	I-disease
lobe	I-disease
.	O

These	O
were	O
thought	O
to	O
be	O
consistent	O
either	O
with	O
pneumonia	B-disease
or	O
asymmetric	B-disease
pulmonary	I-disease
edema	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Associated	B-disease
medical	I-disease
problems	I-disease
include	O
:	O

1.	O
Atonic	B-disease
bladder	I-disease
with	O
a	O
suprapubic	O
tube	O
.	O

2.	O
Anxiety	B-disease
.	O

3.	O
Coronary	B-disease
artery	I-disease
disease	I-disease
with	O
a	O
history	O
of	O
angina	B-disease
in	O
the	O
distant	O
past	O
.	O

4.	O
History	O
of	O
colon	B-disease
cancer	I-disease
with	O
a	O
colectomy	O
in	O
the	O
past	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Ativan	O
1	O
mg	O
po	O
twice	O
a	O
day	O
.	O

2.	O
Trusopt	O
1	O
gtt	O
left	O
eye	O
three	O
times	O
a	O
day	O
.	O

3.	O
Xalatan	O
0.005%	O
one	O
gtt	O
left	O
eye	O
qhs	O
.	O

4.	O
Brimonidine	O
1	O
gtt	O
left	O
eye	O
three	O
times	O
a	O
day	O
.	O

5.	O
Combivent	O
3	O
puffs	O
four	O
times	O
per	O
day	O
.	O

6.	O
Aerobid	O
three	O
puffs	O
twice	O
a	O
day	O
.	O

7.	O
Sorbitol	O
30	O
cc	O
every	O
other	O
day	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

He	O
was	O
an	O
elderly	O
frail	O
gentleman	O
in	O
moderate	B-disease
respiratory	I-disease
distress	I-disease
.	O

He	O
had	O
a	O
blood	O
pressure	O
110/70	O
,	O
heart	O
rate	O
110	O
beats	O
per	O
minute	O
and	O
regular	O
,	O
respiratory	O
rate	O
25	O
.	O

He	O
was	O
in	O
moderate	B-disease
respiratory	I-disease
distress	I-disease
.	O

His	O
temperature	O
was	O
98F	O
.	O

He	O
had	O
a	O
normal	O
head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
exam	O
.	O

Neck	O
exam	O
revealed	O
no	O
jugular	B-disease
venous	I-disease
distention	I-disease
and	O
no	O
masses	B-disease
.	O

Lung	O
exam	O
revealed	O
decreased	B-disease
breath	I-disease
sounds	I-disease
as	O
well	O
as	O
crackles	B-disease
in	I-disease
the	I-disease
bases	I-disease
.	O

There	O
were	O
no	O
wheezes	B-disease
or	O
rhonchi	B-disease
.	O

Heart	O
exam	O
revealed	O
a	O
soft	O
S1	O
and	O
S2	O
,	O
no	O
murmur	B-disease
was	O
heard	O
,	O
no	O
S3	B-disease
.	O

Abdomen	O
was	O
soft	O
,	O
nontender	B-disease
with	O
no	O
masses	B-disease
palpable	I-disease
.	O

Rectal	O
exam	O
was	O
unremarkable	O
with	O
stool	O
heme	O
negative	O
.	O

Neurological	O
exam	O
revealed	O
an	O
alert	O
and	O
oriented	O
x	O
3	O
elderly	O
male	O
.	O

He	O
moved	O
all	O
extremities	O
.	O

Deep	O
tendon	O
reflexes	O
were	O
symmetrical	O
in	O
all	O
extremities	O
.	O

LABORATORY	O
AND	O
RADIOLOGIC	O
DATA	O
:	O

Sodium	O
148	O
,	O
potassium	O
3.4	O
,	O
glucose	O
174	O
,	O
P02	O
102	O
,	O
PC02	O
115	O
,	O
PH	O
7.11	O
on	O
40%	O
02	O
.	O

Blood	O
urea	O
nitrogen	O
11	O
,	O
creatinine	O
.6	O
,	O
uric	O
acid	O
3.0	O
,	O
alkaline	O
phosphatase	O
78	O
,	O
creatinine	B-disease
phosphokinase	I-disease
isoenzymes	I-disease
too	I-disease
low	I-disease
,	O
hematocrit	O
41	O
,	O
white	O
blood	O
cell	O
count	O
11.6	O
.	O

Urine	O
analysis	O
showed	O
20-50	O
white	O
blood	O
cells	O
and	O
3-5	O
red	O
blood	O
cells	O
.	O

Electrocardiogram	O
showed	O
sinus	B-disease
tachycardia	I-disease
at	O
a	O
rate	O
of	O
123	O
beats	O
per	O
minute	O
compared	O
to	O
previous	O
electrocardiogram	O
of	O
1/29	O
there	O
were	O
no	O
significant	B-disease
changes	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
stabilized	O
in	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
.	O

He	O
stayed	O
in	O
the	O
unit	O
for	O
about	O
one	O
day	O
.	O

During	O
that	O
period	O
of	O
time	O
he	O
received	O
nebulizer	O
treatments	O
with	O
Albuterol	O
.	O

He	O
was	O
also	O
started	O
on	O
intravenous	O
Ticarcillin	O
for	O
possible	O
gram	B-disease
negative	I-disease
pneumonia	I-disease
.	O

He	O
was	O
diuresed	O
with	O
intravenous	O
Lasix	O
to	O
which	O
he	O
responded	O
with	O
at	O
lease	O
a	O
2L	O
urine	O
output	O
on	O
the	O
first	O
day	O
and	O
1.5L	O
the	O
second	O
day	O
.	O

After	O
one	O
day	O
in	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
the	O
patient	O
was	O
stable	O
enough	O
to	O
go	O
to	O
the	O
floor	O
where	O
he	O
continued	O
the	O
rest	O
of	O
his	O
treatment	O
.	O

This	O
consisted	O
of	O
continued	O
nebulizer	O
treatments	O
as	O
well	O
as	O
intravenous	O
antibiotics	O
and	O
intravenous	O
Solu-Medrol	O
.	O

As	O
the	O
patient	O
&apos;s	O
diuresis	O
continued	O
his	B-disease
respiratory	I-disease
status	I-disease
improved	O
.	O

A	O
chest	O
x-ray	O
showed	O
clearing	O
of	O
the	B-disease
opacities	I-disease
in	O
the	O
chest	O
x-ray	O
that	O
were	O
consistent	O
with	O
pulmonary	B-disease
edema	I-disease
because	O
he	O
continued	O
to	O
have	O
some	B-disease
abnormality	I-disease
in	I-disease
the	I-disease
right	I-disease
lower	I-disease
lobe	I-disease
.	O

The	O
patient	O
was	O
continued	O
on	O
antibiotics	O
for	O
possible	O
pneumonia	B-disease
.	O

The	O
antibiotic	O
chosen	O
was	O
Levaquin	O
500	O
mg	O
1	O
tab	O
per	O
day	O
.	O

This	O
was	O
started	O
on	O
4/2/99	O
and	O
should	O
be	O
continued	O
for	O
ten	O
days	O
.	O

The	O
Ticarcillin	O
was	O
stopped	O
after	O
two	O
days	O
when	O
it	O
was	O
felt	O
that	O
he	O
did	O
not	O
have	O
a	B-disease
serious	I-disease
pneumonia	I-disease
.	O

The	B-disease
patient	I-disease
&apos;s	I-disease
respiratory	I-disease
status	I-disease
continued	O
to	O
improve	O
but	O
towards	O
the	O
last	O
2-3	O
days	O
of	O
his	O
hospitalization	O
the	O
amount	O
of	O
improvement	O
was	O
minimal	O
.	O

It	O
was	O
felt	O
that	O
his	B-disease
respiratory	I-disease
status	I-disease
has	O
been	O
maximally	O
treated	O
by	O
then	O
.	O

The	O
patient	O
&apos;s	O
major	O
improvement	O
came	O
after	O
the	O
first	O
two	O
days	O
with	O
brisk	O
diuresis	O
with	O
Lasix	O
.	O

While	O
in	O
the	O
Oaksgekesser/	O
Memorial	O
Hospital	O
the	O
patient	O
on	O
4/4/99	O
complained	O
of	O
mild	B-disease
epigastric	I-disease
discomfort	I-disease
because	O
he	O
was	O
put	O
in	O
Cimetidine	O
while	O
in	O
the	O
Intensive	O
Care	O
Unit	O
for	O
prophylaxis	O
against	O
peptic	B-disease
ulcer	I-disease
disease	I-disease
.	O

The	O
patient	O
was	O
upgraded	O
to	O
Prilosec	O
20	O
mg	O
per	O
day	O
for	O
possible	O
treatment	O
of	O
gastritis	B-disease
or	O
gastroesophageal	B-disease
reflux	I-disease
disease	I-disease
.	O

The	O
patient	O
did	O
have	O
any	O
nausea	B-disease
,	O
vomiting	B-disease
or	O
evidence	O
of	O
gastrointestinal	B-disease
bleeding	I-disease
.	O

The	B-disease
patient	I-disease
&apos;s	I-disease
abdominal	I-disease
pain	I-disease
should	O
be	O
followed	O
over	O
the	O
next	O
week	O
or	O
so	O
in	O
case	O
it	O
does	O
not	O
respond	O
to	O
Prilosec	O
.	O

While	O
in	O
Oaksgekesser/	O
Memorial	O
Hospital	O
the	O
patient	O
was	O
never	O
able	O
to	O
get	O
out	O
of	O
bed	O
and	O
walk	O
independently	O
.	O

It	O
is	O
hoped	O
that	O
when	O
he	O
is	O
transferred	O
to	O
a	O
rehab	O
facility	O
that	O
he	O
will	O
continue	O
with	O
physical	O
therapy	O
to	O
regain	O
his	O
strength	O
and	O
regain	O
independence	O
in	O
activities	O
of	O
daily	O
living	O
.	O

Discussion	O
with	O
the	O
family	O
regarding	O
the	O
possibility	O
of	O
sending	O
him	O
to	O
a	O
nursing	O
home	O
was	O
entertained	O
however	O
the	O
family	O
strongly	O
refused	O
to	O
allow	O
him	O
to	O
go	O
a	O
nursing	O
home	O
.	O

They	O
wanted	O
the	O
patient	O
to	O
return	O
to	O
his	O
home	O
after	O
a	O
stay	O
at	O
a	O
rehab	O
facility	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

The	O
patient	O
&apos;s	O
respiratory	O
status	O
was	O
stable	O
.	O

I	O
think	O
his	O
breathing	O
was	O
as	O
good	O
as	O
to	O
be	O
expected	O
with	O
the	O
amount	O
of	O
severe	B-disease
chronic	I-disease
obstructive	I-disease
pulmonary	I-disease
disease	I-disease
he	O
had	O
.	O

He	O
needed	O
to	O
go	O
to	O
a	O
rehab	O
facility	O
for	O
continued	O
respiratory	O
therapy	O
and	O
for	O
Physical	O
Therapy	O
to	O
increase	O
his	O
muscle	O
strength	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Albuterol	O
2.5	O
mg	O
in	O
2.5	O
normal	O
saline	O
q4h	O
.	O

2.	O
Heparin	O
5000	O
units	O
subcutaneously	O
twice	O
a	O
day	O
.	O

3.	O
Ativan	O
.5	O
mg	O
twice	O
a	O
day	O
.	O

4.	O
Nasal	O
oxygen	O
3L	O
per	O
minute	O
.	O

5.	O
Levaquin	O
500	O
mg	O
per	O
day	O
to	O
be	O
continued	O
until	O
4/12/99	O
.	O

6.	O
Lasix	O
40	O
mg	O
per	O
day	O
.	O

7.	O
Prednisone	O
40	O
mg	O
per	O
day	O
to	O
be	O
tapered	O
over	O
two	O
weeks	O
.	O

8.	O
Xalatan	O
eyedrops	O
1	O
gtt	O
in	O
left	O
eye	O
per	O
day	O
.	O

9.	O
Alphagan	O
1	O
gtt	O
in	O
left	O
eye	O
three	O
times	O
a	O
day	O
.	O

10.	O
Trusopt	O
1gtt	O
in	O
left	O
eye	O
three	O
times	O
a	O
day	O
.	O

11.	O
Prilosec	O
20	O
mg	O
per	O
day	O
.	O

FOLLOWUP	O
:	O

The	O
patient	O
should	O
have	O
follow	O
up	O
with	O
his	O
primary	O
care	O
physician	O
Dr.	O
Rod	O
Linkeboltshieltrus	O
at	O
the	O
TRE	O
453	O
about	O
one	O
week	O
after	O
discharge	O
from	O
rehab	O
facility	O
.	O

The	O
telephone	O
number	O
at	O
his	O
office	O
is	O
236-4518	O
.	O

ROD	O
END	O
,	O
M.D.	O

TR	O
:	O

lh	O

DD	O
:	O

04/05/1999	O

TD	O
:	O

04/05/1999	O
3:06	O

Pcc	O
:	O

ROD	O
END	O
,	O
M.D.	O

C.R.TRYGLO	O
HOSPITAL	O
OF	O
STAT	O

708739405	O
DH	O

0606127	O

65761	O

4209641	O

10/29/2003	O
12:00:00	O
AM	O

OB	O
Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O
OB	O
EMR	O
L	O
and	O
D	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

SYSCO	O
TAMARCE	O
DOSE	O

UNIT	O
NUMBER	O
:	O

372-13-02	O

ADMISSION	O
DATE	O
:	O

20031029	O

DISCHARGE	O
DATE	O
:	O

20041101	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
:	O

Normal	O
Vaginal	O
Delivery	O

ASSOCIATED	O
DIAGNOSES	O
:	O

Current	O
Smoker	O
,	O
history	O
of	O
;	O
Depression	B-disease
,	O
history	O
of	O
;	O
Isoimmunization	B-disease
,	I-disease
Rh	I-disease
;	O
Undesired	B-disease
Fertility	I-disease

PRINCIPAL	O
PROCEDURE	O
OR	O
OPERATION	O
:	O

Spontaneous	O
Vertex	O
Vaginal	O
Delivery	O

ASSOCIATED	O
PROCEDURES	O
OR	O
OPERATIONS	O
:	O

POSTPARTUM	O
DIAGNOSTIC	O
PROCEDURES	O
:	O

None	O

POSTPARTUM	O
THERAPEUTIC	O
PROCEDURES	O
:	O

None	O

OTHER	O
POSTPARTUM	O
THERAPIES	O
:	O

Pp	O
Sterilization	O

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

Early	B-disease
Labor	I-disease
/	O
Rule	O
Out	O
Labor	B-disease

PHYSICAL	O
EXAMINATION	O
:	O

HEIGHT	O
HOSPITAL	O
COURSE	O
(	O
include	O
complications	O
if	O
any	O
)	O
:	O

This	O
22	O
year	O
old	O
Gravida	O
4	O
Para	O
2012	O
was	O
admitted	O
to	O
the	O
Naliheall	O
County	O
Memorial	O
Hospital	O
Obstetrical	O
service	O
on	O
10/29/2003	O
at	O
11:14	O
pm	O
for	O
the	O
indication	O
(	O
s	O
)	O
:	O
early	B-disease
labor	I-disease
/	O
rule	O
out	O
labor	B-disease
.	O

She	O
delivered	O
a	O
3263	O
gram	O
female	O
infant	O
on	O
10/30/2003	O
at	O
05:03	O
am	O
with	O
apgar	O
scores	O
of	O
8	O
and	O
9	O
at	O
one	O
and	O
five	O
minutes	O
respectively	O
at	O
40.1	O
weeks	O
gestation	O
via	O
spontaneous	O
vertex	O
vaginal	O
delivery	O
.	O

During	O
her	O
labor	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

During	O
her	O
delivery	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

nuchal	B-disease
cord	I-disease
,	O
x	O
1-	O
reduced	O
prior	O
to	O
delivery	O
.	O

Postpartum	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

She	O
was	O
discharged	O
on	O
11/01/2004	O
at	O
12:00	O
pm	O
in	O
good	O
condition	O
.	O

DISCHARGE	O
ORDERS	O
(	O
medications	O
instructions	O
to	O
patient	O
,	O
follow-up	O
care	O
)	O
:	O

DISCHARGE	O
ACTIVITY	O
:	O

No	O
Restrictions	O

DISCHARGE	O
DIET	O
:	O

No	O
Restrictions	O

POSTPARTUM	O
DISPOSITION	O
:	O

Home	O
With	O
Self-Care	O
(	O
Routine	O
Discharge	O
)	O

POSTPARTUM	O
CARE	O
SITE	O
:	O

Uval	O
General	O
Hospital	O

POSTPARTUM	O
RETURN	O
APPOINTMENT	O
(	O
DAYS	O
)	O
:	O

42	O

BREAST	O
FEEDING	O
AT	O
DISCHARGE	O
:	O

No	O

POSTPARTUM	O
RH	O
IMMUNE	O
GLOBULIN	O
:	O

Given	O

POSTPARTUM	O
MEASLES	O
/	O
MUMPS/RUBELLA	O
VACCINE	O
:	O

Not	O
Indicated	O

MEDICATION	O
(	O
S	O
)	O
ON	O
DISCHARGE	O
:	O

Multivitamins	O
And	O
Folate	O

Electronically	O
Signed	O
:	O

Ockgiernruss	O
,	O
Riret	O
R	O
12/18/2003	O
7:53:30	O
PM	O

Admission	O
Date	O
:	O

2018-12-26	O

Discharge	O
Date	O
:	O

2019-01-10	O

Date	O
of	O
Birth	O
:	O

1949-02-09	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Losartan	O
/	O
Aspirin	O
/	O
Lisinopril-Hctz	O

Attending	O
:	O
Donald	O
I	O
Patrick	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
fever	B-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Intubation	O
for	O
airway	O
protection	O
tunneled	O
line	O
change	O
over	O
wire	O
2019-01-08	O

History	O
of	O
Present	O
Illness	O
:	O

69	O
y/o	O
female	O
wtih	O
PMH	O
significant	O
for	O
ESRD	B-disease
on	O
HD	O
,	O
type	B-disease
2	I-disease
DM	I-disease
,	O
and	O
recent	B-disease
PE	I-disease
resulting	O
in	O
PEA	B-disease
arrest	I-disease
admitted	O
through	O
the	O
Juan	O
with	O
sepsis	B-disease
of	O
unknown	O
etiology	O
.	O

Pt	O
was	O
recently	O
admitted	O
to	O
The	O
Hospital	O
for	O
Orthopedics	O
from	O
12-07	O
thorugh	O
12-14	O
with	O
hypotension	B-disease
thought	O
to	O
be	O
secondary	O
to	O
overdiuresis	B-disease
at	O
HD.	O

However	O
,	O
a	B-disease
septic	I-disease
component	I-disease
to	O
the	B-disease
hypotension	I-disease
was	O
also	O
considered	O
as	O
the	O
pt	O
was	O
found	O
to	O
have	O
citrobacter	B-disease
in	I-disease
her	I-disease
urine	I-disease
and	O
C	B-disease
diff	I-disease
in	I-disease
her	I-disease
stool	I-disease
.	O

Pt	O
was	O
then	O
discharged	O
to	O
Arbour-Fuller	O
Hospital	O
Senior	O
Life	O
where	O
she	O
was	O
in	O
her	O
normal	O
state	O
of	O
health	O
until	O
three	O
days	O
ago	O
.	O

Her	O
son	O
reports	O
that	O
she	O
then	O
developed	O
a	B-disease
headache	I-disease
and	O
fevers	B-disease
started	O
three	O
days	O
ago	O
which	O
were	O
treated	O
with	O
tylenol	O
.	O

Then	O
,	O
this	O
morning	O
she	O
developed	O
fatigue	B-disease
and	O
did	O
not	O
eat	O
well	O
.	O

He	O
son	O
also	O
notes	O
that	O
she	O
appeared	O
to	O
be	O
working	B-disease
hard	I-disease
to	I-disease
breath	I-disease
.	O

She	O
was	O
found	O
to	O
be	O
febrile	B-disease
to	O
101.9	O
and	O
received	O
levoflox	O
and	O
vancomycin	O
.	O

Pt	O
was	O
then	O
sent	O
to	O
the	O
The	O
Hospital	O
for	O
Orthopedics	O
Juan	O
for	O
further	O
evaluation	O
.	O

Per	O
notes	O
,	O
pt	O
denied	O
SOB	B-disease
,	O
CP	B-disease
,	O
and	O
abdominal	B-disease
pain	I-disease
prior	O
to	O
intubation	O
.	O

She	O
did	O
complain	O
of	O
a	B-disease
left	I-disease
frontal	I-disease
headache	I-disease
.	O

In	O
the	O
Juan	O
,	O
the	O
pt	O
's	O
VS	O
were	O
singificant	O
for	O
a	B-disease
fever	I-disease
of	O
103.8	O
,	O
tachycardia	B-disease
in	O
the	O
130s-150s	O
,	O
and	O
initial	B-disease
hypertensive	I-disease
in	O
the	O
140s	O
.	O

Her	O
oxygen	O
saturation	O
was	O
96%	O
on	O
RA	O
but	O
she	O
was	O
tachypneic	B-disease
to	O
31	O
.	O

She	O
was	O
obtunded	B-disease
and	O
was	O
thus	O
intubated	O
for	O
airway	O
protection	O
.	O

Post-intubation	O
,	O
the	O
pt	O
's	O
BP	O
acutely	O
dropped	O
to	O
58/19	O
in	O
the	O
setting	O
of	O
propofol	O
.	O

When	O
this	O
medication	O
was	O
discontinued	O
,	O
her	O
BP	O
came	O
back	O
up	O
to	O
the	O
70s-90s	O
/	O
30s-50s	O
.	O

Pt	O
was	O
then	O
initiated	O
on	O
the	O
sepsis	O
protocol	O
.	O

In	O
the	O
Juan	O
,	O
she	O
received	O
vancomycin	O
,	O
levofloxacin	O
,	O
flagyl	O
,	O
and	O
cefepime	O
(	O
2	O
gm	O
).	O

She	O
received	O
a	O
total	O
of	O
4	O
liters	O
of	O
NS	O
then	O
was	O
started	O
on	O
levophed	O
for	O
continued	B-disease
hypotension	I-disease
.	O

Pt	O
is	O
now	O
transferred	O
to	O
the	O
FICU	O
for	O
further	O
care	O
.	O

Per	O
pt	O
's	O
son	O
,	O
she	O
is	O
bedbound	B-disease
at	O
baseline	O
due	O
to	O
her	B-disease
multiple	I-disease
LE	I-disease
femur	I-disease
fractures	I-disease
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Type	B-disease
2	I-disease
diabetes	I-disease
mellitus	I-disease

2.	O
Diabetic	B-disease
nephropathy	I-disease
resulting	O
in	O
ESRD	B-disease
for	O
which	O
she	O
is	O
on	O
HD	O
.	O

Pt	O
was	O
due	O
for	O
HD	O
but	O
missed	O
it	O
secondary	O
to	O
her	B-disease
illness	I-disease
.	O

She	O
normally	O
receives	O
HD	O
on	O
Mon	O
,	O
Wed	O
,	O
and	O
Fri	O
.	O

3.	O
Status	B-disease
post	I-disease
left	I-disease
femur	I-disease
fracture	I-disease

4.	O
Hyponatremia	B-disease

5.	O
Hypercholesterolemia	B-disease

6.	O
Unsteady	B-disease
gait	I-disease

7.	O
Cataracts	B-disease

8.	O
Back	B-disease
pain	I-disease

9.	O
Hypertension	B-disease

10.	O
Anemia	B-disease
of	I-disease
chronic	I-disease
disease	I-disease

11.	O
S/P	O
L	O
shoulder	O
hemiarthroplasty	O
following	O
a	B-disease
left	I-disease
humeral	I-disease
fracuture	I-disease
in	O
2018-11-10-	O
Dumas	O
was	O
complicated	O
by	O
a	B-disease
PEA	I-disease
arrest	I-disease
secondary	O
to	O
PE	B-disease
.	O

12.	O
PE	B-disease
2018-11-17	O
leading	O
to	O
PEA	B-disease
arrest	I-disease

Social	O
History	O
:	O

Lives	O
with	O
son	O
who	O
is	O
very	O
involved	O
and	O
well	O
informed	O
regarding	O
her	O
care	O
needs	O
.	O

Non	O
smoker	O
.	O

No	O
EtOH	O

Family	O
History	O
:	O

Noncontributory	O

Physical	O
Exam	O
:	O

94.5	O

132/50	O

108	O

15	O

100%	O

AC	O
500	O
/	O
15	O
/	O
.50	O
/	O
PEEP	O
5	O

Gen	O
-	O
Sedated	O
and	O
intubated	O
.	O

Grimaces	O
eyes	O
when	O
they	O
are	O
opened	O
.	O

HEENT	O
-	O
NC	O
AT	O
.	O

Right	O
pupil	O
ERRL	O
.	O

Surgical	O
left	O
pupil	O
.	O

Anicteric	B-disease
sclera	I-disease
.	O

MMM	O
.	O

Cardiac	O
-	O
RRR	O
.	O

S1	O
S2	O
.	O

No	O
m,r,g	B-disease
.	O

Pulm	O
-	O
CTA	O
anteriorlly	O
.	O

Abdomen	O
-	O
Obese	B-disease
.	O

Soft	O
.	O

NT	B-disease
.	O

ND	B-disease
.	O

Positive	O
bowel	O
sounds	O
.	O

Extremities	O
-	O
Feet	B-disease
mildly	I-disease
cool	I-disease
.	O

2+	O
DP	O
pulses	O
bilaterally	O
.	O

2+	B-disease
pitting	I-disease
edema	I-disease
bilateral	I-disease
LE	I-disease
.	O

Skin	B-disease
breakdown	I-disease
between	I-disease
toes	I-disease
.	O

Pressure	B-disease
ulcers	I-disease
under	I-disease
bilateral	I-disease
LE	I-disease
right	O
above	O
the	O
ankles	O
.	O

Do	O
not	O
appear	O
infected	B-disease
.	O

Question	O
mild	B-disease
erythema	I-disease
and	O
warmth	B-disease
of	I-disease
left	I-disease
LE	I-disease
.	O

Neuro	O
-	O
Sedated	B-disease
.	O

Downgoing	O
toes	O
bilaterally	O
.	O

Scruntches	O
eyes	O
closed	O
when	O
try	O
to	O
open	O
them	O
.	O

Pertinent	O
Results	O
:	O

2018-12-26	O
11:10	O
PM	O

LACTATE	O
-	O
1.8	O

2018-12-26	O
10:53	O
PM	O

CRP	O
-	O
46.2	O
*	O

2018-12-26	O
10:53	O
PM	O

SED	O
RATE	O
-	O
33	O
*	O

2018-12-26	O
09:54	O
PM	O

TYPE	O
-	O
MIX	O
TEMP	O
-	O
35.6	O
RATES	O
-/	O
15	O
TIDAL	O
VOL	O
-	O
500	O
PEEP	O
-	O
5	O
O2	O
-	O
50	O
PO2	O
-	O
34	O
*	O
PCO2	O
-	O
39	O
PH	O
-	O
7.32	O
*	O
TOTAL	O
CO2	O
-	O
21	O
BASE	O
XS	O
-	O
-6	O

-	O
ASSIST	O
/	O
CON	O
INTUBATED	O
-	O
INTUBATED	O

2018-12-26	O
09:54	O
PM	O

LACTATE	O
-	O
1.6	O

2018-12-26	O
09:44	O
PM	O

GLUCOSE	O
-	O
210	O
*	O
UREA	O
N	O
-	O
29	O
*	O
CREAT	O
-	O
3.2	O
*	O
SODIUM	O
-	O
139	O
POTASSIUM	O
-	O
3.9	O
CHLORIDE	O
-	O
112	O
*	O
TOTAL	O
CO2	O
-	O
17	O
*	O
ANION	O
GAP	O
-	O
14	O

2018-12-26	O
09:44	O
PM	O

CALCIUM	O
-	O
6.2	O
*	O
PHOSPHATE	O
-	O
1.7	O
*	O
MAGNESIUM	O
-	O
0.9	O
*	O

2018-12-26	O
09:44	O
PM	O

CORTISOL	O
-	O
10.3	O

2018-12-26	O
09:44	O
PM	O

WBC	O
-	O
9.0	O
RBC	O
-	O
2.93	O
*	O
HGB	O
-	O
9.0	O
*	O
HCT	O
-	O
29.7	O
*	O
MCV	O
-	O
101	O
*	O
MCH	O
-	O
30.8	O
MCHC	O
-	O
30.4	O
*	O
RDW	O
-	O
24.1	O
*	O

2018-12-26	O
09:44	O
PM	O

NEUTS	O
-	O
65.2	O
LYMPHS	O
-	O
25.2	O
MONOS	O
-	O
6.0	O
EOS	O
-	O
3.3	O
BASOS	O
-	O
0.4	O

2018-12-26	O
09:44	O
PM	O

HYPOCHROM	O
-	O
3+	O
ANISOCYT	O
-	O
3+	O
POIKILOCY	O
-	O
1+	O
MACROCYT	O
-	O
3+	O
MICROCYT	O
-	O
1+	O

2018-12-26	O
09:44	O
PM	O

PLT	O
COUNT	O
-	O
177	O

2018-12-26	O
08:28	O
PM	O

CORTISOL	O
-	O
9.3	O

2018-12-26	O
08:28	O
PM	O
URINE	O

COLOR	O
-	O
Yellow	O
APPEAR	O
-	O
SlHazy	O
SP	O
Barajas	O
-	O
1.005	O

2018-12-26	O
08:28	O
PM	O
URINE	O

BLOOD	O
-	O
LGE	O
NITRITE	O
-	O
NEG	O
PROTEIN	O
-	O
500	O
GLUCOSE	O
-	O
TR	O
KETONE	O
-	O
NEG	O
BILIRUBIN	O
-	O
NEG	O
UROBILNGN	O
-	O
NEG	O
PH	O
-	O
7.0	O
LEUK	O
-	O
NEG	O

2018-12-26	O
08:28	O
PM	O
URINE	O

RBC	O
-	O
225	O
*	O
WBC	O
-	O
8	O
*	O
BACTERIA	O
-	O
NONE	O
YEAST	O
-	O
NONE	O
EPI	O
-	O
<	O
1	O

2018-12-26	O
02:40	O
PM	O

CK	O
(	O
CPK	O
)-	O
350	O
*	O

2018-12-26	O
02:40	O
PM	O

CK	O
-	O
MB	O
-	O
3	O
cTropnT	O
-	O
0.40	O
*	O

MICRO	O
:	O
sputum	O
12-27	O
:	O
grm	O
stn	O
and	O
cx	O
negative	O

infl	O
A	O
and	O
B	O
12-27	O
:	O
negative	O

CSF	O
grm	O
stn	O
/	O
cx	O
:	O
negative	O

urine	O
cx	O
12-26	O
:	O
>	O
100K	O
VRE	B-disease
likely	O
colonized	O
,	O
01-03	O
yest	O
and	O
VRE	B-disease

c	O
diff	O
neg	O
:	O
12-28	O
,	O
12-31	O
,	O
01-01	O
,	O
01-02	O
.	O

bld	O
cx	O
12-26	O
,	O
12-27	O
,	O
12-28	O
,	O
12-31	O
-	O
NG	O
.	O

01-01	O
,	O
01-02	O
X	O
3	O
,	O
01-03	O
,	O
01-04	O
,	O
11/27X	O
2	O
NGTD	O
.	O

Catheter	O
tip	O
01-05	O
,	O
NG	O
.	O

C.	O
Diff	O
B	O
-	O
negative	O

Tunnled	O
catheter	O
tip	O
01-08	O
-	O
ngtd	O

HERPES	O
SIMPLEX	O
VIRUS	O
PCR	O
-	O
PND	O

Brief	O
Hospital	O
Course	O
:	O

A/P	O
:	O

69	O
y/o	O
female	O
wtih	O
PMH	B-disease
significant	O
for	O
ESRD	B-disease
on	O
HD	O
,	O
type	B-disease
2	I-disease
DM	I-disease
,	O
and	O
recent	B-disease
PE	I-disease
resulting	O
in	O
PEA	B-disease
arrest	I-disease
admitted	O
through	O
the	O
Juan	O
with	O
sepsis	B-disease
of	O
unknown	O
etiology	O
.	O

1.	O
Sepsis	B-disease
/	O
ID-	O
Started	O
on	O
sepsis	O
protocol	O
.	O

Unclear	O
etiology	O
headache	B-disease
over	O
the	O
three	O
days	O
prior	O
to	O
admission	O
in	O
association	O
with	O
fever	B-disease
was	O
concerning	O
for	O
a	O
CNS	O
etiology	O
.	O

Covered	O
broadly	O
with	O
vancomycin	O
,	O
flagyl	O
,	O
and	O
cefipime	O
.	O

Given	O
stress	O
dose	O
steroids	O
empirically	O
and	O
Sanchez	O
stim	O
showed	O
cortisol	O
of	O
9.3	O
-->	O
10.3	O
therefore	O
steroids	O
continued	O
.	O

CXR	O
,	O
LP	O
,	O
UA	O
and	O
abdominal	O
CT	O
showed	O
no	O
sign	O
of	O
infection	B-disease
.	O

PICC	O
line	O
was	O
removed	O
empirically	O
.	O

Tip	O
could	O
not	O
be	O
cultured	O
due	O
to	O
contamination	B-disease
.	O

Cultures	O
drawn	O
off	O
the	O
HD	O
cath	O
are	O
negative	O
to	O
date	O
.	O

Patient	B-disease
's	I-disease
LE	I-disease
ulcers	I-disease
appear	O
chronic	O
and	O
do	O
not	O
appear	O
to	O
be	O
the	O
source	O
of	O
infection	B-disease
.	O

Her	O
left	O
knee	O
is	O
slightly	B-disease
erythematous	I-disease
compared	O
to	O
the	O
right	O
but	O
not	O
impressive	O
.	O

Joint	O
is	O
mobile	O
.	O

Nasal	O
washings	O
for	O
influenza	B-disease
were	O
negative	O
;	O
culture	O
pending	O
.	O

Patient	O
improved	O
over	O
the	O
next	O
few	O
days	O
.	O

Steroids	O
were	O
discontinued	O
.	O

On	O
12-18	O
flagyl	O
and	O
cefepime	O
were	O
discontinued	O
as	O
all	O
culture	O
data	O
negative	O
to	O
date	O
.	O

Plan	O
to	O
continue	O
vancomycin	O
for	O
08-19	O
day	O
course	O
to	O
treat	O
empiric	B-disease
line	I-disease
infection	I-disease
.	O

Urine	O
culture	O
came	O
back	O
positive	O
for	O
VRE	B-disease
,	O
however	O
,	O
since	O
patient	O
improved	O
without	O
treatement	O
(	O
ie	O
Linezolid	O
)	O
initially	O
.	O

After	O
transfer	O
to	O
the	O
floor	O
when	O
she	O
was	O
stable	O
.	O

On	O
the	O
floor	O
the	O
Vancomycin	O
was	O
discontinued	O
as	O
the	O
catheter	O
tip	O
culture	O
was	O
negative	O
.	O

ID	O
was	O
consulted	O
who	O
suggested	O
broad	O
spectrum	O
antibiotics	O
if	O
she	O
were	O
to	O
spike	B-disease
.	O

When	O
pt	O
spiked	O
a	B-disease
temperature	I-disease
and	O
became	O
hypotensive	B-disease
she	O
was	O
started	O
on	O
Linezolid	O
was	O
started	O
for	O
presumed	O
VRE	B-disease
infection	I-disease
in	I-disease
the	I-disease
urine	I-disease
.	O

She	O
will	O
be	O
treated	O
for	O
total	O
14	O
day	O
course	O
.	O

She	O
was	O
also	O
started	O
on	O
fluconazole	O
for	O
yeast	B-disease
in	I-disease
the	I-disease
urine	I-disease
,	O
to	O
be	O
treated	O
with	O
fluconazole	O
for	O
total	O
7	O
days	O
.	O

She	O
was	O
given	O
Flagyl	O
for	O
presumed	O
C.	B-disease
Diff.	I-disease
Colitis	I-disease
,	O
however	O
this	O
was	O
stopped	O
when	O
C.	O
Diff	O
B	O
toxin	O
came	O
back	O
negative	O
on	O
2019-01-10	O
.	O

The	O
tunneled	O
catheter	O
line	O
was	O
changed	O
over	O
a	O
wire	O
and	O
the	O
tip	O
was	O
also	O
negative	O
.	O

2.	O
Respiratory	O
-	O
Intubated	O
for	O
airway	O
protection	O
due	O
to	O
change	B-disease
in	I-disease
mental	I-disease
status	I-disease
.	O

Extubated	O
12-28	O
with	O
no	O
incident	O
.	O

3.	O
ECG	B-disease
changes	I-disease
-	O
Patient	O
had	O
an	O
episode	O
of	O
chest	B-disease
pain	I-disease
during	O
her	O
hospital	O
stay	O
that	O
was	O
both	O
right	O
and	O
left	O
sided	O
with	O
no	O
radiation	O
and	O
no	O
associated	B-disease
symptoms	I-disease
.	O

ECG	O
showed	O
new	B-disease
diffuse	I-disease
TWI	I-disease
in	I-disease
all	I-disease
leads	I-disease
.	O

Cardiac	O
enzymes	O
were	O
cycled	O
and	O
were	O
normal	O
.	O

Echo	O
was	O
obtained	O
which	O
showed	O
WMA	B-disease
and	O
EF	O
of	O
35-40%	O
.	O

Pt	O
was	O
note	O
started	O
on	O
ASA	O
as	O
she	O
does	O
not	O
tolerate	O
this	O
well	O
,	O
BB	O
was	O
also	O
not	O
started	O
given	O
SBPs	O
in	O
the	O
110s	O
.	O

Statin	O
was	O
also	O
deffered	O
.	O

She	O
may	O
be	O
started	O
on	O
ASA	O
,	O
BB	O
,	O
statin	O
by	O
PCP	O
as	O
Stephen	O
.	O

4.	O
Shoulder	B-disease
fracture	I-disease
-	O
Patient	O
is	O
s/p	B-disease
a	I-disease
left	I-disease
hip	I-disease
fracture	I-disease
(	O
decision	O
not	O
to	O
operate	O
)	O
and	O
a	B-disease
left	I-disease
shoulder	I-disease
fracture	I-disease
with	O
hemiarthroplasty	O
11-14	O
.	O

Patient	O
was	O
found	O
to	O
have	O
a	B-disease
new	I-disease
humerus	I-disease
fracture	I-disease
distal	I-disease
to	I-disease
the	I-disease
hardware	I-disease
on	O
film	O
this	O
admission	O
.	O

Assumed	O
to	O
be	O
secondary	O
to	O
trauma	B-disease
when	O
moving	O
patient	O
into	O
ambulance	O
.	O

CMED	O
service	O
was	O
consulted	O
and	O
recommended	O
wtd	O
woulnd	O
care	O
and	O
sling	O
at	O
all	O
times	O
.	O

Wound	O
care	O
should	O
be	O
continued	O
as	O
described	O
after	O
discharge	O
.	O

5.	O
Type	B-disease
2	I-disease
DM	I-disease
-	O
Patient	O
was	O
initially	O
covered	O
with	O
an	O
insulin	O
drip	O
while	O
septic	B-disease
and	O
then	O
transitioned	O
back	O
to	O
insulin	O
sliding	O
scale	O
.	O

6.	O
ESRD	B-disease
on	O
HD	O
-	O
Pt	O
has	O
ESRD	B-disease
secondary	O
to	O
her	B-disease
DM	I-disease
and	O
is	O
on	O
HD	O
.	O

She	O
was	O
dialysed	O
but	O
was	O
slightly	B-disease
limited	I-disease
by	O
hypotension	B-disease
.	O

Dialyzed	O
12-28	O
with	O
plan	O
to	O
dialyze	O
again	O
12-31	O
.	O

Her	O
dialysis	O
was	O
managed	O
by	O
renal	O
service	O
in	O
house	O
.	O

7.	O
PE	B-disease
(	O
11-14	O
)-	O
On	O
heparin	O
drip	O
.	O

Restared	O
coumadin	O
on	O
12-29	O
.	O

Heparin	O
discontinued	O
on	O
01-01	O
when	O
INR	O
was	O
2.0	O
.	O

Coumadin	O
was	O
stopped	O
and	O
she	O
received	O
fFP	O
for	O
tunneled	O
line	O
change	O
over	O
a	O
wire	O
.	O

Coumadin	O
was	O
restarted	O
at	O
a	O
dose	O
of	O
2	O
mg	O
qhs	O
.	O

This	O
should	O
be	O
titrated	O
after	O
discharge	O
for	O
INR	O
goal	O
of	O
2-3	O
.	O

8.	O
PVD	B-disease
:	O

Dry	B-disease
gangrene	I-disease
of	I-disease
toes	I-disease
bilaterally	I-disease
w/	O
necrosis	B-disease
of	I-disease
the	I-disease
heels	I-disease
and	I-disease
posterior	I-disease
calf	I-disease
.	O

Continue	O
to	O
monitor	O
for	O
sign	O
of	O
infection	B-disease
.	O

On	O
vit	O
C.	O
and	O
zinc	O
as	O
well	O
to	O
aid	O
w/	O
wound	O
healing	O
.	O

Wound	O
care	O
consult	O
given	O
anasarca	O
to	O
prevent	O
decub	B-disease
.	O

9.	O
Left	O
UE	O
markedly	O
more	B-disease
edematous	I-disease
than	O
right	O
UE	O
,	O
this	O
could	O
be	O
from	O
fracture	B-disease
,	O
or	O
there	O
could	O
be	O
a	B-disease
clot	I-disease
,	O
an	B-disease
abscess	I-disease
in	I-disease
the	I-disease
area	I-disease
also	O
a	O
possiblity	O
.	O

Ultrasound	O
without	O
clot	B-disease
.	O

Continue	O
elevation	O
and	O
tight	O
dressing	O
to	O
LUE	O
>	O

10.	O
Access	O
-	O
Left	O
IJ	O
placed	O
12-26	O
in	O
Juan	O
was	O
discontinued	O
during	O
the	O
hospitilization	O
.	O

Right	O
dialysis	O
catheter	O
(	O
2018-11-05	O
)	O
was	O
changed	O
over	O
a	O
wire	O
2019-01-08	O
.	O

PICC	O
line	O
placed	O
2019-01-08	O
,	O
this	O
should	O
be	O
discontinued	O
immediately	O
after	O
pt	O
finishes	O
the	O
linezolid	O
course	O
.	O

11.	O
Code	O
status	O
-	O
Initially	O
full	O
code	O
then	O
made	O
DNR	O
/	O
DNI	O
after	O
family	O
meeting	O
on	O
02-27	O
.	O

Made	O
full	O
code	O
again	O
on	O
12-30	O
after	O
family	O
meeting	O
with	O
son	O
.	O

Larry	O
would	O
like	O
everything	O
done	O
.	O

12.	O
Communication	O
-	O
With	O
pt	O
's	O
son	O
.	O

His	O
name	O
is	O
Andrea	O
and	O
his	O
phone	O
number	O
is	O
794	O
1029	O
x.	O
1385	O
.	O

Medications	O
on	O
Admission	O
:	O

1.	O
Ascorbic	O
acid	O
500	O
mg	O
BID	O

2.	O
Folic	O
acid	O
1	O
mg	O
daily	O

3.	O
Humulin	O
insulin	O
2	O
units	O
QAM	O

4.	O
RISS	O

5.	O
Pantoprazole	O
40	O
mg	O
BID	O

6.	O
Neutra	O
phos	O
2	O
tabs	O
BID	O

7.	O
Vitamin	O
B	O
complex	O
1	O
tab	O
daily	O

8.	O
Coumadin	O
-	O
Dose	O
unknown	O

9.	O
Tylenol	O
650	O
mg	O
Q4H	O
PRN	O

10.	O
Ondansetron	O
4	O
mg	O
Q6H	O
PRN	O

Discharge	O
Medications	O
:	O

1.	O
Ascorbic	O
Acid	O
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

2.	O
Folic	O
Acid	O
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

3.	O
Zinc	O
Sulfate	O
220	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

4.	O
Acetaminophen	O
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

5.	O
Papain	O
-	O
Urea	O
544	O
287	O
0616	O
unit	O
-	O
mg	O
/	O
g	O
Ointment	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
DAILY	O
(	O
Daily	O
)	O
.	O

6.	O
Ipratropium	O
Bromide	O
0.02	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
.	O

7.	O
Calcium	O
Acetate	O
667	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
W/	O
MEALS	O
(	O
3	O
TIMES	O
A	O
DAY	O
WITH	O
MEALS	O
)	O
.	O

8.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
:	O
Hold	O
for	O
SBP	O
<	O
100	O
,	O
HR	O
<	O
60	O
.	O

9.	O
Fluconazole	O
200	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
for	O
2	O
days	O
.	O

10.	O
Insulin	O
Regular	O
Human	O
300	O
unit	O
/	O
3	O
mL	O
Insulin	O
Pen	O
Sig	O
:	O
as	O
directed	O
Subcutaneous	O
four	O
times	O
a	O
day	O
:	O
Please	O
administer	O
8	O
units	O
glargine	O
at	O
dinner	O
and	O
regular	O
insulin	O
sliding	O
scale	O
as	O
prescribed	O
.	O

11.	O
Warfarin	O
2	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
:	O
Titrate	O
dose	O
to	O
Goal	O
INR	O
03-15	O
.	O

Tablet	O
(	O
s	O
)	O

12.	O
Linezolid	O
600	O
mg	O
IV	O
Q12H	O

13.	O
Heparin	O
Flush	O
PICC	O
(	O
100	O
units	O
/	O
ml	O
)	O
2	O
ml	O
IV	O
DAILY	O
:	O
PRN	O
10	O
ml	O
NS	O
followed	O
by	O
2	O
ml	O
of	O
100	O
Units	O
/	O
ml	O
heparin	O
(	O
200	O
units	O
heparin	O
)	O
each	O
lumen	O
Daily	O
and	O
PRN	O
.	O

Inspect	O
site	O
every	O
shift	O
.	O

14.	O
Heparin	O
Flush	O
CVL	O
(	O
100	O
units	O
/	O
ml	O
)	O
1	O
ml	O
IV	O
DAILY	O
:	O
PRN	O

10ml	O
NS	O
followed	O
by	O
1ml	O
of	O
100	O
units/ml	O
heparin	O
(	O
100	O
units	O
heparin	O
)	O
each	O
lumen	O
QD	O
and	O
PRN	O
.	O

Inspect	O
site	O
every	O
shift	O

15.	O
Dolasetron	O
Mesylate	O
12.5	O
mg	O
IV	O
Q8H	O
:	O
PRN	O

16.	O
medication	O

Please	O
complete	O
a	O
total	O
14	O
day	O
course	O
of	O
linezolid	O
.	O

Stop	O
linezolid	O
on	O
2019-01-17	O
.	O

The	O
PICC	O
line	O
should	O
be	O
discontinued	O
promptly	O
after	O
the	O
linezolid	O
course	O
is	O
completed	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

Newton-Wellesley	O
Hospital	O
for	O
the	O
Aged	O
-	O
Acute	O
Rehab	O

Discharge	O
Diagnosis	O
:	O

Sepsis	B-disease
-?	O
source	O

Chronic	B-disease
Kidney	I-disease
disease	I-disease
-	O
on	O
hemodialysis	O
type	B-disease
2	I-disease
diabetes	I-disease
hypercholestrolemia	B-disease
anemia	B-disease
of	I-disease
chornic	I-disease
disease	I-disease
h/o	O
PE	B-disease
,	O
s/p	B-disease
PEA	I-disease
arrest	I-disease
11-14	O

Discharge	O
Condition	O
:	O

Stable	O

Discharge	O
Instructions	O
:	O

You	O
were	O
admitted	O
with	O
low	B-disease
blood	I-disease
pressure	I-disease
and	O
fevers	B-disease
likely	O
due	O
to	O
an	B-disease
infection	I-disease
.	O

Although	O
there	O
was	O
never	O
any	B-disease
bacteria	I-disease
isolated	O
from	O
the	O
blood	O
you	O
had	O
some	B-disease
bacteria	I-disease
in	I-disease
the	I-disease
urine	I-disease
which	O
you	O
are	O
being	O
treated	O
for	O
.	O

It	O
is	O
important	O
that	O
you	O
complete	O
the	O
antibiotic	O
course	O
as	O
prescribed	O
.	O

Please	O
continue	O
to	O
take	O
all	O
medications	O
as	O
prescirbed	O
and	O
follow	O
up	O
with	O
all	O
your	O
appointments	O
.	O

If	O
you	O
have	O
chest	B-disease
pain	I-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
diahrrea	B-disease
or	O
fevers	B-disease
please	O
contact	O
your	O
PCP	O
.	O

Robert	O
the	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
gets	O
worse	O
please	O
return	O
to	O
emergency	O
room	O
.	O

If	O
you	O
have	O
fevers	B-disease
please	O
contact	O
your	O
PCP	O
or	O
return	O
to	O
the	O
emergency	O
room	O
.	O

Followup	O
Instructions	O
:	O

Please	O
call	O
(	O
664	O
)	O
369-9786	O
to	O
set	O
up	O
an	O
appointment	O
with	O
your	O
primary	O
care	O
doctor	O
Dr.	O
Andrew	O
Shelton	O
in	O
1-2	O
wks	O
after	O
discharge	O
.	O

Cleveland	O
Barbara	O
MD	O
00-732	O

Completed	O
by	O
:	O
Sharon	O
Frank	O
MD	O
75-572	O
2019-01-10	O
@	O
1333	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Janice	O
Oconnell	O
on	O
:	O
Kent	O
2019-01-10	O
3:28	O
PM	O

(	O
End	O
of	O
Report	O
)	O

223159990	O

PUOMC	O

3546292	O

181083	O

366324	O

7/31/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

AKOTEBONTKAYS	O
,	O
JUANQUINTLEO	O

MRN	O
:	O

3546292	O

Age	O
:	O

37y	O

REGISTRATION	O
DATE	O
:	O

07/31/2000	O
07:36	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
AKOTEBONTKAYS	O
,	O
JUANQUINTLEO	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ph	O
University	O
Of	O
Medical	O
Center	O
on	O
07/31/2000	O
07:36	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
FEVER	B-disease
.	O

Following	O
evaluation	O
and	O
treatment	O
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
PH	O
UNIVERSITY	O
OF	O
MEDICAL	O
CENTER	O
.	O

Your	O
patient	O
was	O
admitted	O
under	O
the	O
care	O
of	O
ANER	O
,	O
AEA	O
M	O
with	O
a	O
preliminary	O
diagnosis	O
of	O
LINE	B-disease
SEPSIS	I-disease
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
639-873-2993	O
.	O

Admission	O
Date	O
:	O

2018-10-25	O

Discharge	O
Date	O
:	O

2018-11-01	O

Date	O
of	O
Birth	O
:	O

1943-11-06	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-disease
Allergies	I-disease
to	I-disease
Drugs	I-disease

Attending	O
:	O
Kelly	O
L.	O
Bradley	O
,	O
M.D.	O

Addendum	O
:	O

Explained	O
to	O
pt	O
which	O
of	O
the	O
meds	O
he	O
should	O
no	O
longer	O
take	O
that	O
he	O
was	O
taking	O
pre-admission	O
.	O

Also	O
,	O
explained	O
which	O
meds	O
are	O
new	O
.	O

Wife	O
verbally	O
agrees	O
to	O
understanding	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Diltiazem	O
HCl	O
240	O
mg	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
DAILY	O
(	O
Daily	O
).	O

2.	O
Simvastatin	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

3.	O
Albuterol-Ipratropium	O
103-18	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
02-26	O
Puffs	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

4.	O
Fluticasone-Salmeterol	O
250-50	O
mcg	O
/	O
Dose	O
Disk	O
with	O
Device	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Disk	O
with	O
Device	O
Inhalation	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

5.	O
Terazosin	O
1	O
mg	O
Capsule	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O

6.	O
Acetaminophen	O
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

7.	O
Nimodipine	O
30	O
mg	O
Capsule	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
for	O
2	O
weeks	O
.	O

Disp	O
:*	O
168	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

8.	O
Ferrous	O
Sulfate	O
325	O
(	O
65	O
)	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

9.	O
Aspirin	O
81	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
DAILY	O
(	O
Daily	O
).	O

10.	O
Ipratropium	O
Bromide	O
0.02	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
).	O

11.	O
Simvastatin	O
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

12.	O
Hydralazine	O
25	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
135	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

13.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
90	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

14.	O
Isosorbide	O
Dinitrate	O
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
90	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

15.	O
Clopidogrel	O
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

16.	O
Glipizide	O
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Jacob	O
Montegut	O
MD	O
71-786	O

Completed	O
by	O
:	O
Oscar	O
Jerome	O
Julian	O
MD	O
39-824	O
2018-11-01	O
@	O
1610	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Joyce	O
Arney	O
on	O
:	O
MON	O
2018-12-03	O
10:55	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2012-11-06	O

Discharge	O
Date	O
:	O

2012-11-11	O

Date	O
of	O
Birth	O
:	O

1965-09-22	O

Sex	O
:	O

M	O

Service	O
:	O

CCU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
47	O
-	O
year-old	O
male	O
with	O
a	O
past	O
medical	O
history	O
of	O
coronary	B-disease
artery	I-disease
disease	I-disease
,	O
status	O
post	O
2-vessel	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
in	O
2005	O
,	O
3-vessel	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
in	O
2009	O
,	O
hypertension	B-disease
,	O
new	B-disease
onset	I-disease
type	I-disease
2	I-disease
diabetes	I-disease
,	O
and	O
hypercholesterolemia	B-disease
who	O
presents	O
with	O
the	O
sudden	O
onset	O
of	O
substernal	B-disease
chest	I-disease
pain	I-disease
status	O
post	O
exercise	O
.	O

The	O
patient	O
presented	O
to	O
Bournewood	O
Hospital	O
on	O
the	O
morning	O
of	O
admission	O
with	O
a	O
chief	O
complaint	O
of	O
substernal	B-disease
burning	I-disease
without	O
radiation	O
which	O
developed	O
while	O
doing	O
exercise	O
.	O

Of	O
note	O
,	O
this	O
is	O
the	O
second	O
time	O
the	O
patient	O
has	O
exercised	O
in	O
many	O
months	O
.	O

The	B-disease
pain	I-disease
became	O
worse	O
over	O
the	O
next	O
few	O
minutes	O
to	O
07-12	O
and	O
increased	O
to	O
10-12	O
while	O
he	O
was	O
in	O
the	O
ambulance	O
.	O

His	O
nitroglycerin	O
patch	O
did	O
not	O
help	O
,	O
and	O
he	O
only	O
had	O
slight	O
relief	O
with	O
sublingual	O
nitroglycerin	O
times	O
three	O
.	O

In	O
addition	O
,	O
he	O
had	O
slight	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
but	O
denies	O
headache	B-disease
,	O
change	B-disease
in	I-disease
vision	I-disease
,	O
dizziness	B-disease
,	O
nausea	B-disease
,	O
vomiting	B-disease
,	O
abdominal	B-disease
pain	I-disease
,	O
change	B-disease
in	I-disease
bowel	I-disease
or	I-disease
urinary	I-disease
habits	I-disease
,	O
or	O
fevers	B-disease
,	O
chills	B-disease
,	O
and	O
sweats	B-disease
.	O

Of	O
note	O
,	O
he	O
had	O
a	O
negative	O
stress	O
test	O
in	O
2012-07-03	O
.	O

He	O
was	O
sent	O
to	O
Bournewood	O
Hospital	O
via	O
ambulance	O
.	O

In	O
the	O
Emergency	O
Department	O
he	O
received	O
aspirin	O
,	O
nitroglycerin	O
drip	O
,	O
heparin	O
drip	O
,	O
Dilaudid	O
,	O
and	O
TNK	O
with	O
decreased	O
in	O
his	B-disease
pain	I-disease
but	O
without	O
resolution	O
of	O
symptoms	B-disease
.	O

Electrocardiogram	O
at	O
that	O
time	O
showed	O
ST	B-disease
elevations	I-disease
and	O
J	B-disease
point	I-disease
elevations	I-disease
in	I-disease
V2	I-disease
through	I-disease
V4	I-disease
.	O

The	O
patient	O
was	O
transferred	O
to	O
Sturdy	O
Memorial	O
where	O
he	O
underwent	O
catheterization	O
.	O

Catheterization	O
results	O
showed	O
100%	B-disease
occlusion	I-disease
of	I-disease
the	I-disease
proximal	I-disease
left	I-disease
anterior	I-disease
descending	I-disease
artery	I-disease
and	O
50%	B-disease
stenosis	I-disease
of	I-disease
first	I-disease
diagonal	I-disease
.	O

Angio-Jet	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
and	O
stenting	O
was	O
performed	O
on	O
proximal	O
left	O
anterior	O
descending	O
artery	O
and	O
the	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
was	O
performed	O
on	O
first	O
diagonal	O
with	O
good	O
results	O
.	O

An	O
intra-aortic	O
balloon	O
pump	O
was	O
placed	O
at	O
this	O
time	O
as	O
well	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Coronary	B-disease
artery	I-disease
disease	I-disease
;	O
the	O
patient	O
is	O
status	O
post	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
times	O
three	O
in	O
2009	O
at	O
Clinton	O
Hospital	O
;	O
the	O
patient	O
is	O
status	O
post	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
times	O
two	O
in	O
2005	O
at	O
Waltham/Weston	O
Hospital	O
.	O

2.	O
Type	B-disease
2	I-disease
diabetes	I-disease
.	O

3.	O
Hypercholesterolemia	B-disease
.	O

4.	O
Hypertension	B-disease
.	O

FAMILY	O
HISTORY	O
:	O

The	O
patient	O
's	O
father	O
died	O
of	O
a	B-disease
myocardial	I-disease
infarction	I-disease
at	O
age	O
40	O
,	O
and	O
a	O
brother	O
who	O
died	O
of	O
a	B-disease
myocardial	I-disease
infarction	I-disease
at	O
age	O
40	O
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
ethanol	O
use	O
.	O

No	O
tobacco	O
at	O
this	O
time	O
;	O
he	O
quit	O
20	O
years	O
ago	O
.	O

The	O
patient	O
is	O
married	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Diltiazem	O
180	O
mg	O
p.o.	O
q.d.	O
,	O
Lipitor	O
10	O
mg	O
p.o.	O
q.d.	O
,	O
Glyset	O
25	O
mg	O
p.o.	O
q.d.	O
,	O
Prevacid	O
30	O
mg	O
p.o.	O
q.d.	O
,	O
metoprolol	O
50	O
mg	O
p.o.	O
b.i.d.	O
,	O
Glucophage	O
500	O
mg	O
p.o.	O
q.d.	O

ALLERGIES	O
:	O

Allergies	B-disease
included	O
PENICILLIN	O
and	O
IODINE	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

Temperature	O
maximum	O
98.7	O
,	O
temperature	O
current	O
98.3	O
,	O
pulse	O
ranged	O
from	O
82	O
to	O
92	O
,	O
blood	O
pressure	O
104	O
to	O
124/67	O
to	O
74	O
with	O
a	O
mean	O
of	O
86	O
to	O
99	O
,	O
respiratory	O
rate	O
of	O
11	O
to	O
16	O
,	O
oxygen	O
saturation	O
94%	O
to	O
98%	O
on	O
2	O
liters	O
.	O

Pulmonary	O
artery	O
pressure	O
was	O
29/15	O
with	O
a	O
mean	O
of	O
22	O
.	O

Cardiac	O
output	O
was	O
7	O
(	O
that	O
was	O
on	O
6	O
of	O
dopamine	O
)	O
.	O

Intra-aortic	O
balloon	O
pump	O
augmented	O
systole	O
was	O
109	O
,	O
augmented	O
diastole	O
was	O
111	O
.	O

The	O
patient	O
was	O
lying	O
flat	O
in	O
no	O
apparent	B-disease
distress	I-disease
.	O

HEENT	O
revealed	O
extraocular	O
movements	O
were	O
intact	O
.	O

Pupils	O
were	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

The	O
oropharynx	O
was	O
clear	O
with	O
moist	O
mucosa	O
.	O

Neck	O
was	O
supple	O
.	O

No	O
lymphadenopathy	B-disease
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	O
bilaterally	O
,	O
anteriorly	O
and	O
laterally	O
.	O

Cardiovascular	O
revealed	O
jugular	B-disease
venous	I-disease
distention	I-disease
not	O
appreciated	O
.	O

Carotids	O
had	O
normal	O
upstroke	O
and	O
normal	O
volume	O
with	O
bilateral	B-disease
bruits	I-disease
.	O

A	O
regular	O
rate	O
.	O

Normal	O
S1	O
and	O
S2	O
.	O

No	O
S3	B-disease
or	O
S4	B-disease
.	O

No	O
murmurs	B-disease
,	O
rubs	B-disease
or	O
gallops	B-disease
.	O

Abdomen	O
had	O
decreased	B-disease
bowel	I-disease
sounds	I-disease
,	O
soft	O
,	O
nontender	B-disease
,	O
and	O
nondistended	B-disease
.	O

No	O
hepatosplenomegaly	B-disease
.	O

Liver	O
was	O
about	O
5	O
cm	O
.	O

Extremities	O
had	O
no	O
edema	B-disease
.	O

The	O
right	O
groin	O
revealed	O
intra-aortic	O
balloon	O
pump	O
site	O
and	O
pulmonary	O
artery	O
catheterization	O
site	O
were	O
clean	O
,	O
dry	O
and	O
intact	O
without	O
tenderness	B-disease
.	O

Dorsalis	O
pedis	O
pulses	O
were	O
2+	O
bilaterally	O
.	O

Neurologic	O
examination	O
revealed	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

Cranial	O
nerves	O
II	O
through	O
XII	O
were	O
intact	O
.	O

LABORATORY	O
DATA	O
ON	O
ADMISSION	O
:	O

Laboratories	O
on	O
admission	O
revealed	O
white	O
count	O
7.8	O
,	O
hematocrit	O
was	O
41.7	O
,	O
platelets	O
of	O
252	O
,	O
MCV	O
89	O
,	O
RDW	O
12.7	O
.	O

Chem-7	O
revealed	O
sodium	O
of	O
136	O
,	O
potassium	O
4.7	O
,	O
chloride	O
103	O
,	O
bicarbonate	O
22	O
,	O
BUN	O
16	O
,	O
creatinine	O
0.8	O
,	O
glucose	O
284	O
.	O

PT	O
14.2	O
,	O
PTT	O
108.5	O
,	O
INR	O
1.3	O
.	O

Creatine	O
kinase	O
at	O
11	O
a.m.	O
was	O
83	O
,	O
at	O
5	O
p.m.	O
was	O
3021	O
.	O

Arterial	O
blood	O
gas	O
at	O
11	O
a.m.	O
was	O
7.33/46/115	O
.	O

Creatine	O
kinases	O
trended	O
from	O
11:15	O
on	O
the	O
day	O
of	O
admission	O
from	O
83	O
to	O
3021	O
at	O
5	O
p.m.	O
to	O
3450	O
at	O
11	O
p.m.	O
,	O
to	O
1734	O
at	O
5:30	O
a.m.	O
on	O
11-07	O
,	O
to	O
1277	O
at	O
11:30	O
a.m.	O
on	O
11-07	O
,	O
to	O
83	O
at	O
9:30	O
a.m.	O
on	O
11-11	O
.	O

RADIOLOGY	O
/	O
IMAGING	O
:	O

Electrocardiogram	O
post	O
catheterization	O
showed	O
continued	B-disease
ST	I-disease
elevations	I-disease
and	O
J	B-disease
point	I-disease
elevations	I-disease
in	I-disease
V2	I-disease
through	I-disease
V3	I-disease
.	O

Post	O
catheterization	O
echocardiogram	O
showed	O
an	O
ejection	O
fraction	O
of	O
30%	O
,	O
moderate	B-disease
systolic	I-disease
dysfunction	I-disease
,	O
basal	B-disease
anterior	I-disease
hypokinesis	I-disease
,	O
mid	B-disease
anterior	I-disease
akinesis	I-disease
,	O
basal	B-disease
anteroseptal	I-disease
hypokinesis	I-disease
,	O
mid	B-disease
anteroseptal	I-disease
akinesis	I-disease
.	O

Anterior	B-disease
apex	I-disease
akinesis	I-disease
,	O
inferior	B-disease
apex	I-disease
akinesis	I-disease
,	O
and	O
apex	B-disease
akinesis	I-disease
.	O

The	O
was	O
trace	B-disease
mitral	I-disease
regurgitation	I-disease
and	O
trace	B-disease
tricuspid	I-disease
regurgitation	I-disease
.	O

IMPRESSION	O
:	O

This	O
is	O
a	O
47	O
-	O
year-old	O
male	O
with	O
a	O
past	O
medical	O
history	O
of	O
type	B-disease
2	I-disease
diabetes	I-disease
,	O
high	B-disease
cholesterol	I-disease
,	O
hypertension	B-disease
,	O
and	O
coronary	B-disease
artery	I-disease
disease	I-disease
,	O
status	O
post	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
times	O
two	O
,	O
who	O
presented	O
with	O
acute	B-disease
coronary	I-disease
syndrome	I-disease
refractory	O
to	O
medical	O
treatment	O
and	O
TNK	O
,	O
now	O
status	O
post	O
Angio-Jet	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
and	O
stent	O
of	O
proximal	O
left	O
anterior	O
descending	O
artery	O
and	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
of	O
first	O
diagonal	O
with	O
intra-aortic	O
balloon	O
pump	O
placement	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
Mass.	O
Mental	O
Health	O
Center	O
hospital	O
course	O
was	O
unremarkable	O
.	O

Dopamine	O
was	O
discontinued	O
on	O
day	O
one	O
.	O

The	O
intra-aortic	O
balloon	O
pump	O
was	O
discontinued	O
on	O
day	O
two	O
.	O

The	O
patient	O
was	O
continued	O
on	O
heparin	O
throughout	O
his	O
hospital	O
course	O
and	O
transitioned	O
to	O
Coumadin	O
on	O
hospital	O
day	O
four	O
.	O

The	O
patient	O
was	O
continued	O
on	O
Lipitor	O
and	O
aspirin	O
,	O
and	O
Plavix	O
was	O
added	O
and	O
will	O
be	O
continued	O
for	O
30	O
days	O
post	O
catheterization	O
.	O

The	O
patient	O
was	O
continued	O
on	O
Lopressor	O
and	O
captopril	O
throughout	O
his	O
hospital	O
course	O
,	O
and	O
changed	O
to	O

Zestril	O
10	O
mg	O
q.d.	O
and	O
atenolol	O
25	O
mg	O
q.d.	O
at	O
discharge	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
the	O
medical	O
floor	O
on	O
hospital	O
day	O
three	O
and	O
discharged	O
from	O
the	O
hospital	O
once	O
his	O
INR	O
was	O
within	O
the	O
2	O
to	O
2.5	O
range	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

The	O
patient	O
's	O
condition	O
on	O
discharge	O
was	O
stable	O
.	O

DISCHARGE	O
STATUS	O
:	O

He	O
was	O
discharged	O
home	O
.	O

DISCHARGE	O
FOLLOWUP	O
:	O

Instructions	O
to	O
follow	O
up	O
with	O
his	O
primary	O
care	O
physician	O
on	O
the	O
Heather	O
after	O
discharge	O
.	O

Primary	O
care	O
physician	O
was	O
to	O
check	O
INR	O
and	O
titrate	O
Zestril	O
up	O
and	O
atenolol	O
as	O
tolerated	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Lipitor	O
10	O
mg	O
p.o.	O
q.d.	O

2.	O
Aspirin	O
325	O
mg	O
p.o.	O
q.d.	O

3.	O
Plavix	O
75	O
mg	O
p.o.	O
q.d.	O
times	O
30	O
days	O
.	O

4.	O
Prevacid	O
30	O
mg	O
p.o.	O
q.d.	O

5.	O
Atenolol	O
25	O
mg	O
p.o.	O
q.d.	O

6.	O
Zestril	O
10	O
mg	O
p.o.	O
q.d.	O

7.	O
Glyset	O
25	O
mg	O
p.o.	O
q.d.	O

8.	O
Glucophage	O
500	O
mg	O
p.o.	O
q.d.	O

9.	O
Coumadin	O
5	O
mg	O
p.o.	O
q.d.	O

Tina	O
Squillace	O
,	O
M.D.	O
30-977	O

Dictated	O
By	O
:	O
Lloyd	O
U.	O
King	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-11-12	O
21:57	O

T	O
:	O
2012-11-15	O
14:05	O

JOB	O
#	O
:	O
15711	O

cc	O
:	O
Beau	O
J.	O
Box	O
,	O
M.D.	O

332803550	O

PUOMC	O

6548851	O

97371/52b3	O

854510	O

6/22/1993	O
12:00:00	O
AM	O

CHRONIC	B-disease
OBSTRUCTIVE	I-disease
PULMONARY	I-disease
DISEASE	I-disease

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

06-22-93	O

DISCHARGE	O
DATE	O
:	O

06-27-93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Chronic	B-disease
obstructive	I-disease
pulmonary	I-disease
disease	I-disease

ASSOCIATED	O
DIAGNOSES	O
:	O

Steroid	B-disease
complications	I-disease
,	O
including	O
cataract	B-disease
,	O
osteoporosis	B-disease
,	O
diffuse	B-disease
fibrocystic	I-disease
breast	I-disease
disease	I-disease
,	O
trigeminal	B-disease
neuralgia	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mrs.	O
Cast	O
is	O
a	O
50	O
year	O
old	O
white	O
female	O
with	O
a	O
history	O
of	O
chronic	B-disease
obstructive	I-disease
pulmonary	I-disease
disease	I-disease
and	O
evidence	O
of	O
severe	B-disease
lobular	I-disease
emphysema	I-disease
,	O
who	O
has	O
progressive	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
and	O
inability	O
to	O
carry	O
on	O
with	O
activities	O
of	O
daily	O
living	O
without	O
assistance	O
.	O

She	O
was	O
admitted	O
to	O
the	O
hospital	O
for	O
a	O
pre	O
lung	O
transplant	O
evaluation	O
.	O

The	O
patient	O
has	O
been	O
steroid	B-disease
dependent	I-disease
for	O
two	O
years	O
and	O
has	O
been	O
intubated	O
in	O
the	O
past	O
only	O
once	O
for	O
a	O
surgical	O
repair	O
of	O
trigeminal	O
neuralgia	O
.	O

Her	O
previous	O
occupation	O
was	O
an	O
executive	O
secretary	O
,	O
home	O
trainer	O
/	O
nurse	O
,	O
rental	O
aide	O
.	O

She	O
has	O
no	O
history	O
of	O
asbestos	B-disease
exposure	I-disease
or	O
tuberculosis	B-disease
exposure	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Notable	O
for	O
a	O
history	O
of	O
trigeminal	B-disease
neuralgia	I-disease
,	O
left	O
shoulder	O
surgery	O
,	O
fibrocystic	B-disease
breast	I-disease
disease	I-disease
,	O
endometriosis	B-disease
and	O
status	O
post	O
total	B-disease
abdominal	I-disease
hysterectomy	I-disease
.	O

ALLERGIES	O
:	O

History	O
of	O
gastrointestinal	B-disease
intolerance	I-disease
to	O
Tetracycline	O
,	O
Erythromycin	O
,	O
declomycin	O
associated	O
with	O
edema	B-disease
and	O
rash	B-disease
,	O
Talwin	O
associated	O
with	O
disorientation	B-disease
and	O
gastrointestinal	B-disease
symptoms	I-disease
,	O
Dilantin	O
has	O
caused	O
rash	B-disease
and	O
edema	B-disease
,	O
morphine	O
associated	O
with	O
itching	B-disease
and	O
gastrointestinal	B-disease
symptoms	I-disease
,	O
Demerol	O
unclear	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
a	O
divorced	O
mother	O
of	O
two	O
on	O
Medicaid	O
.	O

FAMILY	O
HISTORY	O
:	O

Non	O
contributory	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Notable	O
for	O
her	B-disease
diffuse	I-disease
expiratory	I-disease
wheezes	I-disease
and	O
scattered	B-disease
expiratory	I-disease
crackles	I-disease
.	O

Cranial	O
nerves	O
were	O
intact	O
except	O
for	O
paresthesias	B-disease
on	O
the	O
left	O
in	O
the	O
VII	O
and	O
VIII	O
distribution	O
.	O

The	O
breasts	O
were	O
notable	O
for	O
fibrocystic	B-disease
changes	I-disease
.	O

LABORATORY	O
DATA	O
:	O

Serum	O
sodium	O
141	O
,	O
potassium	O
4.0	O
,	O
chloride	O
106	O
,	O
C02	O
29.6	O
,	O
calcium	O
9.2	O
,	O
phosphorus	O
3.6	O
.	O

Magnesium	O
1.7	O
.	O

BUN	O
12	O
,	O
creatinine	O
0.6	O
,	O
glucose	O
92	O
,	O
uric	O
acid	O
3.3.	O
Cholesterol	O
236	O
,	O
triglycerides	O
115	O
,	O
HDL	O
99	O
,	O
LDL	O
114	O
,	O
total	O
protein	O
6.2	O
,	O
globulin	O
2.6	O
,	O
direct	O
bilirubin	O
0	O
,	O
total	O
bilirubin	O
0.2	O
,	O
alkaline	O
phosphatase	O
59	O
,	O
amylase	O
64	O
,	O
SGOT	O
16	O
,	O
LDH	O
141	O
,	O
CPK	O
57	O
.	O

The	O
LH	O
was	O
4.9	O
,	O
FSH	O
3.3	O
.	O

TSH	O
was	O
124	O
,	O
cortisol	O
2.1	O
,	O
25	O
hydroxy	O
vitamin	O
D	O
,	O
and	O
125	O
dihydroxy	O
vitamin	O
D	O
levels	O
were	O
pending	O
.	O

Urine	O
cotenine	O
level	O
none	O
detected	O
.	O

Estradialol	O
pending	O
.	O

White	O
blood	O
count	O
9.6	O
,	O
hematocrit	O
38.8	O
,	O
platelet	O
348,000	O
,	O
mean	O
corpuscular	O
volume	O
85	O
and	O
86	O
,	O
MCH	O
29	O
,	O
MCHC	O
34	O
.	O

PT	O
9.5/10.0	O
,	O
PTT	O
23.9	O
.	O

Urinalysis	O
was	O
normal	O
.	O

Sed	O
rate	O
6	O
.	O

Varicella	O
antibody	O
positive	O
,	O
CMV	O
antibody	O
positive	O
,	O
toxo	O
negative	O
,	O
RPR	O
non	O
reactive	O
.	O

The	O
patient	O
was	O
A+	O
.	O

FEV1	O
0.78	O
liters	O
,	O
vital	O
capacity	O
2.12	O
liters	O
,	O
total	O
lung	O
capacity	O
5.51	O
liters	O
,	O
single	O
breath	O
DLCO	O
5.3	O
(	O
25%	O
predicted	O
)	O
.	O

Cardiopulmonary	O
exercise	O
study	O
results	O
are	O
pending	O
.	O

Echocardiogram	O
showed	O
normal	O
right	O
ventricular	O
and	O
left	O
ventricular	O
size	O
and	O
systolic	O
function	O
.	O

A	O
left	O
and	O
right	O
heart	O
catheterization	O
and	O
coronary	O
angiogram	O
revealed	O
aortic	O
120/70	O
,	O
mean	O
95	O
,	O
PA	O
26/10	O
,	O
mean	O
17	O
,	O
PC	O
7	O
,	O
RV	O
26/6	O
,	O
RA	O
4	O
,	O
cardiac	O
output	O
5.7	O
,	O
index	O
3.8	O
.	O

Systemic	O
arterial	O
resistance	O
12/81	O
.	O

The	O
electrocardiogram	O
showed	O
a	B-disease
short	I-disease
PR	I-disease
interval	I-disease
with	O
no	O
delta	B-disease
wave	I-disease
,	O
clockwise	B-disease
rotation	I-disease
present	I-disease
.	O

A	O
quantitative	O
VQ	O
scan	O
of	O
the	O
lung	O
showed	O
42%	O
ventilation	O
to	O
the	O
left	O
,	O
57%	O
ventilation	O
to	O
the	O
right	O
,	O
42%	O
perfusion	O
to	O
the	O
left	O
,	O
57%	O
perfusion	O
to	O
the	O
right	O
.	O

Abdominal	O
ultrasound	O
was	O
unremarkable	O
.	O

HIV	O
testing	O
results	O
pending	O
.	O

Hepatitis	O
serologies	O
pending	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
a	O
variety	O
of	O
consultants	O
including	O
Infectious	O
Disease	O
,	O
Cardiology	O
,	O
Endocrine	O
,	O
Psychiatry	O
,	O
ENT	O
,	O
and	O
Neuro-ophthalmology	O
.	O

She	O
was	O
noted	O
to	O
have	O
mild	B-disease
cataracts	I-disease
,	O
possibly	O
due	O
to	O
chronic	O
steroids	O
,	O
as	O
well	O
as	O
a	B-disease
subtle	I-disease
temporal	I-disease
disc	I-disease
pallor	I-disease
OD	I-disease
,	O
possibly	O
due	O
to	O
previous	O
episode	O
of	O
optic	B-disease
neuritis	I-disease
.	O

No	O
acute	B-disease
pathology	I-disease
was	O
noted	O
and	O
no	O
treatment	B-disease
was	O
necessary	O
at	O
this	O
time	O
.	O

Dr.	O
Koteelks	O
indicated	O
that	O
the	O
patient	O
did	O
not	O
have	O
sinus	B-disease
problems	I-disease
currently	O
but	O
thought	O
that	O
the	B-disease
trigeminal	I-disease
pain	I-disease
might	O
be	O
investigated	O
further	O
and	O
that	O
the	B-disease
sphenoid	I-disease
might	O
account	O
for	O
some	O
of	O
the	B-disease
patient	I-disease
&apos;s	I-disease
discomfort	I-disease
.	O

If	O
so	O
,	O
he	O
considers	O
the	O
possibility	O
that	O
this	O
could	O
be	O
opened	O
.	O

This	O
is	O
left	O
for	O
further	O
follow	O
up	O
as	O
an	O
outpatient	O
.	O

Dr.	O
Tikkerth	O
felt	O
that	O
the	O
patient	O
had	O
mild	B-disease
adjustment	I-disease
related	I-disease
anxiety	I-disease
under	O
good	O
control	O
with	O
a	O
history	O
of	O
tobacco	O
abuse	O
in	O
the	O
past	O
.	O

The	O
patient	O
completed	O
the	O
studies	O
and	O
to	O
be	O
informed	O
of	O
the	O
results	O
as	O
an	O
outpatient	O
.	O

She	O
knows	O
to	O
return	O
to	O
her	O
local	O
physician	O
for	O
her	O
routine	O
care	O
with	O
her	B-disease
condition	I-disease
unchanged	O
at	O
the	O
time	O
of	O
discharge	O
.	O

I	O
L.	O
STERPSKOLK	O
,	O
M.D.	O

TR	O
:	O

bg	O
/	O
bmot	O

DD	O
:	O

09-08-93	O

TD	O
:	O

09/09/93	O

CC	O
:	O

596437842	O

CTMC	O

63056604	O

547591	O

02/08/1991	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

02/08/1991	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

02/18/1991	O

DISCHARGE	O
DIAGNOSES	O
:	O

1)	O
ACQUIRED	B-disease
IMMUNODEFICIENCY	I-disease
SYNDROME	I-disease
.	O

2)	O
PNEUMOCYSTIS	B-disease
CARINII	I-disease
PNEUMONIA	I-disease
.	O

3)	O
ADULT	B-disease
RESPIRATORY	I-disease
DISTRESS	I-disease
SYNDROME	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Breutzfarstxei	O
is	O
a	O
30	O
year	O
old	O
man	O
with	O
recently	O
diagnosed	O
acquired	B-disease
immunodeficiency	I-disease
syndrome	I-disease
and	O
Pneumocystis	B-disease
carinii	I-disease
pneumonia	I-disease
who	O
presented	O
with	O
pneumonia	B-disease
,	O
developed	O
adult	B-disease
respiratory	I-disease
distress	I-disease
syndrome	I-disease
,	O
and	O
died	O
in	O
the	O
hospital	O
after	O
failed	O
efforts	O
of	O
ventilatory	O
support	O
.	O

Mr.	O
Breutzfarstxei	O
was	O
recently	O
diagnosed	O
with	O
acquired	B-disease
immunodeficiency	I-disease
syndrome	I-disease
when	O
he	O
had	O
Pneumocystis	B-disease
carinii	I-disease
pneumonia	I-disease
on	O
01/17/91	O
.	O

He	O
was	O
admitted	O
to	O
the	O
Retelk	O
County	O
Medical	O
Center	O
at	O
that	O
time	O
and	O
was	O
treated	O
with	O
Bactrim	O
and	O
steroids	O
.	O

He	O
was	O
actually	O
intubated	O
and	O
underwent	O
bronchoscopy	O
where	O
the	O
diagnosis	O
was	O
made	O
with	O
a	B-disease
positive	I-disease
toluidine	I-disease
blue	I-disease
study	I-disease
.	O

He	O
initially	O
did	O
well	O
after	O
extubation	O
and	O
completed	O
approximately	O
two	O
weeks	O
of	O
Bactrim	O
and	O
a	O
steroid	O
taper	O
.	O

At	O
discharge	O
after	O
about	O
two	O
weeks	O
post-extubation	O
,	O
he	O
had	O
an	O
O2	O
saturation	O
of	O
approximately	O
95%	O
on	O
room	O
air	O
.	O

He	O
was	O
seen	O
by	O
Dr.	O
Seen	O
and	O
Dr.	O
Seen	O
as	O
an	O
out-patient	O
.	O

On	O
02/06/91	O
,	O
he	O
was	O
seen	O
in	O
FLFDMC	O
and	O
at	O
that	O
point	O
,	O
his	O
temperature	O
was	O
noted	O
to	O
be	O
101.4	O
and	O
he	O
had	O
malaise	B-disease
and	O
diarrhea	B-disease
.	O

He	O
was	O
evaluated	O
in	O
the	O
Emergency	O
Room	O
.	O

At	O
that	O
time	O
,	O
his	O
oxygen	O
saturation	O
was	O
only	O
90%	O
on	O
room	O
air	O
and	O
his	O
chest	O
X-Ray	O
showed	O
no	O
change	O
.	O

Cultures	O
were	O
taken	O
and	O
he	O
was	O
sent	O
out	O
.	O

On	O
02/08/91	O
,	O
the	O
patient	O
called	O
Dr.	O
Seen	O
because	O
of	O
increased	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
and	O
malaise	B-disease
.	O

He	O
was	O
seen	O
in	O
FLFDMC	O
where	O
he	O
was	O
noted	O
to	O
have	O
jaundice	B-disease
and	O
newly	B-disease
palpable	I-disease
liver	I-disease
edge	I-disease
.	O

Review	O
of	O
liver	O
function	O
tests	O
revealed	O
a	B-disease
cholestatic	I-disease
picture	I-disease
which	O
was	O
not	O
previously	O
found	O
and	O
it	O
was	O
felt	O
that	O
this	O
was	O
secondary	O
to	O
the	O
Bactrim	O
which	O
had	O
been	O
recently	O
stopped	O
anyway	O
.	O

His	O
oxygen	O
saturation	O
at	O
that	O
time	O
was	O
only	O
86%	O
on	O
room	O
air	O
and	O
he	O
was	O
admitted	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1)	O
HIV	B-disease
positive	I-disease
with	O
a	O
CD4	O
count	O
of	O
74	O
.	O

2)	O
Recent	B-disease
PCP	I-disease
.	O

3)	O
Status	O
post	O
right	O
elbow	O
surgery	O
.	O

4)	O
Venereal	B-disease
disease	I-disease
history	I-disease
.	O

5)	O
PPD	B-disease
anergic	I-disease
.	O

The	O
patient	O
&apos;s	O
HIV	O
risk	O
factors	O
include	O
history	O
of	O
intravenous	O
drug	O
abuse	O
,	O
prostitution	O
,	O
and	O
a	O
former	O
prisoner	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
presentation	O
,	O
the	O
patient	O
was	O
a	O
young	O
appearing	O
Hispanic	O
male	O
in	O
mild	B-disease
respiratory	I-disease
distress	I-disease
with	O
a	O
blood	O
pressure	O
of	O
140/90	O
,	O
heart	O
rate	O
120	O
,	O
respirations	O
32	O
,	O
and	O
temperature	O
101	O
.	O

SKIN	O
:	O

Jaundiced	O
.	O

HEENT	O
:	O

Revealed	O
icteric	B-disease
sclerae	I-disease
,	O
the	B-disease
oropharynx	I-disease
with	I-disease
extensive	I-disease
thrush	I-disease
,	O
and	O
an	B-disease
ulcer	I-disease
under	I-disease
his	I-disease
tongue	I-disease
.	O

NECK	O
:	O

He	O
had	O
no	O
cervical	B-disease
adenopathy	I-disease
and	O
his	O
neck	O
was	O
supple	O
.	O

LUNGS	O
:	O

Had	O
tubular	B-disease
breath	I-disease
sounds	I-disease
especially	O
in	O
the	O
lower	O
lung	O
fields	O
.	O

CARDIAC	O
:	O

Showed	O
regular	O
rate	O
and	O
rhythm	O
without	O
murmurs	B-disease
,	O
rubs	B-disease
,	O
or	O
gallops	B-disease
.	O

There	O
was	O
no	O
costovertebral	B-disease
angle	I-disease
tenderness	I-disease
.	O

ABDOMEN	O
:	O

Soft	O
with	O
bowel	O
sounds	O
and	O
there	O
was	O
mid	B-disease
epigastric	I-disease
and	I-disease
right	I-disease
upper	I-disease
quadrant	I-disease
tenderness	I-disease
.	O

His	O
liver	O
was	O
10	O
cm	O
and	O
was	O
felt	O
three	O
finger	O
breadths	O
below	O
the	O
costal	O
margin	O
.	O

His	O
spleen	O
was	O
not	O
palpable	O
.	O

RECTAL	O
:	O

He	O
had	O
guaiac	B-disease
positive	I-disease
stools	I-disease
.	O

EXTREMITIES	O
:	O

Unremarkable	O
.	O

GENITOURINARY	O
:	O

His	O
penis	O
had	O
a	O
1/2	B-disease
cm	I-disease
ulcer	I-disease
with	O
yellowish	B-disease
discharge	I-disease
.	O

NEUROLOGICAL	O
:	O

Non-focal	O
.	O

LABORATORY	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
white	O
count	O
was	O
7.2	O
with	O
57%	O
neutrophils	O
,	O
40%	O
lymphocytes	O
,	O
l	O
mononuclear	O
cell	O
,	O
and	O
1.6	O
eosinophils	O
.	O

PT	O
was	O
12.6	O
and	O
PTT	O
was	O
29	O
.	O

Sodium	O
was	O
133	O
,	O
potassium	O
was	O
4.2	O
,	O
chloride	O
100	O
,	O
CO2	O
19	O
,	O
BUN	O
21	O
,	O
creatinine	O
1.2	O
,	O
and	O
glucose	O
122	O
.	O

ALT	O
was	O
181	O
,	O
AST	O
was	O
156	O
,	O
LDH	O
was	O
336	O
,	O
alkaline	O
phosphatase	O
was	O
214	O
,	O
and	O
bilirubin	O
was	O
12.7	O
total	O
.	O

(	O
On	O
02/06	O
,	O
his	O
bilirubin	O
had	O
been	O
7.2	O
with	O
6	O
direct	O
)	O
.	O

His	O
arterial	O
blood	O
gas	O
on	O
50%	O
was	O
pO2	O
92	O
,	O
pCO2	O
24	O
,	O
and	O
pH	O
7.46	O
.	O

His	O
chest	O
X-Ray	O
showed	O
bilateral	B-disease
nodular	I-disease
infiltrates	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
work-up	O
of	O
his	B-disease
cholestatic	I-disease
jaundice	I-disease
picture	I-disease
along	O
with	O
work-up	O
for	O
his	B-disease
pulmonary	I-disease
process	I-disease
and	O
treatment	O
of	O
both	O
.	O

In	O
terms	O
of	O
pulmonary	O
function	O
,	O
it	O
was	O
felt	O
that	O
one	O
possibility	O
was	O
that	O
the	O
patient	O
was	O
a	B-disease
Bactrim	I-disease
failure	I-disease
for	O
PCP	B-disease
although	O
this	O
was	O
unusual	O
.	O

He	O
was	O
started	O
on	O
Pentamidine	O
,	O
especially	O
in	O
light	O
of	O
the	O
fact	O
that	O
it	O
was	O
felt	O
that	O
his	O
liver	O
function	O
tests	O
were	O
due	O
possibly	O
to	O
Bactrim	O
.	O

The	O
patient	O
was	O
also	O
covered	O
with	O
Erythromycin	O
and	O
Gentamicin	O
for	O
coverage	O
of	O
community	B-disease
acquired	I-disease
pneumonias	I-disease
and	O
gram	B-disease
negative	I-disease
rods	I-disease
.	O

He	O
was	O
given	O
supplemental	O
oxygen	O
.	O

In	O
terms	O
of	O
his	B-disease
liver	I-disease
abnormalities	I-disease
,	O
it	O
was	O
felt	O
that	O
viral	B-disease
hepatitis	I-disease
was	O
in	O
the	O
differential	O
as	O
well	O
as	O
several	B-disease
opportunistic	I-disease
infections	I-disease
of	I-disease
the	I-disease
liver	I-disease
but	O
also	O
was	O
felt	O
that	O
Bactrim	O
could	O
be	O
a	O
cause	O
of	O
these	B-disease
abnormalities	I-disease
.	O

Titers	O
for	O
CMV	B-disease
and	O
Epstein-Barr	B-disease
virus	I-disease
were	O
sent	O
and	O
a	O
titer	O
for	O
toxoplasma	B-disease
was	O
sent	O
.	O

Stool	O
was	O
sent	O
for	O
ova	B-disease
and	O
parasites	B-disease
.	O

Gastrointestinal	O
was	O
consulted	O
.	O

Initially	O
,	O
the	O
patient	O
did	O
well	O
in	O
terms	O
of	O
his	O
pre-status	O
and	O
required	O
less	O
oxygen	O
.	O

However	O
,	O
on	O
02/10/91	O
,	O
his	O
respiratory	O
rate	O
increased	O
and	O
his	O
oxygen	O
saturation	O
decreased	O
.	O

Actually	O
in	O
reviewing	O
the	O
records	O
at	O
this	O
point	O
,	O
it	O
appears	O
that	O
Pentamidine	O
was	O
not	O
started	O
initially	O
so	O
on	O
the	O
antibiotics	O
of	O
Erythromycin	O
and	O
Gentamicin	O
,	O
the	O
patient	O
&apos;s	O
respiratory	O
status	O
worsened	O
and	O
his	O
LDH	O
climbed	O
so	O
he	O
began	O
Pentamidine	O
on	O
02/10/91	O
.	O

On	O
02/11/91	O
,	O
the	O
patient	O
again	O
appeared	O
more	O
comfortable	O
this	O
time	O
with	O
50%	O
facemask	O
but	O
then	O
required	O
more	O
oxygen	O
,	O
dropped	O
his	O
O2	O
saturations	O
,	O
and	O
was	O
intubated	O
on	O
02/11/91	O
.	O

He	O
was	O
transferred	O
to	O
the	O
Intensive	O
Care	O
Unit	O
on	O
12/12/90	O
on	O
Gentamicin	O
,	O
Vancomycin	O
,	O
Pentamidine	O
,	O
and	O
Prednisone	O
.	O

Also	O
of	O
note	O
at	O
that	O
point	O
,	O
hepatitis	O
C	O
virus	O
serologies	O
had	O
come	O
back	O
positive	O
.	O

However	O
,	O
at	O
this	O
point	O
,	O
his	B-disease
liver	I-disease
function	I-disease
test	I-disease
abnormalities	I-disease
appeared	O
more	O
consistent	O
with	O
a	B-disease
cholestatic	I-disease
picture	I-disease
with	O
his	O
direct	O
bilirubin	O
being	O
12.1	O
and	O
total	O
being	O
14.1	O
.	O

The	O
patient	O
&apos;s	O
abdominal	O
CT	O
scan	O
showed	O
no	O
liver	B-disease
disease	I-disease
and	O
no	O
obstruction	B-disease
.	O

The	O
patient	O
&apos;s	O
liver	O
function	O
tests	O
appeared	O
to	O
improve	O
.	O

The	B-disease
patient	I-disease
&apos;s	I-disease
penile	I-disease
ulcer	I-disease
was	O
cultured	O
and	O
grew	O
positive	B-disease
herpes	I-disease
simplex	I-disease
virus	I-disease
and	O
the	O
patient	O
was	O
started	O
on	O
Acyclovir	O
.	O

On	O
02/13/91	O
,	O
the	O
patient	O
had	O
a	O
bronchoalveolar	O
lavage	O
performed	O
which	O
showed	O
a	B-disease
toluidine	I-disease
blue	I-disease
with	O
many	B-disease
pneumocysts	I-disease
noted	O
.	O

No	O
other	O
cultures	O
grew	O
out	O
and	O
the	O
patient	O
&apos;s	O
clinical	O
status	O
deteriorated	O
.	O

The	O
patient	O
required	O
100%	O
oxygen	O
to	O
maintain	O
adequate	O
oxygen	O
saturations	O
on	O
the	O
ventilator	O
.	O

He	O
required	O
elevated	O
ventilatory	O
pressures	O
with	O
PIPS	O
often	O
above	O
60	O
.	O

Fortunately	O
,	O
no	O
evidence	O
of	O
baratroma	B-disease
was	O
ever	O
discerned	O
.	O

However	O
,	O
the	O
patient	O
&apos;s	O
respiratory	O
status	O
continued	O
to	O
decline	O
and	O
we	O
were	O
unable	O
to	O
maintain	O
oxygen	O
saturations	O
above	O
80%	O
even	O
using	O
reverse	O
I	O
to	O
E	O
ventilation	O
,	O
paralysis	O
,	O
sedation	O
,	O
and	O
other	O
modes	O
of	O
ventilation	O
.	O

Patient	O
underwent	O
liver	O
biopsy	O
on	O
02/16/91	O
and	O
the	O
results	O
of	O
this	O
were	O
pending	O
when	O
the	O
patient	O
died	O
.	O

The	O
patient	O
actually	O
developed	O
decreasing	B-disease
counts	I-disease
with	O
white	O
count	O
as	O
low	O
as	O
1.75	O
,	O
hematocrit	O
as	O
low	O
as	O
26	O
,	O
and	O
platelets	O
as	O
low	O
as	O
68	O
noted	O
on	O
02/15/91	O
.	O

These	O
were	O
supported	O
with	O
blood	O
products	O
and	O
Hematology	O
was	O
consulted	O
.	O

They	O
felt	O
that	O
it	O
was	O
most	O
likely	O
secondary	O
to	O
Bactrim	O
and	O
these	O
actually	O
were	O
getting	O
better	O
when	O
the	O
patient	O
died	O
.	O

Bone	O
marrow	O
biopsy	O
was	O
not	O
attempted	O
.	O

Discussions	O
were	O
begun	O
with	O
the	O
family	O
regarding	O
limits	O
of	O
supportive	O
care	O
.	O

Due	O
to	O
continued	B-disease
worsening	I-disease
pulmonary	I-disease
status	I-disease
and	O
an	O
overall	O
grim	O
prognosis	O
,	O
the	O
family	O
decided	O
,	O
in	O
consultation	O
with	O
the	O
Medical	O
Team	O
,	O
to	O
withdraw	O
ventilatory	O
support	O
.	O

This	O
was	O
done	O
on	O
the	O
evening	O
of	O
02/18/91	O
.	O

Patient	O
expired	O
after	O
the	O
endotracheal	O
tube	O
was	O
withdrawn	O
at	O
6:40	O
p.m.	O

DISPOSITION	O
:	O

The	O
patient	O
died	O
in	O
hospital	O
.	O

An	O
autopsy	O
will	O
be	O
performed	O
.	O

An	O
autopsy	O
was	O
performed	O
as	O
per	O
the	O
family	O
&apos;s	O
wishes	O
.	O

WE221/9850	O
TAKO	O
C.	O
INSKE	O
,	O
M.D.	O
,	O
PH.	O
JT2	O
FF2	O

D	O
:	O

02/18/91	O

Batch	O
:	O

8600	O

Report	O
:	O

V7238B57	O

T	O
:	O

02/20/91	O

Dicatated	O
By	O
:	O

LATO	O
L.	O
TIKFREIERM	O
,	O
M.D.	O

cc	O
:	O

1.	O
LERMA	O
N.	O
WYNBRANTESXELL	O
,	O
M.D.	O

2.	O
ANA	O
V.	O
A	O
,	O
M.D.	O

3.	O
DALLI	O
A.	O
SEEN	O
,	O
M.D	O

4.	O
ARC	O
N.	O
SEEN	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2012-06-07	O

Discharge	O
Date	O
:	O

2012-06-09	O

Date	O
of	O
Birth	O
:	O

1963-12-03	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-disease
Allergies	I-disease
to	I-disease
Drugs	I-disease

Attending	O
:	O
Christopher	O
KJ	O
Cater	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Overdose	B-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

NG	O
tube	O

History	O
of	O
Present	O
Illness	O
:	O

Mr.	O
Vazquez	O
is	O
a	O
48	O
year	O
old	O
man	O
with	O
a	O
history	O
of	O
hepatitis	B-disease
C	I-disease
,	O
bipolar	B-disease
disorder	I-disease
with	O
suicide	O
attempts	O
in	O
the	O
past	O
,	O
recent	O
CMED	O
admit	O
earlier	O
in	O
4/05	O
who	O
was	O
found	O
alert	O
approximately	O
one	O
hour	O
after	O
taking	O
an	O
unspecified	O
number	O
of	O
pills	O
.	O

Per	O
report	O
,	O
there	O
were	O
empty	O
bottles	O
of	O
Inderal	O
and	O
Klonopin	O
found	O
at	O
bedside	O
,	O
as	O
well	O
as	O
02-26	O
full	O
bottles	O
of	O
geodon	O
,	O
gabapentin	O
,	O
Lescol	O
and	O
paroxitine	O
.	O

The	O
patient	O
was	O
reportedly	O
alert	O
at	O
scene	O
,	O
and	O
then	O
became	O
unresponsive	B-disease
in	O
route	O
to	O
the	O
hospital	O
.	O

In	O
the	O
Rita	O
,	O
the	O
patient	O
was	O
intubated	O
and	O
given	O
activated	O
charcoal	O
.	O

His	O
initial	O
BP	O
was	O
60/P	O
with	O
a	O
pulse	O
in	O
the	O
60	O
s.	O

He	O
was	O
given	O
4	O
amps	O
of	O
calcium	O
gluconate	O
,	O
and	O
started	O
on	O
a	O
Calcium	O
gtt	O
.	O

He	O
was	O
also	O
given	O
5mg	O
of	O
glucagon	O
and	O
started	O
on	O
a	O
glucagon	O
drip	O
with	O
good	O
response	O
.	O

His	O
urine	O
and	O
serum	O
tox	O
screens	O
were	O
notable	O
only	O
for	O
benzos	O
,	O
otherwise	O
negative	O
.	O

He	O
was	O
seen	O
by	O
cardiology	O
,	O
and	O
toxicology	O
was	O
consulted	O
via	O
telephone	O
.	O

He	O
was	O
admitted	O
to	O
the	O
CMED	O
,	O
intubated	O
for	O
airway	O
protection	O
and	O
started	O
on	O
both	O
a	O
calcium	O
and	O
glucagon	O
drip	O
.	O

There	O
was	O
evidence	O
of	O
possible	O
aspiration	B-disease
pneumonia	I-disease
on	O
CXR	O
,	O
though	O
he	O
was	O
extubated	O
without	O
incident	O
on	O
the	O
AM	O
of	O
transfer	O
to	O
the	O
medicine	O
floor	O
.	O

CMED	O
was	O
made	O
aware	O
,	O
and	O
they	O
are	O
actively	O
involved	O
in	O
his	O
care	O
.	O

Past	O
Medical	O
History	O
:	O

Hep	B-disease
C	I-disease

Bipolar	B-disease
D/O	I-disease
with	O
one	O
suicide	O
attempt	O
by	O
overdose	B-disease
several	O
years	O
ago	O

Agoraphobia	B-disease

Panic	B-disease
disorder	I-disease

Narcissism	B-disease

No	O
history	O
of	O
head	B-disease
trauma	I-disease
or	O
seizure	B-disease
disorder	I-disease

Social	O
History	O
:	O

Denies	O
alcohol	O
use	O
.	O

Has	O
a	O
history	O
of	O
cocaine	O
abuse	O
-	O
in	O
remission	O
for	O
6	O
years	O
,	O
with	O
one	O
relapse	O
2.5	O
years	O
ago	O
.	O

Has	O
a	O
history	O
of	O
qualude	O
use	O
since	O
high	O
school	O
,	O
also	O
in	O
remission	O
.	O

Denies	O
use	O
of	O
AA/NA	O
.	O
Smokes	O
1ppd	O
.	O

Patient	O
lives	O
at	O
home	O
with	O
his	O
mother	O
,	O
father	O
and	O
brother	O
.	O

Reports	O
that	O
he	O
has	O
suffered	O
from	O
anxiety	B-disease
since	O
childhood	O
and	O
needed	O
to	O
drop	O
out	O
of	O
college	O
.	O

Unemployed	O
and	O
on	O
disability	O
.	O

Waiting	O
for	O
a	O
subsidized	O
apartment	O
.	O

No	O
current	O
relationship	O
.	O

Family	O
History	O
:	O

Denies	O
.	O

Physical	O
Exam	O
:	O

Vitals	O
:	O
99.3	O
67	O
(	O
60-70	O
)	O
99/53	O
(	O
90-100	O
s)	O
96%	O
on	O
RA	O
3.7L	O
+	O
LOS	O

Gen	O
:	O
caucasian	O
man	O
lying	O
in	O
bed	O
,	O
NAD	B-disease

HEENT	O
:	O
NCAT	O
,	O
PERRL	O
,	O
EOMI	O
,	O
no	O
icterus	B-disease
,	O
OP	O
clear	O
,	O
MMM	O
,	O
no	O
tongue	B-disease
fasciculations	I-disease

Neck	O
:	O
supple	O
,	O
no	O
LAD	B-disease
,	O
no	O
JVD	B-disease

CV	O
:	O
RRR	O
,	O
nl	O
s1	O
s2	O
,	O
no	O
m/g/r	B-disease

Lungs	O
:	O
?	O
decreased	B-disease
BS	I-disease
over	I-disease
left	I-disease
middle	I-disease
lung	I-disease
,	O
otherwise	O
CTA	O

Abd	O
:	O
normal	O
size	O
,	O
nd	B-disease
,	O
no	O
scars	B-disease
,	O
nl	O
bs	O
,	O
soft	O
,	O
nt	B-disease
,	O
palp	O
liver	O

Ext	O
:	O
no	O
c/c/e	B-disease
,	O
no	O
edema	B-disease

Neuro	O
:	O
no	O
asterixis	B-disease
,	O
CN	O
II-XII	O
intact	O
,	O
5/5	O
strength	O
throughout	O
,	O
sensation	O
to	O
LT	O
intact	O
throughout	O
,	O
gait	O
deferred	O

CMED	O
:	O
A+Ox3	O
,	O
mood	O
"	O
great	O
,"	O
affect	O
approp	O
,	O
speech	B-disease
stuttering	I-disease
,	O
linear	O
TP	O
,	O
no	O
SI	B-disease
or	O
HI	B-disease

Pertinent	O
Results	O
:	O

Labs	O
on	O
admit	O
:	O

2012-06-07	O
09:55	O
PM	O
BLOOD	O
WBC	O
-	O
8.9	O
RBC	O
-	O
4.94	O
Hgb	O
-	O
15.8	O
Hct	O
-	O
45.3	O
MCV	O
-	O
92	O
MCH	O
-	O
31.9	O
MCHC	O
-	O
34.8	O
RDW	O
-	O
12.4	O
Plt	O
Ct	O
-	O
175	O

2012-06-07	O
09:55	O
PM	O
BLOOD	O
Neuts	O
-	O
49.9	O
*	O
Lymphs	O
-	O
42.4	O
*	O
Monos	O
-	O
5.5	O
Eos	O
-	O
1.6	O
Baso	O
-	O
0.6	O

2012-06-07	O
09:55	O
PM	O
BLOOD	O
Plt	O
Ct	O
-	O
175	O

2012-06-07	O
09:55	O
PM	O
BLOOD	O
PT	O
-	O
12.8	O
PTT	O
-	O
25.7	O
INR(PT)	O
-	O
1.0	O

2012-06-07	O
09:55	O
PM	O
BLOOD	O
Glucose	O
-	O
108	O
*	O
UreaN	O
-	O
13	O
Creat	O
-	O
0.7	O
Na	O
-	O
146	O
*	O
K	O
-	O
3.7	O
Cl	O
-	O
109	O
*	O
HCO3	O
-	O
30	O
*	O
AnGap	O
-	O
11	O

2012-06-07	O
09:55	O
PM	O
BLOOD	O
Albumin	O
-	O
3.9	O
Calcium	O
-	O
8.5	O
Phos	O
-	O
4.2	O
Mg	O
-	O
2.0	O

2012-06-07	O
09:55	O
PM	O
BLOOD	O
ALT	O
-	O
44	O
*	O
AST	O
-	O
31	O
AlkPhos	O
-	O
36	O
*	O
TotBili	O
-	O
0.2	O

2012-06-07	O
09:55	O
PM	O
BLOOD	O
ASA	O
-	O
NEG	O
Ethanol	O
-	O
NEG	O
Acetmnp	O
-	O
NEG	O
Bnzodzp	O
-	O
NEG	O
Barbitr	O
-	O
NEG	O
Tricycl	O
-	O
NEG	O

Labs	O
today	O
:	O

2012-06-08	O
09:30	O
AM	O
BLOOD	O
WBC	O
-	O
10.1	O
RBC	O
-	O
4.35	O
*	O
Hgb	O
-	O
14.2	O
Hct	O
-	O
39.9	O
*	O
MCV	O
-	O
92	O
MCH	O
-	O
32.6	O
*	O
MCHC	O
-	O
35.6	O
*	O
RDW	O
-	O
12.4	O
Plt	O
Ct	O
-	O
151	O

2012-06-08	O
09:30	O
AM	O
BLOOD	O
Glucose	O
-	O
115	O
*	O
UreaN	O
-	O
14	O
Creat	O
-	O
0.8	O
Na	O
-	O
142	O
K	O
-	O
4.1	O
Cl	O
-	O
112	O
*	O
HCO3	O
-	O
26	O
AnGap	O
-	O
8	O

2012-06-08	O
09:30	O
AM	O
BLOOD	O
Calcium	O
-	O
10.4	O
*	O
Phos	O
-	O
2.8	O
Mg	O
-	O
1.8	O

2012-06-08	O

CXR	O
:	O

An	O
endotracheal	O
tube	O
terminates	O
just	O
above	O
the	O
thoracic	O
inlet	O
approximately	O
6.5	O
cm	O
above	O
the	O
carina	O
.	O

The	O
nasogastric	O
tube	O
terminates	O
within	O
the	O
stomach	O
.	O

Cardiac	O
and	O
mediastinal	O
contours	O
are	O
within	O
normal	O
limits	O
.	O

There	O
is	O
a	B-disease
patchy	I-disease
area	I-disease
of	I-disease
increased	I-disease
opacity	I-disease
in	O
the	O
left	O
retrocardiac	O
region	O
,	O
which	O
was	O
not	O
seen	O
on	O
the	O
earlier	O
study	O
.	O

Right	O
lung	O
is	O
clear	O
.	O

Left	O
costophrenic	O
angle	O
has	O
been	O
excluded	O
from	O
the	O
study	O
and	O
cannot	O
be	O
assessed	O
.	O

There	O
is	O
no	O
evidence	O
of	O
right	B-disease
pleural	I-disease
effusion	I-disease
or	O
right	B-disease
pneumothorax	I-disease
.	O

IMPRESSION	O
:	O

1)	O
Endotracheal	O
tube	O
is	O
slightly	O
proximal	O
in	O
location	O
,	O
and	O
could	O
be	O
advanced	O
approximately	O
1.5	O
cm	O
for	O
more	O
optimal	O
placement	O
.	O

2)	O
Patchy	B-disease
left	I-disease
retrocardiac	I-disease
opacity	I-disease
which	O
may	O
be	O
due	O
to	O
patchy	B-disease
atelectasis	I-disease
,	O
aspiration	B-disease
,	O
or	O
early	B-disease
pneumonia	I-disease
.	O

Followup	O
radiograph	O
suggested	O

Brief	O
Hospital	O
Course	O
:	O

A/P	O
:	O
48yo	O
man	O
with	O
h/o	O
HCV	B-disease
,	O
bipolar	B-disease
DO	I-disease
,	O
h/o	O
suicide	O
attempts	O
,	O
a/w	O
overdose	B-disease
of	O
Inderal	O
,	O
Klonopin	O
,	O
Geodon	O
,	O
s/T	O
Jackson	O
stay	O
with	O
intubation	O
for	O
airway	O
protection	O
,	O
with	O
question	O
of	O
L	B-disease
retrocardiac	I-disease
infiltrate	I-disease
,	O
now	O
doing	O
well	O
.	O

Overdose	O
:	O

-	O
monitor	O
on	O
tele	O
overnight	O

-	O
if	O
HR	O
drops	O
,	O
restart	O
glucagon	O
gtt	O

-	O
watch	O
for	O
BZD	B-disease
withdrawal	I-disease
,	O
agitation	B-disease

Bipolar	B-disease
disorder	I-disease
:	O

-	O
appreciate	O
CMED	O
consult	O
;	O
patient	O
to	O
be	O
discharged	O
to	O
inpatient	O
CMED	O
facility	O
once	O
stable	O

-	O
suicide	O
precautions	O

Activity	O
:	O
OOB	O
with	O
assist	O

FEN	O
:	O
house	O
diet	O

PPX	O
:	O
SC	O
heparin	O
,	O
bowel	O
regimen	O
,	O
nicotine	O
patch	O

CODE	O
:	O
full	O

DISPO	O
:	O
transfer	O
to	O
inpatient	O
CMED	O
likely	O
tomorrow	O

Medications	O
on	O
Admission	O
:	O

Neurontin	O
800	O
mg	O
tid	O

Ziprasidone	O
bid	O

Propanolol	O
20	O
mg	O
tid	O

Klonopin	O
2	O
mg	O
tid	O

Paxil	O
30	O
mg	O
qd	O

Protonix	O
40	O
mg	O
qd	O

Folate	O
1	O
mg	O
qd	O

Lescol	O
40	O
qd	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Depression	B-disease

Discharge	O
Condition	O
:	O

Depressed	B-disease

Discharge	O
Instructions	O
:	O

Going	O
to	O
UMass	O
Memorial	O
Medical	O
Center	O
4	O
.	O

Followup	O
Instructions	O
:	O

Please	O
f	O
/	O
u	O
with	O
PCP	O
D	O
2	O
weeks	O
.	O

Joseph	O
Judy	O
MD	O
35-943	O

Completed	O
by	O
:	O
John	O
Konderla	O
MD	O
01-196	O
2012-06-09	O
@	O
1707	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Felix	O
Garcia	O
on	O
:	O
FRI	O
2012-06-15	O
4:29	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2019-01-09	O

Discharge	O
Date	O
:	O

2019-01-15	O

Date	O
of	O
Birth	O
:	O

1973-11-18	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Erythromycin	O
Base	O

Attending	O
:	O
Stephanie	O
I	O
Sept	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Syncope	B-disease
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

None	O
.	O

History	O
of	O
Present	O
Illness	O
:	O

45M	O
w/no	O
PMH	O
presented	O
to	O
Chelseahospital	O
after	O
a	B-disease
syncopal	I-disease
episode	I-disease
on	O
the	O
morning	O
of	O
admission	O
.	O

Pt	O
was	O
preparing	O
lunch	O
when	O
suddenly	O
felt	O
lightheaded	B-disease
/	O
faint	B-disease
and	O
immediately	O
fell	O
to	O
the	O
kitchen	O
floor	O
face	O
first	O
.	O

He	O
denies	O
LOC	B-disease
.	O

Immediately	O
there	O
after	O
he	O
was	O
very	B-disease
short	I-disease
of	I-disease
breath	I-disease
,	O
felt	O
lightheaded	B-disease
again	O
and	O
called	O
911	O
.	O

At	O
Springfield	O
,	O
CT	O
chest	O
was	O
positive	O
for	O
saddle	B-disease
PE	I-disease
.	O

VS	O
were	O
with	O
stable	O
BPs	O
,	O
tachy	B-disease
to	O
110-120	O
,	O
sat	O
98%	O
RA	O
.	O

He	O
received	O
Lovenox	O
91	O
mg	O
SC	O
prior	O
to	O
transport	O
and	O
was	O
transferred	O
to	O
Arbour	O
Hospital	O
for	O
further	O
care	O
.	O

Mr.	O
Anders	O
states	O
that	O
2	O
weeks	O
prior	O
to	O
his	O
presentation	O
he	O
hurt	O
his	O
left	O
knee	O
.	O

He	O
was	O
sitting	O
on	O
the	O
floor	O
legs	O
crossed	O
and	O
stood	O
up	O
when	O
he	O
heard	O
his	O
knee	O
CMED	O
CCU	O
.	O

Then	O
again	O
on	O
Sunday	O
,	O
3	O
days	O
PTA	O
,	O
again	O
from	O
sitting	O
to	O
standing	O
heard	O
his	O
knee	O
CMED	O
CCU	O
.	O

He	O
was	O
essentially	B-disease
bed	I-disease
bound	I-disease
for	O
3	O
days	O
prior	O
to	O
admission	O
,	O
unable	B-disease
to	I-disease
ambulate	I-disease
.	O

He	O
started	O
to	O
notice	O
inflammation	B-disease
of	I-disease
his	I-disease
L	I-disease
calf	I-disease
/	I-disease
leg	I-disease
worse	O
2	O
days	O
prior	O
to	O
presentation	O
.	O

In	O
this	O
2	O
week	O
interval	O
he	O
denied	O
having	O
CP	B-disease
/	O
chest	B-disease
discomfort	I-disease
or	O
difficulty	B-disease
breathing	I-disease
,	O
no	O
cough	B-disease
or	O
hemoptysis	B-disease
.	O

No	O
f/c/	B-disease
sweats	B-disease
.	O

Pt	O
denied	O
any	B-disease
bleeding	I-disease
or	I-disease
clotting	I-disease
disorders	I-disease
and	O
has	O
never	O
had	O
a	B-disease
clot	I-disease
in	O
the	O
past	O
.	O

Past	O
Medical	O
History	O
:	O

Left	B-disease
knee	I-disease
injury	I-disease
.	O

Seasonal	B-disease
allergies	I-disease
.	O

Social	O
History	O
:	O

-	O
Lives	O
w/	O
wife	O
&	O
son	O
in	O
Jose	O
,	O
MA	O

-	O
Denies	O
TOB	O
use	O
,	O
occasional	O
ETOH	O
use	O

Family	O
History	O
:	O

-	O
M	O
:	O

HTN	B-disease
,	O
DM	B-disease

-	O
F	O
:	O

COPD	B-disease
,	O
Prostate	B-disease
CA	I-disease

-	O
Grandfather	O
died	O
of	O
MI	B-disease
at	O
age	O
75	O

Physical	O
Exam	O
:	O

VS	O
:	O
99.4	O
HR	O
111	O
BP	O
110/64	O
RR16	O
97%	O
2LNC	O

GEN	O
:	O
NAD	B-disease
,	O
pleasant	O
speaking	O
in	O
full	O
sentences	O

HEENT	O
:	O
MMM	O
,	O
OP	O
clear	O
,	O
dried	B-disease
blood	I-disease
in	I-disease
nasal	I-disease
mucosa	I-disease

RESP	O
:	O
CTABL	O
,	O
no	O
crackles	B-disease
,	O
no	O
wheezing	B-disease
or	O
rhonchi	B-disease

CV	O
:	O
Reg	O
,	O
tachy	B-disease
Nml	O
S1	O
,	O
S2	O
,	O
no	O
M/R/G	B-disease

ABD	O
:	O
soft	O
ND/NT	B-disease
+BS	O

EXT	O
:	O
L	B-disease
leg/calf	I-disease
swollen	I-disease
,	O
+	O
Johnson	O
sign	O
,	O
not	O
tense	B-disease
,	O
no	O
cord	O
palpable	O
,	O
L	O
knee	O
w/	O
medial	B-disease
meniscus	I-disease
area	I-disease
inflammed	I-disease
,	O
not	O
warm	B-disease
,	O
no	O
crepitus	B-disease
,	O
feet-2+DP	O
pulses	O
b/l	O

Pertinent	O
Results	O
:	O

1.	O
CT	O
OF	O
HEAD	O
WITHOUT	O
CONTRAST	O
:	O

No	O
evidence	O
of	O
acute	B-disease
intracranial	I-disease
hemorrhage	I-disease
or	O
fractures	B-disease
.	O

2.	O
ECHO	O

Conclusions	O
:	O

The	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

The	O
estimated	O
right	O
atrial	O
pressure	O
is	O
16-20	O
mmHg	O
.	O

Left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

The	O
left	O
ventricular	O
cavity	O
is	O
small	O
.	O

Left	O
ventricular	O
systolic	O
function	O
is	O
hyperdynamic	B-disease
(	O
EF	O
>	O
75%	O
)	O
.	O

There	O
is	O
no	O
ventricular	B-disease
septal	I-disease
defect	I-disease
.	O

The	O
right	O
ventricular	O
cavity	O
is	O
mildly	B-disease
dilated	I-disease
.	O

Right	O
ventricular	O
systolic	O
function	O
is	O
borderline	O
normal	O
.	O

The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B-disease
regurgitation	I-disease
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

There	O
is	O
no	O
mitral	B-disease
valve	I-disease
prolapse	I-disease
.	O

There	O
is	O
moderate	B-disease
pulmonary	I-disease
artery	I-disease
systolic	I-disease
hypertension	I-disease
.	O

There	O
is	O
no	O
pericardial	B-disease
effusion	I-disease
.	O

Impression	O
:	O
mildly	B-disease
dilated	I-disease
right	I-disease
ventricle	I-disease
;	O
small	B-disease
,	I-disease
hyperdynamic	I-disease
left	I-disease
ventricle	I-disease
;	O
at	O
least	O
moderate	B-disease
pulmonary	I-disease
hypertension	I-disease

3.	O
BILATERAL	O
LENI	O
's	O

IMPRESSION	O
:	O

No	O
evidence	O
of	O
DVT	B-disease
in	I-disease
either	I-disease
lower	I-disease
limb	I-disease
.	O

OSH	O
IMAGING	O
:	O

-	O
saddle	B-disease
PE	I-disease
,	O
no	O
CD	O
or	O
report	O
sent	O

EKG	O
:	O

-	O
Sinus	B-disease
Tach	I-disease
,	O
normal	O
axis	O
HR	O
119	O
ST	B-disease
Depression	I-disease
V3-V5	I-disease
;	O
S1Q3T3	B-disease
,	O
p-pulmonale	B-disease
.	O

01-11	O
MRI	O
Left	O
Knee	O
w/o	O
Contrast	O

1.	O
Bucket	B-disease
handle	I-disease
medial	I-disease
meniscal	I-disease
tear	I-disease
with	O
flipped	B-disease
fragment	I-disease
in	I-disease
the	I-disease
intercondylar	I-disease
notch	I-disease
.	O

Complex	B-disease
tear	I-disease
involving	O
the	O
posterior	O
Ellison	O
and	O
body	O
.	O

2.	O
Moderate	B-disease
knee	I-disease
joint	I-disease
effusion	I-disease
with	O
possible	O
ganglion	B-disease
cyst	I-disease
at	I-disease
the	I-disease
insertion	I-disease
of	I-disease
the	I-disease
PCL	I-disease
.	O

3.	O
Discoid	B-disease
lateral	I-disease
meniscus	I-disease
.	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Anders	O
was	O
admitted	O
for	O
anticoagulation	O
and	O
hemodynamic	O
monitoring	O
in	O
the	O
setting	O
of	O
saddle	B-disease
pulmonary	I-disease
embolus	I-disease
and	O
left	B-disease
knee	I-disease
injury	I-disease
.	O

#.	O
PE	B-disease
:	O

Given	O
no	O
other	O
risk	O
factors	O
or	O
likely	O
causes	O
,	O
the	O
most	O
likely	O
etiology	O
for	O
his	B-disease
embolus	I-disease
is	O
DVT	B-disease
from	I-disease
the	I-disease
left	I-disease
leg	I-disease
.	O

He	O
has	O
no	O
known	B-disease
clotting	I-disease
disorder	I-disease
but	O
did	O
have	O
trauma	B-disease
to	I-disease
leg	I-disease
prompting	O
immobility	B-disease
and	O
stasis	B-disease
.	O

He	O
remained	O
hemodynmically	O
stable	O
throughout	O
his	O
hospitalization	O
and	O
did	O
not	O
have	O
an	B-disease
oxygen	I-disease
requirement	I-disease
upon	O
discharge	O
.	O

Given	O
no	O
evidence	O
of	O
hemodynamic	B-disease
instability	I-disease
,	O
lysis	O
was	O
not	O
required	O
.	O

He	O
was	O
anticoagulated	O
with	O
heparin	O
and	O
coumadin	O
.	O

He	O
will	O
need	O
to	O
follow	O
up	O
with	O
hematology	O
for	O
an	O
outpatient	O
thrombophilia	O
work-up	O
(	O
not	O
done	O
as	O
inpatient	O
as	O
results	O
would	O
not	O
change	O
acute	O
management	O
of	O
PE	B-disease
).	O

He	O
will	O
also	O
require	O
close	O
follow	O
up	O
with	O
his	O
primary	O
care	O
provider	O
for	O
coumadin	O
management	O
.	O

Duration	O
of	O
his	O
coumadin	O
therapy	O
to	O
be	O
determined	O
by	O
hematology	O
,	O
but	O
likely	O
to	O
be	O
at	O
least	O
6	O
months	O
in	O
duration	O
.	O

#.	O
Syncope	B-disease
:	O

In	O
setting	O
of	O
PE	B-disease
.	O

Remainder	O
of	O
his	O
cardiac	O
workup	O
was	O
negative	O
.	O

He	O
did	O
have	O
a	B-disease
small	I-disease
troponin	I-disease
leak	I-disease
,	O
felt	O
to	O
be	O
related	O
to	O
right	B-disease
heart	I-disease
strain	I-disease
in	O
the	O
setting	O
of	O
P-pulmonale	B-disease
related	O
to	O
clot	B-disease
burden	I-disease
.	O

His	O
tronponin	O
quickly	O
trended	O
down	O
and	O
he	O
did	O
not	O
have	O
EKG	O
evidence	O
of	O
ischemia	B-disease
.	O

An	O
ECHO	O
did	O
not	O
reveal	O
any	B-disease
wall	I-disease
motion	I-disease
abnormalities	I-disease
related	O
to	O
ischemia	B-disease
.	O

#.	O
Hematocrit	O
:	O

Dropped	O
from	O
42.7	O
to	O
36	O
in	O
setting	O
of	O
anticoagulation	O
for	O
saddle	B-disease
PE	I-disease
and	O
IV	O
fluids	O
.	O

No	O
active	B-disease
bleeding	I-disease
noted	O
.	O

Pt	O
asymptomatic	B-disease
.	O

#.	O
L	B-disease
knee	I-disease
injury	I-disease
:	O

Given	O
his	O
history	O
and	O
physical	O
exam	O
,	O
Mr.	O
Anders	O
presented	O
with	O
an	B-disease
injury	I-disease
most	O
consistent	O
with	O
meniscal	B-disease
tear	I-disease
.	O

In	O
order	O
to	O
facilitate	O
therapy	O
and	O
to	O
promote	O
mobility	O
,	O
an	O
MRI	O
of	O
the	O
knee	O
was	O
done	O
.	O

He	O
was	O
seen	O
by	O
physical	O
therapy	O
and	O
will	O
need	O
to	O
follow	O
up	O
with	O
orthopaedics	O
upon	O
discharge	O
for	O
repeat	O
evaluation	O
.	O

#.	O
CODE	O
:	O

FULL	O
CODE	O
.	O

Medications	O
on	O
Admission	O
:	O

-	O
Claritin	O
prn	O

-	O
Flonase	O
prn	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Pulmonary	B-disease
embolus	I-disease

Left	B-disease
knee	I-disease
meniscal	I-disease
tear	I-disease

Discharge	O
Condition	O
:	O

Stable	O

Discharge	O
Instructions	O
:	O

You	O
were	O
admitted	O
to	O
the	O
hospital	O
for	O
a	B-disease
pulmonary	I-disease
embolism	I-disease
.	O

You	O
were	O
treated	O
with	O
blood	O
thinners	O
.	O

You	O
have	O
been	O
started	O
on	O
an	O
oral	O
blood	O
thinner	O
called	O
Coumadin	O
(	O
Warfarin	O
).	O

Please	O
continue	O
to	O
take	O
this	O
medication	O
as	O
prescribed	O
.	O

You	O
must	O
have	O
your	O
INR	O
(	O
blood	O
levels	O
)	O
checked	O
on	O
a	O
regular	O
basis	O
until	O
your	O
INR	O
levels	O
remain	O
01-19	O
.	O

The	O
MRI	O
of	O
your	O
knee	O
showed	O
a	B-disease
meniscal	I-disease
tear	I-disease
.	O

Please	O
schedule	O
an	O
appointment	O
with	O
your	O
orthopedic	O
surgeon	O
to	O
determine	O
a	O
plan	O
for	O
treatment	O
.	O

Please	O
follow-up	O
with	O
your	O
Primary	O
Care	O
doctor	O
Marion	O
Bock	O
as	O
below	O
.	O

Please	O
return	O
to	O
the	O
hospital	O
if	O
you	O
experience	O
chest	B-disease
pain	I-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
lightheadedness	B-disease
or	O
dizziness	B-disease
.	O

Followup	O
Instructions	O
:	O

Please	O
follow-up	O
with	O
your	O
Primary	O
care	O
doctor	O
Larry	O
Bock	O
2019-01-16	O
at	O
8:30	O
AM	O
.	O

At	O
this	O
appointment	O
,	O
you	O
should	O
confirm	O
orthopedic	O
follow-up	O
and	O
request	O
a	O
hematology	O
referral	O
.	O

Call	O
to	O
reschedule	O
.	O

Heidi	O
Laura	O
MD	O
44-725	O

Completed	O
by	O
:	O
Daniel	O
Tapaha	O
MD	O
73-060	O
2019-01-15	O
@	O
0918	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Steven	O
W.	O
Weekley	O
on	O
:	O
Sandra	O
2019-01-15	O
10:22	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-04-24	O

Discharge	O
Date	O
:	O

2013-05-11	O

Date	O
of	O
Birth	O
:	O

2013-04-24	O

Sex	O
:	O

F	O

Service	O
:	O

NEONATOLOGY	O

HISTORY	O
:	O

Richard	O
Williams	O
,	O
Twin	O
number	O
II	O
,	O
was	O
born	O
at	O
31-6/7	O
weeks	O
gestation	O
by	O
cesarean	O
section	O
for	O
rupture	B-disease
of	I-disease
membranes	I-disease
of	O
Twin	O
number	O
I	O
and	O
progressive	B-disease
preterm	I-disease
labor	I-disease
.	O

Mother	O
is	O
a	O
37	O
year	O
old	O
Gravida	O
1	O
,	O
Para	O
0	O
now	O
2	O
woman	O
whose	O
blood	O
type	O
is	O
A	O
negative	O
,	O
antibody	O
negative	O
,	O
rubella	O
immune	O
,	O
RPR	O
nonreactive	O
,	O
hepatitis	O
B	O
surface	O
antigen	O
negative	O
and	O
Group	O
B	O
Streptococcus	O
unknown	O
.	O

The	O
mother	O
had	O
received	O
a	O
complete	O
course	O
of	O
betamethasone	O
prior	O
to	O
delivery	O
.	O

This	O
pregnancy	O
was	O
achieved	O
with	O
in	O
Bartley	O
fertilization	O
.	O

A	O
cerclage	O
was	O
placed	O
at	O
18	O
weeks	O
gestation	O
.	O

Cesarean	O
section	O
was	O
performed	O
under	O
spinal	O
anesthesia	O
.	O

This	O
infant	O
emerged	O
with	O
Apgars	O
of	O
8	O
at	O
one	O
minute	O
and	O
8	O
at	O
five	O
minutes	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
revealed	O
a	O
vigorous	O
non-dysmorphic	O
premature	O
infant	O
,	O
with	O
moderate	B-disease
subcostal	I-disease
retractions	I-disease
and	O
some	B-disease
occasional	I-disease
grunting	I-disease
,	O
normal	O
S1	O
,	O
S2	O
heart	O
sounds	O
,	O
no	O
murmur	B-disease
.	O

Pink	O
and	O
well	O
perfused	O
.	O

Normal	O
hip	O
examination	O
and	O
age	O
appropriate	O
tone	O
and	O
reflexes	O
.	O

The	O
birth	O
weight	O
was	O
1,980	O
grams	O
,	O
80th	O
percentile	O
.	O

The	O
birth	O
length	O
was	O
44	O
centimeters	O
,	O
the	O
75th	O
percentile	O
and	O
the	O
birth	O
head	O
circumference	O
was	O
30.6	O
centimeters	O
,	O
in	O
the	O
65th	O
percentile	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEMS	O
:	O

1.	O
Respiratory	O
Status	O
:	O

The	O
infant	O
was	O
intubated	O
soon	O
after	O
admission	O
to	O
the	O
CMED	O
CSRU	O
and	O
received	O
two	O
doses	O
of	O
surfactant	O
.	O

She	O
weaned	O
to	O
room	O
air	O
on	O
day	O
of	O
life	O
one	O
where	O
she	O
has	O
remained	O
since	O
that	O
time	O
.	O

Her	O
respirations	O
are	O
comfortable	O
.	O

Her	O
lung	O
sounds	O
are	O
clear	O
and	O
equal	O
.	O

She	O
has	O
had	O
no	O
apnea	B-disease
,	O
bradycardia	B-disease
or	O
desaturation	B-disease
.	O

2.	O
Cardiovascular	O
Status	O
:	O

She	O
had	O
remained	O
normotensive	O
throughout	O
her	O
CMED	O
CSRU	O
stay	O
.	O

She	O
has	O
a	O
normal	O
S1	O
,	O
S2	O
heart	O
sound	O
and	O
no	O
murmur	B-disease
.	O

She	O
is	O
pink	O
and	O
well	O
perfused	O
.	O

3.	O
Fluids	O
,	O
Electrolytes	O
and	O
Nutrition	O
Status	O
:	O

She	O
started	O
on	O
enteral	O
feeds	O
on	O
day	O
of	O
life	O
number	O
two	O
and	O
progressed	O
without	O
difficulty	O
to	O
full	O
volume	O
feedings	O
by	O
day	O
of	O
life	O
five	O
and	O
then	O
was	O
advanced	O
to	O
calorie	O
enhanced	O
breast	O
milk	O
of	O
24	O
calories	O
per	O
ounce	O
.	O

She	O
has	O
been	O
taking	O
from	O
130	O
to	O
160	O
cc.	O
per	O
kilo	O
per	O
day	O
on	O
an	O
ad	O
lib	O
feeding	O
plan	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
her	O
weight	O
is	O
2,200	O
grams	O
;	O
her	O
length	O
is	O
49.5	O
centimeters	O
(	O
19.5	O
inches	O
)	O
and	O
her	O
head	O
circumference	O
is	O
30.5	O
centimeters	O
.	O

4.	O
Gastrointestinal	O
Status	O
:	O

Her	O
peak	O
bilirubin	O
occurred	O
on	O
day	O
of	O
life	O
five	O
and	O
was	O
total	O
12.1	O
,	O
direct	O
0.3	O
;	O
the	O
last	O
bilirubin	O
on	O
day	O
of	O
life	O
six	O
was	O
total	O
11.1	O
,	O
direct	O
0.4	O
.	O

She	O
never	O
required	O
phototherapy	O
.	O

5.	O
Hematological	O
Status	O
:	O

Her	O
hematocrit	O
at	O
the	O
time	O
of	O
admission	O
was	O
45.4	O
,	O
platelets	O
were	O
360,000	O
.	O

She	O
is	O
receiving	O
supplemental	O
iron	O
to	O
provide	O
2	O
mg	O
per	O
kilo	O
per	O
day	O
as	O
elemental	O
iron	O
.	O

She	O
has	O
never	O
received	O
any	O
blood	O
products	O
during	O
this	O
CMED	O
CSRU	O
stay	O
.	O

6.	O
Infectious	O
Disease	O
Status	O
:	O

The	O
infant	O
was	O
started	O
on	O
Ampicillin	O
and	O
Gentamycin	O
at	O
the	O
time	O
of	O
admission	O
for	O
sepsis	B-disease
risk	I-disease
factor	I-disease
.	O

The	O
antibiotics	O
were	O
discontinued	O
after	O
48	O
hours	O
when	O
the	O
infant	O
was	O
clinically	O
well	O
and	O
the	O
blood	O
cultures	O
remained	O
negative	O
.	O

7.	O
Neurological	O
Status	O
:	O

She	O
had	O
a	O
head	O
ultrasound	O
on	O
2013-05-02	O
,	O
that	O
was	O
completely	O
within	O
normal	O
limits	O
.	O

8.	O
Psychosocial	O
:	O

The	O
parents	O
have	O
been	O
very	O
involved	O
in	O
the	O
infant	O
's	O
care	O
throughout	O
her	O
CMED	O
CSRU	O
stay	O
.	O

She	O
is	O
the	O
first	O
twin	O
to	O
go	O
home	O
.	O

The	O
infant	O
's	O
first	O
name	O
is	O
Ralph	O
and	O
after	O
discharge	O
the	O
infant	O
's	O
last	O
name	O
will	O
be	O
Neoma	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

DISPOSITION	O
:	O

The	O
infant	O
is	O
being	O
discharged	O
home	O
with	O
her	O
parents	O
.	O

Primary	O
pediatric	O
care	O
will	O
be	O
provided	O
by	O
Dr.	O
Hortencia	O
Conner	O
of	O
Milton	O
Hospital	O
Pediatric	O
Group	O
,	O
3408	O
E.	O
Fifth	O
Rd.	O
,	O
Bridgewater	O
State	O
Hospital	O
,	O
Tennessee	O
06546	O
,	O
telephone	O
number	O
is	O
433-0531	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
:	O

1.	O
Feedings	O
:	O

The	O
infant	O
is	O
on	O
breast	O
milk	O
with	O
Enfamil	O
Powder	O
to	O
provide	O
24	O
calories	O
per	O
ounce	O
and	O
on	O
an	O
ad	O
lib	O
feeding	O
schedule	O
.	O

2.	O
Medications	O
:	O

Ferinsol	O
0.2	O
cc.	O
to	O
provide	O
5	O
mg	O
a	O
day	O
.	O

3.	O
The	O
infant	O
passed	O
a	O
car	O
seat	O
positioning	O
test	O
on	O
2013-05-11	O
.	O

4.	O
State	O
Screens	O
were	O
sent	O
on	O
04-27	O
and	O
2013-05-08	O
.	O

5.	O
The	O
infant	O
received	O
the	O
hepatitis	O
B	O
vaccine	O
on	O
2013-05-09	O
,	O
and	O
Synagis	O
on	O
2013-05-11	O
.	O

Immunization	O
recommended	O
:	O

1)	O
Synagis	O
RSV	O
prophylaxis	O
should	O
be	O
considered	O
from	O
October	O
through	O
April	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
three	O
criteria	O
:	O

Born	O
at	O
less	O
than	O
32	O
weeks	O
;	O
born	O
between	O
32	O
and	O
35	O
weeks	O
with	O
plans	O
for	O
day	O
care	O
during	O
the	O
RSV	O
season	O
,	O
with	O
a	O

smoker	O
in	O
the	O
household	O
,	O
with	O
preschool	O
siblings	O
,	O
or	O
with	O
chronic	B-disease
lung	I-disease
disease	I-disease
;	O

2)	O
Influenza	O
immunization	O
should	O
be	O
considered	O
annually	O
in	O
the	O
Fall	O
for	O
preterm	O
infants	O
with	O
chronic	B-disease
lung	I-disease
disease	I-disease
once	O
they	O
reach	O
six	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
,	O
the	O
family	O
and	O
other	O
care	O
givers	O
should	O
be	O
considered	O
for	O
immunization	O
against	O
influenza	B-disease
to	O
protect	O
the	O
infant	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

1.	O
Follow-up	O
appointments	O
,	O
the	O
parents	O
have	O
an	O
appointment	O
with	O
Dr.	O
Avon	O
on	O
Tuesday	O
,	O
05-14	O
.	O

2.	O
Visiting	O
Nurses	O
Association	O
of	O
the	O
L.F.	O
Quigley	O
Memorial	O
Hospital	O
will	O
visit	O
on	O
Sunday	O
,	O
2013-05-12	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Prematurity	B-disease
at	O
31-6/7	O
weeks	O
gestation	O
.	O

2.	O
Twin	O
II	O
.	O

3.	O
Sepsis	B-disease
,	O
ruled	O
out	O
.	O

4.	O
Status	O
post	O
respiratory	B-disease
distress	I-disease
syndrome	I-disease
.	O

Brian	O
LT	O
Wentzel	O
,	O
M.D.	O

96-131	O

Dictated	O
By	O
:	O
Tammy	O
T.K.	O
Farless	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2013-05-11	O
17:49	O

T	O
:	O
2013-05-11	O
18:43	O

JOB	O
#:	O

06197	O

Signed	O
electronically	O
by	O
:	O
DR.	O
John	O
Bonilla	O
on	O
:	O
MON	O
2013-05-13	O
4:49	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2015-06-05	O

Discharge	O
Date	O
:	O

2015-06-10	O

Date	O
of	O
Birth	O
:	O

2015-06-05	O

Sex	O
:	O

M	O

Service	O
:	O

Neonatology	O

HISTORY	O
:	O

The	O
patient	O
is	O
a	O
1,770	O
gram	O
male	O
infant	O
born	O
by	O
stat	O
cesarean	O
section	O
for	O
fetal	B-disease
bradycardia	I-disease
at	O
30-6/7	O
weeks	O
gestation	O
to	O
a	O
29-year-old	O
gravida	O
3	O
,	O
para	O
0	O
now	O
1	O
mother	O
.	O

The	O
pregnancy	O
was	O
unremarkable	O
until	O
2015-06-01	O
when	O
the	O
mother	O
presented	O
to	O
Shriner	O
's	O
Hospital	O
for	O
Crippled	O
Children	O
for	O
increased	B-disease
blood	I-disease
pressure	I-disease
and	O
proteinuria	B-disease
.	O

She	O
was	O
transferred	O
to	O
Charles	O
River	O
Hospital	O
and	O
was	O
treated	O
with	O
magnesium	O
sulfate	O
and	O
betamethasone	O
.	O

The	O
morning	O
of	O
admission	O
the	O
mother	O
developed	O
vaginal	B-disease
bleeding	I-disease
and	O
fetal	B-disease
bradycardia	I-disease
was	O
noted	O
.	O

Therefore	O
,	O
a	O
stat	O
cesarean	O
section	O
was	O
performed	O
.	O

The	O
infant	O
emerged	O
limp	B-disease
and	O
without	O
spontaneous	B-disease
respiratory	I-disease
effort	I-disease
.	O

He	O
was	O
given	O
bag	O
mask	O
ventilation	O
with	O
good	O
response	O
.	O

Apgar	O
scores	O
were	O
6	O
at	O
one	O
minute	O
and	O
8	O
at	O
five	O
minutes	O
.	O

PRENATAL	O
SCREENS	O
:	O

O+	O
,	O
hepatitis	O
B	O
surface	O
antigen	O
negative	O
,	O

RPR	O
nonreactive	O
,	O
rubella	B-disease
immune	O
.	O

ADMISSION	O
PHYSICAL	O
EXAMINATION	O
:	O

The	O
birth	O
weight	O
was	O
1,770	O
grams	O
.	O

The	O
patient	O
was	O
in	O
mild	B-disease
to	I-disease
moderate	I-disease
respiratory	I-disease
distress	I-disease
.	O

He	O
was	O
a	O
nondysmorphic	O
male	O
.	O

Anterior	O
fontanel	O
was	O
soft	O
,	O
open	O
and	O
flat	O
.	O

The	O
ears	O
and	O
eyes	O
were	O
normally	O
placed	O
.	O

The	O
palate	O
was	O
intact	O
.	O

The	O
oropharynx	O
was	O
benign	O
.	O

Neck	O
was	O
supple	O
without	O
masses	B-disease
or	O
defects	B-disease
.	O

The	O
lungs	O
were	O
coarse	B-disease
bilaterally	I-disease
with	O
moderate	B-disease
retractions	I-disease
.	O

The	O
cardiovascular	O
examination	O
revealed	O
S1	O
and	O
S2	O
regular	O
,	O
no	O
murmurs	B-disease
,	O
2+	O
femoral	O
pulses	O
.	O

He	O
was	O
warm	O
and	O
well	O
perfused	O
.	O

The	O
abdomen	O
was	O
benign	O
,	O
flat	O
,	O
nontender	B-disease
,	O
nondistended	B-disease
,	O
no	O
hepatosplenomegaly	B-disease
.	O

He	O
had	O
a	O
normal	O
male	O
phallus	O
and	O
bilaterally	O
descended	O
testes	O
.	O

The	O
anus	O
was	O
patent	O
and	O
normally	O
placed	O
.	O

Hips	O
were	O
stable	O
without	O
clunk	B-disease
.	O

The	O
extremities	O
were	O
normal	O
in	O
appearance	O
.	O

The	O
skin	O
was	O
without	O
lesions	B-disease
.	O

The	O
neurological	O
examination	O
was	O
appropriate	O
for	O
age	O
with	O
normal	O
tone	O
and	O
strength	O
and	O
appropriate	O
reflexes	O
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
Cardiovascular	O
:	O

The	O
patient	O
remained	O
cardiovascularly	O
stable	O
throughout	O
the	O
admission	O
.	O

He	O
was	O
noted	O
to	O
have	O
some	B-disease
apnea	I-disease
and	O
bradycardic	B-disease
spells	I-disease
of	I-disease
prematurity	I-disease
and	O
was	O
therefore	O
started	O
on	O
caffeine	O
.	O

With	O
the	O
initiation	O
of	O
caffeine	O
therapy	O
the	O
patient	O
has	O
had	O
no	O
more	O
apnea	B-disease
or	O
bradycardic	B-disease
events	I-disease
.	O

2.	O
Respiratory	O
:	O

The	O
patient	O
was	O
initially	O
started	O
on	O
nasal	O
prong	O
CPAP	O
at	O
6	O
and	O
required	O
additional	O
oxygen	O
to	O
35%	O
.	O

However	O
by	O
24	O
hours	O
he	O
transitioned	O
to	O
low-flow	O
nasal	O
cannula	O
and	O
on	O
day	O
of	O
life	O
five	O
transitioned	O
to	O
room	O
air	O
where	O
he	O
currently	O
remains	O
.	O

3.	O
Fluids	O
,	O
electrolytes	O
and	O
nutrition	O
:	O

The	O
patient	O
was	O
initially	O
maintained	O
on	O
intravenous	O
fluids	O
only	O
and	O
when	O
his	B-disease
respiratory	I-disease
distress	I-disease
resolved	O
he	O
was	O
transitioned	O
to	O
enteral	O
feeds	O
.	O

The	O
morning	O
of	O
transfer	O
his	O
IV	O
came	O
out	O
so	O
he	O
has	O
just	O
been	O
advanced	O
to	O
120	O
cc	O
per	O
kg	O
per	O
day	O
of	O
PE-20	O
and	O
his	O
tolerating	O
these	O
PG	O
feedings	O
without	O
difficulty	O
.	O

Last	O
set	O
of	O
electrolytes	O
on	O
06-08	O
,	O
DOL3	O
:	O

Na	O
145	O
,	O
K	O
4.3	O
,	O
Cl	O
110	O
,	O
tCO2	O
25	O
.	O

Discharge	O
Wt	O
1645	O
gms	O
.	O

4.	O
Hematology	O
:	O

His	O
admission	O
complete	O
blood	O
count	O
was	O
notable	O
for	O
a	O
white	O
count	O
of	O
11.8	O
,	O
25	O
polys	O
and	O
no	O
bands	B-disease
.	O

Hematocrit	O
was	O
45	O
,	O
platelet	O
count	O
270	O
.	O

He	O
developed	O
physiologic	B-disease
hyperbilirubinemia	I-disease
(	O
peak	O
bili	O
8.6/0.3	O
on	O
06-08	O
,	O
DOL3	O
)	O
for	O
which	O
he	O
was	O
treated	O
with	O
a	O
single	O
phototherapy	O
.	O

His	O
most	O
recent	O
bilirubin	O
was	O
6.6	O
on	O
day	O
of	O
life	O
six	O
,	O
the	O
day	O
of	O
discharge	O
,	O
and	O
his	O
phototherapy	O
was	O
discontinued.	O
He	O
will	O
need	O
a	O
rebound	O
bilirubin	O
level	O
in	O
am	O
.	O

5.	O
Infectious	O
disease	O
:	O

Blood	O
culture	O
was	O
sent	O
but	O
he	O
was	O
never	O
started	O
on	O
antibiotics	O
.	O

The	O
blood	O
culture	O
remained	O
sterile	O
.	O

He	O
was	O
noted	O
to	O
have	O
an	B-disease
erythematous	I-disease
perianal	I-disease
rash	I-disease
and	O
for	O
this	O
was	O
started	O
on	O
Nystatin	O
powder	O
.	O

The	O
parents	O
were	O
updated	O
throughout	O
the	O
admission	O
and	O
a	O
family	O
meeting	O
was	O
held	O
on	O
2015-06-09	O
.	O

6.	O
Sensory	O
:	O

The	O
patient	O
has	O
not	O
had	O
an	O
CMED	O
examination	O
or	O
hearing	O
test	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

DISPOSITION	O
:	O

To	O
Kindred	O
Hospital	O
Special	O
Care	O
Nursery	O
.	O

NAME	O
OF	O
PEDIATRICIAN	O
:	O

Hale	O
Air	O
Force	O
Base	O
Pediatrics	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
:	O

Feeds	O
at	O
discharge	O
are	O
PE-20	O
currently	O
at	O
120	O
cc	O
per	O
kg	O
per	O
day	O
due	O
to	O
advance	O
15	O
cc	O
per	O
kg	O
per	O
day	O
to	O
a	O
total	O
of	O
150	O
cc	O
per	O
kg	O
per	O
day	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Caffeine	O
12	O
mg	O
pg	O
q	O
day.	O
He	O
has	O
not	O
had	O
his	O
06-10	O
dose	O
.	O

STATE	O
NEWBORN	O
SCREENING	O
STATUS	O
:	O

He	O
is	O
due	O
to	O
have	O
his	O
state	O
screen	O
sent	O
today	O
.	O

IMMUNIZATIONS	O
:	O

Not	O
yet	O
received	O
.	O

Synagis	O
RSV	O
prophylaxis	O
should	O
be	O
considered	O
from	O
October	O
through	O
April	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
criteria	O
:	O

1.	O
Born	O
at	O
less	O
than	O
32	O
weeks	O
.	O

2.	O
Born	O
at	O
32-35	O
weeks	O
with	O
plans	O
for	O
day	O
care	O
during	O
RSV	O
season	O
with	O
a	O
smoker	O
in	O
the	O
household	O
,	O
or	O
with	O
preschool	O
age	O
siblings	O
.	O

3.	O
With	O
chronic	B-disease
lung	I-disease
disease	I-disease
.	O

Influenza	O
vaccination	O
should	O
be	O
considered	O
annually	O
in	O
the	O
fall	O
for	O
preterm	O
infants	O
with	O
chronic	B-disease
lung	I-disease
disease	I-disease
once	O
they	O
reach	O
six	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
,	O
the	O
family	O
and	O
other	O
caregivers	O
should	O
be	O
considered	O
for	O
immunization	O
against	O
influenza	B-disease
to	O
protect	O
the	O
infant	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Prematurity	B-disease
at	O
30-6/7	O
weeks	O
.	O

2.	O
Rule	O
out	O
sepsis	B-disease
,	O
off	O
antibiotics	O
.	O

3.	O
Apnea	B-disease
and	O
bradycardia	B-disease
of	O
prematurity	B-disease
.	O

4.	O
Hyperbilirubinemia	B-disease
.	O

5.	O
Feeding	B-disease
immaturity	I-disease
.	O

Freddy	O
Stephen	O
,	O
M.D.	O

55-454	O

Dictated	O
By:Nathan	O
D.	O
Delgadillo	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O

2015-06-10	O

09:35	O

T	O
:	O

2015-06-10	O

09:51	O

JOB#	O
:	O

53951	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Freddy	O
King	O
on	O
:	O

WED	O
2015-06-10	O
11:54	O
AM	O

(	O
End	O
of	O
Report	O
)	O

614746156	O

CTMC	O

48720920	O

513332	O

7/3/1999	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

07/03/1999	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

EHC9	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
71-year-old	O
police	O
chief	O
who	O
presents	O
with	O
painless	B-disease
jaundice	I-disease
x1	O
day	O
.	O

The	O
patient	O
was	O
generally	O
in	O
excellent	O
health	O
with	O
a	O
past	O
medical	O
history	O
significant	O
only	O
for	O
noninsulin	B-disease
dependent	I-disease
diabetes	I-disease
mellitus	I-disease
who	O
was	O
presented	O
with	O
painless	B-disease
jaundice	I-disease
x2	O
days	O
.	O

He	O
also	O
noted	O
a	B-disease
23	I-disease
pound	I-disease
weight	I-disease
loss	I-disease
in	O
the	O
past	O
11	O
months	O
despite	O
having	O
an	B-disease
increased	I-disease
appetite	I-disease
.	O

The	O
patient	O
also	O
complained	O
of	O
fatigue	B-disease
and	O
&quot;	B-disease
feeling	I-disease
down	I-disease
&quot;	I-disease
.	O

His	O
wife	O
noted	O
personality	B-disease
changes	I-disease
with	O
increased	B-disease
irritability	I-disease
.	O

Patient	O
denies	O
night	B-disease
sweats	I-disease
in	O
the	O
past	O
month	O
.	O

The	O
patient	O
denies	O
melena	B-disease
,	O
hematochezia	B-disease
,	O
nausea	B-disease
,	O
and	O
abdominal	B-disease
pain	I-disease
.	O

The	O
patient	O
states	O
that	O
he	O
is	O
occasionally	B-disease
constipated	I-disease
.	O

Also	O
denies	O
tenesmus	B-disease
.	O

On	O
the	O
day	O
prior	O
to	O
admission	O
,	O
the	O
patient	O
&apos;s	O
family	O
noted	O
that	O
&quot;	O
he	O
looked	O
yellow	B-disease
&quot;	O
and	O
presented	O
to	O
the	O
Lorough	O
Medical	O
Center	O
&apos;s	O
Emergency	O
Department	O
this	O
after	O
noon	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Type	B-disease
II	I-disease
diabetes	I-disease
mellitus	I-disease
diagnosed	O
06/94	O
,	O
well-controlled	O
with	O
last	O
hemoglobin	O
A1C	O
6.2	O

2.	O
Vocal	B-disease
cord	I-disease
polyps	I-disease

3.	O
Question	O
of	O
history	O
of	O
AVN	B-disease
or	O
osseous	B-disease
necrosis	I-disease

4.	O
History	O
of	O
hyperkalemia	B-disease
.	O

Question	O
RTA	B-disease
type	I-disease
4	I-disease

MEDICATIONS	O
:	O

Glucotrol	O
10	O
q.a.m.	O
and	O
vitamins	O

ALLERGIES	O
:	O

The	O
patient	O
is	O
allergic	B-disease
to	O
MSG	O
from	O
which	O
he	O
gets	O
hives	B-disease
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
ethanol	O
use	O
,	O
remote	O
pipe	O
smoking	O
use	O
which	O
he	O
discontinued	O
20	O
years	O
ago	O
,	O
no	O
illicit	O
drug	O
use	O
.	O

FAMILY	O
HISTORY	O
:	O

Noncontributory	O
.	O

The	O
patient	O
&apos;s	O
father	O
died	O
at	O
the	O
age	O
of	O
83	O
of	O
CHF	B-disease
.	O

The	O
patient	O
&apos;s	O
mother	O
is	O
alive	O
at	O
the	O
age	O
of	O
114y	O
.	O

The	O
patient	O
has	O
six	O
children	O
and	O
10	O
grandchildren	O
,	O
all	O
in	O
excellent	O
health	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
presented	O
to	O
the	O
Emergency	O
Department	O
with	O
a	O
complaint	O
of	O
painless	B-disease
jaundice	I-disease
,	O
weight	B-disease
loss	I-disease
,	O
and	O
fatigue	B-disease
.	O

Abdominal	O
CT	O
while	O
in	O
the	O
Emergency	O
Department	O
revealed	O
likely	O
primary	B-disease
colorectal	I-disease
adenocarcinoma	I-disease
with	O
multiple	B-disease
liver	I-disease
metastases	I-disease
.	O

Hematocrit	O
was	O
24	O
in	O
the	O
Emergency	O
Department	O
.	O

The	O
patient	O
received	O
two	O
units	O
of	O
packed	O
red	O
blood	O
cells	O
and	O
the	O
hematocrit	O
rose	O
to	O
30	O
the	O
following	O
day	O
.	O

The	O
patient	O
was	O
seen	O
by	O
both	O
Gastroenterology	O
and	O
Oncology	O
.	O

Biopsy	O
was	O
taken	O
at	O
colonoscopy	O
on	O
7/5/99	O
.	O

Head	O
CT	O
was	O
done	O
with	O
final	O
results	O
pending	O
on	O
discharge	O
.	O

The	O
patient	O
was	O
to	O
follow-up	O
with	O
the	O
Petersly	O
Hospital	O
And	O
Medical	O
Center	O
as	O
an	O
outpatient	O
for	O
further	O
treatment	O
.	O

The	O
patient	O
is	O
discharged	O
to	O
home	O
.	O

His	O
condition	O
is	O
stable	O
and	O
he	O
was	O
discharged	O
with	O
the	O
following	O
medications	O
:	O

Iron	O
300	O
mg	O
p.o.	O
t.i.d.	O
,	O
Glucotrol	O
,	O
Acel	O
10	O
mg	O
p.o.	O
q.d.	O
,	O
and	O
Bactrim	O
SS	O
1	O
tablet	O
p.o.	O
b.i.d.	O

Dicatated	O
By	O
:	O

STEPH	O
ALEA	O
,	O
M.D.	O

Attending	O
:	O

BREANA	O
G.	O
CORNEA	O
,	O
M.D.	O
IS68	O
ON208/5303	O

Batch	O
:	O

31863	O

Index	O
No.	O
MIEQVK9Q4Z	O

D	O
:	O

07/05/99	O

T	O
:	O

07/05/99	O

CC	O
:	O

1.	O
BREANA	O
G.	O
CORNEA	O
,	O
M.D.*	O
CONFORD	O
GHACOLL	O
HEALTHCARE	O

Admission	O
Date	O
:	O

2015-09-16	O

Discharge	O
Date	O
:	O

2015-09-21	O

Date	O
of	O
Birth	O
:	O

1962-09-26	O

Sex	O
:	O

M	O

Service	O
:	O

CARDIOTHOR	O

REASON	O
FOR	O
ADMISSION	O
:	O

Mitral	O
valve	O
repair	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
52	O
year	O
old	O
Czech	O
speaking	O
gentleman	O
with	O
a	O
history	O
of	O
severe	B-disease
mitral	I-disease
regurgitation	I-disease
.	O

For	O
the	O
past	O
several	O
years	O
,	O
the	O
patient	O
has	O
continued	O
to	O
have	O
significant	B-disease
exercise	I-disease
intolerance	I-disease
which	O
has	O
limited	O
his	O
ability	O
to	O
work	O
.	O

He	O
reports	O
severe	B-disease
dyspnea	I-disease
on	O
exertion	O
.	O

The	O
patient	O
had	O
a	O
recent	O
admission	O
earlier	O
in	O
the	O
month	O
and	O
he	O
was	O
discharged	O
on	O
2015-09-10	O
,	O
after	O
undergoing	O
cardiac	O
catheterization	O
.	O

This	O
was	O
significant	O
for	O
demonstrating	O
no	O
flow-limited	B-disease
disease	I-disease
in	I-disease
the	I-disease
coronaries	I-disease
but	O
several	B-disease
fistulae	I-disease

from	O
the	O
left	O
anterior	O
descending	O
to	O
the	O
PA	O
.	O

Several	O
of	O
these	O
were	O
coil	O
embolized	O
during	O
this	O
admission	O
.	O

He	O
tolerated	O
this	O
well	O
,	O
was	O
sent	O
home	O
,	O
and	O
now	O
returns	O
for	O
his	O
mitral	O
valve	O
repair	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Mitral	B-disease
valve	I-disease
regurgitation	I-disease
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

None	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Atenolol	O
25	O
mg	O
p.o.	O
q.	O
day	O
.	O

2.	O
Enteric-coated	O
aspirin	O
325	O
mg	O
p.o.	O
q.	O
day	O
.	O

3.	O
Nitroglycerin	O
sublingual	O
p.r.n.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
currently	O
on	O
Disability	O
and	O
lives	O
at	O
home	O
with	O
his	O
wife	O
.	O

Kimberly	O
was	O
born	O
in	O
Great	O
Britain	O
.	O

He	O
denies	O
any	O
ETOH	O
or	O
tobacco	O
use	O
.	O

FAMILY	O
HISTORY	O
:	O

Negative	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
is	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

Temperature	O
is	O
98.3	O
F.	O
;	O
pulse	O
is	O
76	O
;	O
blood	O
pressure	O
113/52	O
;	O
breathing	O
18	O
;	O
98%	O
on	O
room	O
air	O
.	O

HEENT	O
:	O

The	O
patient	O
is	O
missing	B-disease
many	I-disease
teeth	I-disease
.	O

Oropharynx	O
is	O
clear	O
.	O

There	O
is	O
no	O
cervical	B-disease
lymphadenopathy	I-disease
.	O

Supple	O
neck	O
.	O

Heart	O
is	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	B-disease
III/VI	I-disease
systolic	I-disease
ejection	I-disease
murmur	I-disease
.	O

His	O
lungs	O
are	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

Abdomen	O
is	O
soft	O
and	O
nontender	B-disease
.	O

The	O
patient	O
has	O
no	O
cyanosis	B-disease
,	O
clubbing	B-disease
or	O
edema	B-disease
in	I-disease
extremities	I-disease
.	O

LABORATORY	O
:	O

On	O
admission	O
include	O
a	O
white	O
blood	O
cell	O
count	O
of	O
5.6	O
,	O
hematocrit	O
of	O
32.5	O
,	O
platelets	O
of	O
202	O
.	O

Sodium	O
of	O
140	O
,	O
potassium	O
of	O
3.5	O
,	O
BUN	O
of	O
4	O
,	O
creatinine	O
of	O
0.6	O
,	O
glucose	O
of	O
137	O
.	O

Chest	O
x-ray	O
shows	O
no	O
infiltrate	B-disease
or	O
pneumothorax	B-disease
.	O

Cardiac	O
catheterization	O
demonstrates	O
no	O
significant	B-disease
disease	I-disease
in	I-disease
the	I-disease
coronary	I-disease
arteries	I-disease
.	O

Two	O
branches	O
of	O
an	B-disease
left	I-disease
anterior	I-disease
descending	I-disease
to	I-disease
PA	I-disease
fistula	I-disease
which	O
was	O
successfully	O
coiled	O
.	O

There	O
is	O
a	B-disease
persistent	I-disease
flow	I-disease
through	O
an	O
inferior	O
branch	O
of	O
the	O
left	O
anterior	O
descending	O
to	O
PA	B-disease
fistula	I-disease
and	O
a	O
persistent	O
branch	O
of	O
the	B-disease
circumflex	I-disease
to	I-disease
PA	I-disease
branch	I-disease
fistula	I-disease
which	O
anatomically	O
were	O
not	O
suitable	O
for	O
coil	O
embolization	O
.	O

Ejection	O
fraction	O
was	O
60%	O
.	O

HOSPITAL	O
COURSE	O
:	O

On	O
the	O
day	O
of	O
admission	O
,	O
the	O
patient	O
went	O
to	O
the	O
Operating	O
Room	O
and	O
underwent	O
a	O
minimally	O
invasive	O

mitral	O
valve	O
repair	O
.	O

He	O
tolerated	O
this	O
procedure	O
well	O
.	O

The	O
patient	O
was	O
brought	O
to	O
the	O
cardiothoracic	O
Intensive	O
Care	O
Unit	O
in	O
stable	O
condition	O
on	O
minimal	O
pressor	O
support	O
.	O

He	O
was	O
successfully	O
weaned	O
off	O
this	O
support	O
.	O

The	O
patient	O
was	O
fully	O
weaned	O
from	O
ventilatory	O
support	O
secondary	O
to	O
a	B-disease
persistent	I-disease
acidemia	I-disease
.	O

This	O
was	O
treated	O
with	O
sodium	O
bicarbonate	O
and	O
a	O
Swan-Ganz	O
was	O
placed	O
to	O
provide	O
close	O
hemodynamic	O
monitoring	O
.	O

The	O
patient	O
was	O
found	O
to	O
have	O
stable	O
hemodynamics	O
with	O
appropriate	O
mixed	O
venous	O
saturations	O
in	O
the	O
70%	O
range	O
.	O

The	O
patient	O
was	O
corrected	O
to	O
a	O
normal	O
pH	O
of	O
7.41	O
by	O
the	O
first	O
postoperative	O
night	O
and	O
remained	O
stable	O
.	O

He	O
was	O
then	O
weaned	O
off	O
of	O
ventilatory	O
support	O
and	O
was	O
successfully	O
extubated	O
.	O

The	O
patient	O
did	O
have	O
a	B-disease
slight	I-disease
bit	I-disease
of	I-disease
confusion	I-disease
early	O
in	O
post-extubation	O
course	O
which	O
cleared	O
.	O

This	O
was	O
also	O
compounded	O
by	O
a	O
language	O
barrier	O
since	O
the	O
patient	O
cannot	O
speak	O
English	O
.	O

In	O
addition	O
,	O
the	O
patient	O
's	O
early	O
postoperative	O
course	O
had	O
a	O
tremendous	O
urine	O
output	O
.	O

It	O
was	O
equally	O
up	O
to	O
700	O
cc.	O
an	O
hour	O
and	O
a	O
renal	O
consultation	O
was	O
obtained	O
.	O

He	O
underwent	O
a	O
head	O
CT	O
scan	O
to	O
rule	O
out	O
intracranial	B-disease
pathology	I-disease
leading	O
to	O
diabetes	B-disease
insipidus	I-disease
.	O

This	O
was	O
negative	O
.	O

The	O
patient	O
's	O
serum	O
and	O
urine	O
electrolytes	O
indicated	O
that	O
this	O
diuresis	O
was	O
appropriate	O
.	O

The	O
patient	O
's	O
urine	O
output	O
has	O
decreased	O
and	O
his	O
BUN	O
and	O
creatinine	O
remained	O
normal	O
.	O

The	O
patient	O
's	O
Foley	O
was	O
discontinued	O
.	O

He	O
had	O
developed	O
some	B-disease
hematuria	I-disease
which	O
has	O
resolved	O
.	O

The	O
patient	O
has	O
remained	O
stable	O
and	O
is	O
now	O
ready	O
for	O
discharge	O
to	O
home	O
with	O
follow-up	O
in	O
approximately	O
four	O
weeks	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Mitral	B-disease
regurgitation	I-disease
status	O
post	O
minimally	O
invasive	O
mitral	O
valve	O
repair	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Lopressor	O
75	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

2.	O
Colace	O
100	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

3.	O
Percocet	O
one	O
to	O
two	O
p.o.	O
q.	O
four	O
hours	O
p.r.n.	O

4.	O
Aspirin	O
325	O
mg	O
p.o.	O
q.	O
day	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DIGibsonE	O
INSTRUCTIONS	O
:	O

1.	O
The	O
patient	O
will	O
follow-up	O
with	O
Dr.	O
de	O
las	O
Grau	O
in	O
four	O
weeks	O
.	O

2.	O
He	O
will	O
follow-up	O
with	O
his	O
primary	O
care	O
physician	O
,	O
Dr.	O
Blake	O
,	O
in	O
two	O
weeks	O
.	O

3.	O
The	O
patient	O
will	O
call	O
for	O
any	B-disease
fevers	I-disease
or	O
difficulties	B-disease
with	I-disease
the	I-disease
wound	I-disease
care	I-disease
,	O
and	O
will	O
be	O
instructed	O
with	O
an	O
interpreter	O
present	O
.	O

Bruce	O
lou	O
Murphy	O
,	O
M.D.	O

07-760	O

Dictated	O
By	O
:	O
Ellen	O
V	O
Wise	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2015-09-21	O
08:34	O

T	O
:	O
2015-09-26	O
15:44	O

JO	O
B#:	O

18430	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Mary	O
van	O
den	O
Mosley	O
on	O
:	O
WED	O
2015-10-14	O
7:16	O
PM	O

(	O
End	O
of	O
Report	O
)	O

